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ABSTRACT 
 
BACKGROUND 
Generally hypothesized hemodynamic forces and procedures (surgical and 
stenting) leading to arteriosclerosis and in-stent restenosis still remain 
entirely unclear.  More so, it is difficult to identify and differentiate which of 
the procedural injury and/or changes in the local hemodynamic forces due to 
stent presence influence the onset of undesired clinical events. This difficulty 
in identifying the main factors leading to in-stent restenosis is compounded 
as procedural injury and change in hemodynamic stresses usually co-exist 
in-vivo. To simplify the complexity in identifying the predictors of in-stent 
restenosis, this thesis focused on the effects of local hemodynamic forces 
within stented artery on endothelial cells that could lead to in-stent 
restenosis.   
Endothelial cells (ECs) play a critical element in the maintenance of healthy 
artery. Experimental studies of endothelial structure and function have 
presented evidence that physiological hemodynamic forces promote ECs 
elongation and atheroprotective endothelial phenotype whilst unphysiological 
hemodynamic forces promote atheroprone and polygonal shaped 
endothelial. Based on the above stated evidence, an experimental stent-cells 
interaction flow bio-reactor system was developed. This system is capable of 
subjecting ECs cultured in vitro to similar hemodynamic forces present within 
stented arteries in vivo. Computational models have been developed and 
used as complementary tool in the quantitative analysis of the mechanical 
forces being applied to the cultured cells. The computational models were 
validated to guarantee accuracy of computational results.  
METHODS AND RESULTS 
Human umbilical vein endothelial cells (HUVECs) were subjected to steady 
and realistic physiological left anterior descending artery (LAD) flow 
waveforms at hydrostatic pressures of 120/80 mmHg and 100 mmHg 
respectively at timescales of 6, 12 and 24 hours within the stent-cell 
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interaction model. The morphology of cells after exposure to the flow 
conditions where quantified by using a commercial computational image 
processing programme built on a MATLAB platform. The cells were also 
labelled for nuclear factor – kappaB (NFkB), a key regulator of inflammatory 
response [375, 425] and intercellular adhesion molecule (ICAM-1) after being 
stimulated with 200 U/ml of tumour necrosis factor-alpha (TNF-α) or exposed 
to the above stipulated flow and pressure conditions.   
Cultured HUVECs located anterior and proximal to the stented region of the 
stent-cell interaction model were observed to elongate and align more to the 
impinged flow direction with increasing time. These regions where marked by 
uniform wall shear stress (WSSs), spatial wall shear stress gradient 
(SWSSGs) and negligible oscillatory shear index (OSIs). This observation is 
consistent with investigations of the morphological changes of endothelial 
cells subjected to stresses in vivo and in vitro from other researchers [59, 
87]. Cells within the stented region however did not show strong alignment to 
the fluid flow direction. These regions were marked by non-uniform WSSs, 
SWSSGs and very high OSIs (0.35 – 0.45). Also HUVECs within the stented 
region were more polygonal shaped. It was also observed that in the 
absence of fluid stress, hydrostatic pressure stimulated cell proliferation, 
elongation, random alignment and a formation of cell multi layering structure. 
The phenomenon of cell multi layering is however absent when there is 
presence of fluid shear stress. HUVECs stimulated with TNF-α for 1 hour 
showed very high NF-kB expression whilst those cells exposed to the 
stipulated combined stress and pressure conditions for the same duration did 
not show NF-kB expression. Increased levels of ICAM-1 were observed 
when cells were stimulated with TNF-α for 6, 12 and 24 hours. However cells 
exposed to stipulated fluid stress and pressure conditions exhibited a time-
dependent selective expression of ICAM-1.    
CONCLUSION 
It is concluded from results of the experiments performed that different types 
of combined and/or individual stresses have distinctive effects on HUVECs 
morphological response and the genes that may be expressed by the cells.  
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INTRODUCTION AND OVERVIEW 
 
1.1 CORONARY ARTERY DISEASE:  IN – STENT RESTENOSIS 
 
Coronary artery disease (CAD) is the leading cause of death related to 
cardiovascular diseases worldwide [1-3]. The onset of this disease is initiated 
by the intimal thickening which reduces the arterial lumen size and possibly 
distal blood flow. This can cause tissue death downstream of the occluded 
artery as there is inadequate perfusion and ischemia due to reduced flow.  
It has been well documented that stent implantation in occluded coronary 
arteries improve resting coronary blood flow [4, 5]. However, the influence of 
stent geometry on local fluid dynamics and hemodynamic forces within the 
stented artery could lead to undesirable clinical events such as restenosis 
and in-stent restenosis (ISR) [6, 7]. Some researchers have shed light on 
how these local flow dynamics characterised by low WSS, high OSI and high 
SWSSG could be conducive to the continuous dysfunction of the 
endothelium and ISR progression [8-14].  Unfortunately clinical investigations 
into the changes of cells signalling cascade due to unphysiological 
mechanical force present at the stented site has not been firmly and fully 
established hence the pathophysiology of ISR still remains complex. 
Additionally, some clinical studies have postulated differences in risk factors 
associated with restenosis and those of native CADs. So, although there 
may be many similarities in the formation of restenosis and other CADs, 
each disease’s pathophysiology could be very distinct. Indeed, the 
pathophysiology of atherosclerosis involves lipid accumulation, inflammation  
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and smooth muscle cell proliferation that carries on for many years whilst 
restenosis is primarily a self-limited intimal hyperplasic process that results 
from damage to the integrity of the arterial wall by endovascular devices [14, 
15].  Hence, some mechanical stimuli such as WSSs may not necessarily 
play similar a role in the progression of ISR as have been associated with 
plaque formation in atherosclerosis [16, 17]. Mechanisms for ISR 
progression should therefore be independently evaluated for its contribution 
to the disease state.  
Computational studies have provided an alternate method in understanding 
and quantifying the hemodynamic forces which the cells are being predicted 
to experience. It has been hypothesized that WSS alters the functional 
properties and morphology of the cells which result in the activation of 
restenosis mechanisms [18, 19]. Whilst this assumption might not be totally 
flawed, it is difficult to make meaningful correlation between computational 
and experimental analyses of cells response to stresses and flow dynamics 
that influence the onset/progression of ISR. More so, computational analyses 
of the impact of local flow dynamics within stented arteries on arterial cells 
are built on several assumptions and fixed mathematical parameters. 
Computational limitations such as simplified simulation of complex stented 
artery geometry could also influence the ability to retrieve comprehensive 
data about the hemodynamic forces present in vivo. These factors therefore 
introduce a level of inaccuracy in the exact representation of flow dynamics 
and mechanical environment within a stented artery.  
There is therefore a need to establish a method that could relate 
computational data and experimental data to understand the sequential 
process and independent factors of cells response that initiate restenosis. 
The aim of my PhD project is therefore to address this need. To achieve this 
target, the project followed consecutively the below proposed plan: 
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1. Establishing computational model of a 2D cell-stent interaction design. 
2. Fabricating an experimental model of the 2D cell-stent interaction 
design. 
3. Analysing the effect of predicted mechanical forces on cellular 
response.  
 
1.2     FORMULATION OF HYPOTHESIS AND BASIS OF PROPOSED 
STUDIES 
 
1.2.1     COMPUTATIONAL MODELLING 
 
Hemodynamic forces experienced within the cardiovascular system could be 
analytically modelled and/or quantified by computational fluid dynamics 
(CFD) modelling. This could be achieved essentially by simplifying real 
events and physical parameters of the cardiovascular system into 
physiologically relevant and simple enough simulation models whilst taking 
into consideration the limitations of each analysis package. Some common 
limitations encountered with the use of either analytical models or CFD 
models are computational power and tools, measurement methods and 
mathematical parameters which could hinder in retrieving of detailed and 
accurate information. Thus to ensure true results of the mechanical 
environment present within the cardiovascular system from either analytical 
or CFD modelling, each model ideally needs to be validated against 
experimental data [20-22].  Blood flow dynamics within the cardiovascular 
system is complex as flow at each cardiac cycle is unique; both between 
different parts of the cardiovascular system as well as during time within 
each specific part. It is therefore important to note that the use of analytical 
models which could be an adequate tool to determine some mechanical 
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forces such as shear stresses experienced on arterial cells with simple flows 
could not be that adequate to provide accurate results for complex flows. For 
example early studies investigating mean WSS being subjected to vascular 
cells were calculated analytically using the Hagen-Poiseuille equation as 
shown below: 
 𝜏𝑚𝑒𝑎𝑛  =  
4𝜇𝑄
𝜋𝑅3
  1.1 
where µ is the dynamic viscosity of blood, R is the radius of the vascular 
lumen and Q is the total volume flow rate. The assumptions used in this 
calculation are as follows: 
 The vascular lumen is of exactly circular geometry 
 Blood flow velocity profiles are axisymmetric and perfectly parabolic in 
both time and space 
 Flow is laminar (Reynolds number; Re < 1000) 
This method therefore obviates the need for CFD modelling especially if the 
physical system being analysed agrees with the assumptions made. 
However, healthy arterial lumen which may be considered nearly circular 
might necessarily not have axisymmetric blood velocity profiles due to 
complex geometry of the vascular vessel. Also, stenosed arteries do not 
have circular lumen which makes application of this method to a diseased 
artery not justifiable.  Additionally, this analytical calculation does not capture 
SWSSG and TWSSG which may be experienced on the arterial cells. So, to 
accurately evaluate the mechanical environment of either a healthy or 
diseased artery and especially when considering physiologically realistic flow 
profiles and factors, CFD modelling may be required.   
There have been several studies on the successful application of CFD 
simulations in evaluating the mechanical forces being subjected to arterial 
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endothelial cells (ECs). For example, Chaichana et al. [23] employed CFD 
simulations to model plaques in a left anterior descending (LAD) coronary 
artery generated from a patient’s data and investigated the hemodynamic 
effect of the stimulated plaques under realistic physiological cardiac 
conditions. Results from the CFD analysis of this study showed low flow 
velocity post-plaque region and high pressure gradient at the stenotic region 
in the LAD as compared to the LAD without plaques. It was consequently 
suggested that there is a direct parallel between coronary plaques and 
hemodynamic changes. The study by White et al. [24] is also another 
example where CFD analysis was successfully applied to flow systems used 
to subject ECs to mechanical stimuli. In this study, the effect of TWSSG and 
SWSSG on ECs under sudden or ramped onset of flow in a modified parallel 
plate flow chamber was investigated. The modified parallel plate flow 
chamber had a backward facing step which would simulate spatial patterns 
of fluid flow separation, re-attachment and recirculation. CFD results 
revealed locations of the reattachment points and the highest TWSSG within 
the modified parallel flow chamber to the different flow conditions. Cells 
responses were thereby able to be mapped to the fluid dynamics and 
mechanical forces present. 
In establishing an accurate computational model for the proposed study, it is 
considered imperative to determine the most appropriate rheological blood 
model to use especially if results are to be physiologically representative of 
occurrences in vivo. This is because there are some disparities in the 
analysis of blood flow phenomena and mechanical forces in some studies as 
these studies have used different blood rheological models. Hence, 
assessing the impact of blood flow fields and dynamics has varied. There 
have been many investigations, both theoretical and experimental studies 
which have led to the understanding of blood behaviour in stented and non-
stented coronary arteries [25-30].  
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Many computational studies in simulating blood flow in arteries have 
assumed blood to be Newtonian [31-34]. However, it is known that the 
rheology of blood is non-Newtonian. Bearing in mind the geometrical 
complexity of the human coronary artery, results achieved from assuming 
blood to be Newtonian to determine predictors of CADs could differ greatly 
from that achieved from a non-Newtonian simulations. Some studies argue in 
favour of using non-Newtonian models in analysing blood dynamics, albeit 
the assumption of blood flow in coronary artery as a Newtonian fluid could be 
a good approximation of blood characteristic [35-37].  
Soulis et al. [35] in an investigation into non-Newtonian models for molecular 
viscosity and WSS in the left coronary artery reported that for non-Newtonian 
blood behaviour, viscosity depended on the velocity gradient and varied 
depending on the flow conditions, the geometry of the artery and flow 
particulates. Hence there are many non-Newtonian viscosity models, the 
choice of the model of which could have noticeable quantitative and 
qualitative effects on the flow fields and shear stresses given the distinct 
geometry of the artery and parameters of each model. However, a standard 
non-Newtonian rheological model is not available to describe the exact 
behaviour of blood under all circumstances. So it is important to consider 
each investigation of blood flow and dynamics in the coronary artery 
individually. It is therefore important to choose the appropriate non-
Newtonian model to achieve acceptable results in the analysis of the effect of 
blood dynamics in the artery. Benard et al. [29] analysed the effect various 
blood rheological models on changes in intra-stent flow. In the study, it was 
reported that steady flow simulations of Newtonian model and non- 
Newtonian model based on Carreau-Yasuda in a 3.5mm diameter straight 
coronary artery with Helistent© implantation and subjected to flow rates of 
60mL/min and 140mL/min showed different WSS magnitudes. The WSSs 
achieved with the Newtonian model were under-estimated when compared 
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to the non-Newtonian model. However, a characteristic viscosity Newtonian 
model showed similar WSS magnitudes and distributions when compared to 
the non-Newtonian model. From this study, it was deduced that the use of 
characteristic viscosity Newtonian model could be a useful option in 
appropriately capturing the physics of a region of interest of which the use of 
a Newtonian model wouldn’t be ideal.    
Based on the above discussions, it is clear that the application of CFD 
simulations has been very useful in optimising and reproducing more realistic 
representation of the mechanical environment within physiological parts. It 
has also been useful in extending the range of quantifiable mechanical 
forces within cell culture fluidic flow systems; thus improving our 
understanding of cell mechanobiology.    
 
1.2.2     EXPERIMENTAL MODEL 
 
The damage to the integrity of endothelial monolayer during and after 
endovascular procedures has been proposed by studies as the initiator of 
some mechanisms that promotes restenosis and ISR [38-40]. As a result, 
there has been an active resurgence of studies into the technical and 
mechanical factors that could contribute to these adverse clinical events. For 
example, Briguori et al. [41] investigated the impact of stent strut thickness in 
relation to the rate of restenosis of nonrandomised group of patients with 
successful stent placement. Results achieved from the investigation led to 
the conclusion that thinner stent struts reduced the rate of restenosis. This 
result tend to agree with experimental findings which suggested that stent 
strut thickness could affect strut tissue coverage and therefore could lead to 
a delay in endothelialisation [42]. Jimenez et al. [43] and Mejia et al. [30] 
concluded from their studies on the effects of stent strut designs on 
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hemodynamic performance that stent strut designs did play a major role on 
influencing either a positive or negative hemodynamic performance within 
the stented artery.  Both studies also investigated into non-streamlined and 
streamlined struts and suggested that streamlined stent struts prevented 
blood flow conditions and hemodynamic forces that were conducive to 
initiate mechanisms that led to restenosis.  Mejia et al. [30] reported from 
their studies that more streamlined stent struts such as tear-drop shaped 
struts showed better hemodynamic performance than square or circular 
shaped struts. Hence, for tear-drop shaped struts, 96% of the inter-strut 
regions were exposed to favourable flow and hemodynamic conditions which 
prevented restenosis and for square shaped struts only 19.4%.  The 
significant progresses made within this research field have led to the 
optimisation of stents and stent designs as well as proposals of better and 
efficient methods of stent implantation. 
Comprehensive animal and human studies into restenosis and ISR have also 
helped to affirm mechanisms postulated to initiate these CADs. Karas et al. 
[44] and Farb et al. [45] linked arterial injury to neointimal thickness (NI) in 
stented coronary artery of a porcine and human respectively. Clinical 
investigations into the role of hemodynamic forces to the formation of NI 
hyperplasia in stented human coronary artery by Wentzel et al. [46] revealed 
the important interrelation that existed between them. It is crucial to note that 
these studies carried out have provided a more informed perspective into 
understanding the occurrence of the disease and its complexities. 
Nonetheless, running of these studies are expensive and so in vitro models 
have provided a much cheaper alternative to analyse predictors of CADs.   
The design of cell culture flow systems to subject cells to predicted 
mechanical stimuli has facilitated the understanding of the effects of 
hemodynamic forces to ECs. Bio-reactor flow systems capable of producing 
either physiological or non-physiological flow profiles onto cultured 
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monolayer of ECs on a microscopic glass slide within a parallel plate flow 
chamber (PPFC) or modified PPFC have been used to elucidate the 
independent and combined effects of varied stresses on ECs [24, 47-52]. 
Breen et al. [52] designed a flow bio-reactor system capable of applying 
WSS and tensile strain of physiological proportions concomitantly to ECs 
monolayers. Evidence in the studies demonstrated that whilst investigation of 
ECs response to isolated forces in vitro could provide valuable information; 
the effect of combined mechanical forces on ECs in vitro could provide more 
accurate information of cellular response similar to in vivo conditions. Also an 
important revelation from this literature was that it was critical that the bio-
reactor developed was biocompatible, non-cytotoxic, and appropriate for the 
cellular mechanical loading desired and for the duration needed in order to 
achieve accurate data.   
Therefore, in designing an experimental model able to provide the 
mechanical environment realistic to that of a stented artery in vivo; it is clear 
that the bio-reactor flow system used be able to meet the above stipulated 
conditions.  Also from the referenced literature on the application of bio-
reactors to study ECs response to fluid dynamics [24, 47-52], it is apparent 
that ECs cultured on microscopic glass slide is adequate enough to 
represent the structural ECs lining of the artery in vivo. However, the analysis 
of the response of ECs cultured on microscopic glass slide substrate to 
simulated arterial fluid flow could be comparable to that within an artery, if 
arterial wall is assumed rigid. As the focus of this project is to investigate into 
ECs response to fluid dynamic within stented artery, the assumption that 
artery is rigid is justified as diseased artery is marked by calcified lesions 
resulting in reduced or zero arterial compliance [4, 53]. Also the presence of 
stent in artery may reduce flexibility of artery [54]. So, in establishing our 
simple cell-stent experimental model it is proposed that a microscopic glass 
slide be used. However, since our investigation is to mimic the fluid dynamic 
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within a stented artery, the glass slide would be modified to represent a 2D 
local geometry of a stented artery. This is achieved by using two photon 
polymerisation (TPP) technique to fabricate stent like polymer microstructure 
features on the microscopic glass slide.  
TPP is a powerful microfabrication tool which has proved very useful in 
tissue engineering and biomedical engineering applications. Gittard et al. [55] 
in a review discussed how some researchers have used TPP technology to 
fabricate 3D microstructured medical devices, prostheses and scaffolds for 
tissue engineering. Koskela et al. [56] investigated into the biomedical 
applications of TPP by polymerising PEGda and poly(𝜀-caprolactone)-based 
oligomer (PCL-o) to create arbitrary microstructures on glass slide and 
studied the cell attachment, viability and migration on these structures. 
Human embryonic stem cells (hESCs) were static cultured on the two 
different polymer microstructures and results achieved showed the hESCs to 
have attached on the surface of both polymer microstructures. The cells 
were verified as viable and non-cytotoxicity of both polymers with the hESCs 
was also reported. However, the polymers did not promote cell migration. 
These two different polymer fabricated microstructures were therefore 
concluded to have potential for cell-based applications.  
Employing the TPP technology as part of the process in designing the cell-
stent interaction model is therefore thought to be suitable as bespoke 
biocompatible microstructures could be fabricated with micron accuracy for 
the cell-based application model. However microstructures fabricated using 
TPP may be unsuitable for direct fluid stress experimentation for numerous 
reasons that soft lithography method can address. For example, it is 
reasoned that the leaching out of uncured polymer process after the 
fabrication of microstructures via TPP could cause the fabricated structures 
to weaken. Thus the leached out structures may easily deform during the 
fluid flow experiment. To overcome this problem, soft lithography technique 
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was added to the design fabrication process. Soft lithography allows for 
microstructures fabricated via TPP to be replicated and also reinforces the 
structural strength of features fabricated. Hence, it is suggested that 
fabricating the stent like microstructure features on the microscopic glass 
slide via TPP and soft lithography would prevent significant deformation of 
the structures during flow experimentation which consequently could 
influence result analysis. The fabrication of stent like features on the glass 
slide is thought to simulate the local geometric change of artery as a result of 
stent implantation. Furthermore, flow conditions observed within the stented 
artery such as flow separation, flow recirculation and disturbed shear 
stresses are also believed to be captured when flow is simulated over the 
micro-fabricated stent like features. Therefore the microfabrication of the 
stent like features on the microscopic glass slide would create the 
mechanical milieu assumed to be present within stented artery.  
Correlating the two studies discussed above, it is hypothesized that the 
presence of stent within artery creates unphysiological mechanical stimuli 
which may influence cells response leading to activation of ISR. 
 
1.2.3     HYPOTHESIS 
 
It is hypothesized that local mechanical forces such as WSS, T/SWSSG and 
OSI present due to stent implantation into artery could influence the 
morphology and molecular response of ECs which could initiate ISR.  
To test this hypothesis, a computational model of a simple semi-circular 
helical stent was developed. This is discussed in chapter 4. This model 
would serve as a foundation to establish a cell-stent interaction model to 
study cells response under the determined flow dynamics. Chapters 6 
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discusses into details the mechanical forces present within the cell-stent 
interaction model. Correlating the computational model analyses to 
experimental cell-stent interaction studies which are discussed in Chapters 7 
and 8 provide an understanding to how cells respond to the flow dynamics. 
This analytical study is also indicative of the local mechanical conditions 
within the stented artery that might/might not influence the activation of ISR.   
The aim and objectives to address the proposed hypothesis are discussed 
below. 
 
1.3        AIM AND OBJECTIVES 
 
The aim is to quantitatively analyse the influence of mechanical forces on 
ECs within a stented artery and determine what mechanical forces, if any, 
correlate most strongly with the development of ISR. Particular emphasis of 
this study would be on the effect of the mechanical parameters at 
physiologically relevant levels on ECs.    
 
To achieve the stated aim, the following main objectives are addressed:   
 Use CFD to establish the most appropriate rheological blood model to 
use in the cell-stent experimental model. 
 Develop computational simulation of a simple cell-stent experimental 
model to predict WSS, T/SWSSG and OSI within the model. 
 Design a flow bio-reactor system to apply the predicted mechanical 
forces at physiologically relevant parameters on ECs.  
 Quantitatively analyse the images of ECs and determine their 
morphological changes in response to the mechanical forces 
experienced.  
 Label ECs for inflammatory and adhesion molecules to determine 
 13 
 
  CHAPTER 1 INTRODUCTION AND OVERVIEW 
 
cellular response of the cells to the predicted stimuli.    
 
1.4        RESEARCH OUTLINE 
 
Figure 1 shows a workflow diagram with the set objectives to achieve the 
given aim of project. 
 
     
Figure 1. Diagram showing workflow of objectives to achieve aim 
120/80 mmHg 
mmHg 
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CHAPTER  2 
 
BACKGROUND 
 
2.1        CORONARY ARTERY 
 
Coronary arteries are vessels that carry and supply oxygen rich blood to the 
heart muscle.  As the heart is a very important organ in the body, it is 
necessary to ensure that the heart is always healthy. In that, blood vessels 
that supply nutrients to the cardiac muscles to enable the heart work must 
also be healthy. The heart has two main coronary arteries namely [57]: 
 Right coronary artery (RCA): This artery supplies oxygenated blood to 
the right atrium and also to the walls of the ventricles. 
 Left main artery (LM): This artery distributes oxygenated blood to the 
left anterior descending and the left circumflex. The LM is bigger than 
RCA in diameter. 
Each of these main arteries also then branches into daughter arteries; thus 
the right coronary artery branches into the posterior descending artery and 
the left coronary artery also branches into the left anterior descending (LAD) 
and the left circumflex (LCx).  Figure 2.1 shows an illustration of these 
arteries. The daughter arteries all supply oxygenated blood to specific parts 
of the heart. Blood flow at the cardiac flow phases (systole and diastole) 
within the different vessels of the coronary artery are however distinct [58]. 
For instance, the extravascular compression of the myocardial vessels in the 
left ventricle where intra-ventricular pressure is at its highest causes flow in 
the LAD to fall to zero or even sub-zero during the systolic phase. In the RCA 
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however, intra-ventricular pressure is low during systole phase and so blood 
flow in the RCA is not heavily influenced as compared to that of the LAD. 
During the diastolic phase, the LAD becomes patent which causes an initial 
heavy inflow of blood and subsequently flow under aortic pressure. The 
blood flow in the LAD is therefore characterised by negative and positive flow 
in the systole and diastole phase respectively whereas in RCA there is 
positive blood flow at both systole and diastole phase.       
 
 
 
 
 
Figure 2.1  Anatomical illustration of the distribution of coronary arteries [55]. 
Left coronary artery 
Left circumflex artery 
Left anterior 
descending artery 
Right coronary artery 
Posterior descending 
artery 
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2.1.1     ARTERIAL WALL ANATOMY  
 
Arteries are built of three distinctive wall layers: 
 Tunica Intima: This layer is composed of three components; a simple 
squamous epithelium called endothelium, a basement membrane and 
an internal elastic lamina. The tunica intima rests on a tissue 
membrane rich in elastic and collagenous fibre. It also serves as an 
antithrombotic surface.  
 Tunica Media: This layer consists of mostly smooth muscles fibres 
which encloses the tunica intima and an external elastic lamina. The 
elastic lamina helps the artery to expand and recoil during the 
expansion and contraction of the heart in circulating blood into the 
arterial system. The vasoconstriction and vasodilation of the smooth 
muscle fibres help to regulate the blood pressure. 
 Tunica Externa: This layer is relatively thin as compared to the other 
two layers and has connective tissue made up of irregularly arranged 
elastic and collagenous fibres. The tunica externa provides tensile 
strength to the artery. 
These distinctive arterial wall layers are illustrated in Figure 2.2. 
Arteries are constantly being subjected to mechanical stresses as a result of 
continuous flow of blood through them as shown in Figure 2.3. Some of the 
mechanical stresses which may be experienced in arteries are the hoop 
stresses and compressive stresses which are as a result of the pressure of 
blood flow. The endothelium also experiences a direct impact of shear 
stresses which is caused by the friction of blood flow on the endothelial 
surface. These and other stresses in arteries are important stimuli that 
influence atherogenesis by regulating the functions of ECs, activities of the 
smooth muscle cells and the interaction of ECs with blood components.   
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Figure 2.2  Anatomy of arterial wall layers 
 
 
 
Figure 2.3  Diagram of stresses experienced on arterial wall 
Tunica Externa 
Tunica Media 
Tunica Intima 
Endothelium 
Radial Stress 
Hoop Stress 
Blood Pressure 
Fluid Shear 
Stress 
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Additionally, there is evidence that mechanical forces associated with blood 
flow in the artery play a vital role in the acute control of the vascular tone and 
the regulation of the arterial architecture [59-61]. A review article by Epstein 
et al. [62] reported a direct correlation between arterial remodelling and 
arterial stress. For example, there is an increase in width of arterial wall to 
width of artery lumen ratio when there is an elevation in arterial stress. 
Therefore increase in local blood flow in the artery is associated with arterial 
lumen diameter increase, whereas decrease in flow results to a decreased 
lumen diameter. Kohler et al. [63] investigated the effect of increased blood 
flow on neointimal thickening of endothelialised polytetrafluoroethylene grafts 
in male baboons. Results from the studies showed a significant decrease in 
the cross-sectional area of neointimal thickness with increase of blood flow 
and stress (arterial lumen increase), whereas decrease or complete 
cessation of blood flow resulted in a rapid elevation of neointimal thickness 
(arterial lumen decrease).   
Although the biological process of arterial remodelling may involve the 
cellular activities of many different cells in the artery, it is suggested that the 
endothelium plays a prominent role [62]. In that, the endothelium which 
ideally lines the interior surface of the artery is constantly being subjected to 
direct impact of mechanical forces and humoral factors. The endothelium 
therefore serves as sensory cells which transduces mechanical and humoral 
stimuli and elicit biological responses which consequently may affect the 
arterial structure.  
In the next section of this chapter, an overview to the cause and treatment of 
coronary artery disease are discussed. Additionally, this section would 
discuss the role of endothelium dysfunction to mediate the initiation and or 
progression of coronary artery disease.   
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2.2        CORONARY ARTERY DISEASE 
 
Coronary artery disease (CAD) is the hardening and thickening of the walls 
of arteries that supply blood to the myocardium; hence obstructing adequate 
perfusion throughout the blood vessels. This is caused by the build-up of 
fatty substances, calcium and cholesterol-containing deposits (plaques). 
Whilst the exact cause of this disease still remains unknown there are 
various factors which have been attributed to aid the progression of the 
disease such as smoking, high blood pressure, diabetes, obesity and high 
cholesterol.  
Symptoms of coronary artery disease are not always obvious as some may 
go unnoticed and only become apparent after an episode of a heart attack. 
However, some associated symptoms of CAD are angina, palpitations and 
irregular heartbeat. 
CAD is the most common cause of death in developed countries such as the 
UK and USA. Clinical review reports on CAD by the National Health Service 
(NHS) in the UK showed that about one in five men and one in seven women 
die from this disease [1]. The 2010 statistical update on CAD in the USA also 
showed that CAD was the main cause of death in one is six people [2]. 
Despite these disturbing statistics, it has been reported that there has been a 
recent decline in CAD mortality in developed countries whilst in the 
developing world both CAD mortality and the prevalence of CAD risk factors 
are on the sharp increase [3]. The decline of CAD mortality in developed 
countries is thought to be attributable to the identification of CAD risk factors 
which have led to better treatments for CAD patients and successful 
preventive efforts [64]. Over the past years, CAD mortality in the US has 
declined by 60% [65]. A study to show CAD mortality rates in developing 
countries estimated that mortality rate of CAD in developing countries would  
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double from 1990 to 2020 accounting for approximately 82% of death 
relating to CAD worldwide [3]. The increase in CAD mortality in developing 
countries is thought to be attributable to the urbanisation and “globalisation of 
dietary habits” – thus the culture of fast-food in the developing countries [66-
68]. For instance in some developing countries, increased tobacco use is 
associated with urbanisation and hence such lifestyle is adopted by the 
people living in these countries. Unfortunately smoking tobacco increases 
the risk of developing atheromatous plaques in the coronary artery which 
contributes to the progression of CAD. In 2003, a survey conducted on 
tobacco use in India showed that 30% of the Indian population between the 
ages of 15 years and over either smoked or chewed tobacco [69]. A study 
found CAD prevalence in the urban parts of India to have risen from 1% in 
1988 to 13.2% in the year 2007 [70]. 
 
2.3        CAUSES OF CAD 
 
Dawber et al. [71] indicated that the underlying cause for CAD was 
atherosclerosis. Atherosclerosis could lead to myocardial infarction (MI) or 
acute myocardial infarction (AMI). These can cause total blockage of blood 
flow through the coronary artery causing the heart cells to die. As discussed 
in a review by Aboyans et al. [72], atherosclerosis occurs mostly in large 
arteries. However, it was acknowledged that there was a wide disparity in 
what constituted a large and/or a small artery in relation other types of 
arteries being compared. Hence definition of a small or a large artery was 
based on the site where the atherosclerosis was present; thus proximal 
atherosclerosis occurred in large arteries and distal atherosclerosis occurred 
in small arteries. Atherosclerotic lesions could also be classified based on 
their severity. A report by Stary et al. [73] characterised the lesions into four 
main types based on their morphological features. The first two (type I and 
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type II) found mostly in children although could occur in adults.  
 The initial stage of the lesion development is known as type I. Lesions 
at this stage are marked by small amounts of lipids in the arterial 
intima.  
 The type II lesions consist mainly of macrophages foam cells and 
more distinctively defined.        
Atherosclerotic lesions could be termed type III when smooth muscle cells 
(SMCs) start to colocalize in the intima. At this point also, there is a 
significant presence of extracellular lipid droplets observed at lesion site and 
lesions tend to produce extracellular matrix [74]. This is the last stage of 
when the lesion is considered clinically silent (thus type I to type III) and 
before classed as an advanced lesions.   
Further development of the lesion and continuous stimulation of SMCs 
proliferation and migration into the intima by chemoattractant factors 
eventually lead to fibrous cap forming on top of the lesion [75]. This stage of 
the lesion is classified as type IV. The advanced stage of the lesion is further 
categorised into sub-types with each type indicating the developmental stage 
of the fibrous cap, its clinical manifestations and fatal outcomes [73].          
 
2.3.1     ASSOCIATION OF ARTERY MORPHOLOGY WITH 
ATHEROSCLEROSIS 
 
Studies have shown that atherosclerosis is more prone in arterial regions 
which are curved and bifurcated [8, 76, 77]. It has been suggested that these 
geometrical complexities of the artery could lead to complex flow field which 
possibly changes the haemodynamic conditions of the artery and hence 
influence the pathogenesis of atherosclerosis [78]. Dvir et al. [79] in a study 
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investigating the relationship between RCA morphology with atherosclerosis 
reported that C-shaped RCA was associated with atherosclerosis whilst the 
sigma-shaped RCA was not. In the study, the coronary angiogram of 120 
patients with RCA dominance was examined. Out of the 120 patients, 60 of 
them had no significant obstruction in the RCA whilst the other 60 patients 
had significant obstruction in the RCA. In the examination, it was reported 
that C-shaped RCA was shorter in length (115 ± 23 mm) compared to the 
sigma-shaped RCA (140 ± 31 mm). More so, there was significantly more 
atherosclerosis in the proximal region of the C-shaped RCA compared to the 
sigma-shaped RCA. 
These findings tended to agree with Dvir’s previous studies which made 
strong relation between short RCA and atherosclerosis [80]. In the previous 
studies by Dvir et al. [80] it was suggested that short RCA had a higher 
possibility of having fibrous plaque; hence higher susceptibility to 
atherosclerosis. Conversely in a long RCA, pressure decreases 
proportionally to the length of the RCA and therefore the longer the RCA the 
more the RCA is able to absorb cardiac cycle pulsations which could change 
the haemodynamic conditions in the artery and influence the onset of 
atherosclerosis.  
Several autopsy and angiography studies have reported proximal 
atherosclerosis to be more dominant in the coronary arteries [81-85], 
especially in the LAD and LCx arteries [86] as compared to distal 
atherosclerosis. Strong et al. [87] also attested strongly to these reports that 
stated LAD and LCx to be more disposed to atherosclerosis as it was 
reported that these arteries had more proximal branches which are described 
as predilection sites of atherosclerosis lesion formation. Gazetopoulos et al. 
[88] examined the association of the length of LM artery and the degree of 
atherosclerosis formation in 204 dead patients. In the investigation it was 
found that atherosclerotic lesions in LAD and LCx arteries with short LM  
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occurred quicker and progressed rapidly as compared to atherosclerotic 
lesions in LAD and LCx arteries with long LM. It was therefore suggested 
that the long LM artery may employ some protective mechanism against the 
development of atherosclerosis in its branches. 
 
2.3.2     ASSOCIATION OF MECHANICAL FACTORS WITH 
ATHEROSCLEROSIS 
 
As briefly discussed in section 2.1.1, ECs are known to play an important 
role in the homeostatic functions in response to several chemical and 
mechanical stimuli due to blood flow and blood pressure [89-91]. Hence 
normal functions of the ECs are essential and dysfunction of the cells plays a 
significant role in the occurrence and progression of the arterial disease. 
Many studies have reported that local mechanical and haemodynamic 
factors may be significant to the progression of atherosclerosis [92-94]. More 
so, WSSs in particular have been often linked to influence the development 
and localisation of the atherosclerotic plaque [16, 95, 96]. This principle is 
supported by the reasoning that WSS is proportional to the gradient of the 
flowing blood velocity particularly of a laminar flow in a regular sized artery.   
Hence WSS closely represents the local blood flow and could be considered 
as the most probable stimulus to cause ECs to respond to changes in blood 
flow rate. Experimental studies on the effect of WSSs on endothelial function 
revealed that WSSs above 4Pa cause the endothelium surface to be 
irreversibly damaged [97]. Additionally, the rapid flow change, oscillatory flow 
with flow reversal and low net flow could encourage endothelial dysfunction 
which may promote atherosclerotic plaque formation in the artery [98-100]. 
It has been postulated that low WSS due to low blood velocity leads to the 
arterial region becoming prone to atherosclerosis. In a study by Morrisett, low  
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WSSs were reported to influence the increase of low density lipoproteins 
which have been associated to atherosclerosis formation [101], whilst at the 
same time increase the permeability of the endothelium layer to the 
lipoprotein. 
The progression of these phenomena over a period of time initiates the onset 
and formation of atherosclerotic plaque. The growing plaque tends to 
minimise the lumen size which therefore causes lower and disturbed flow at 
the post-stenotic regions of the artery. These occurrences and flow pulsation 
which generates oscillatory shear stress (OSS) which may further facilitate 
the formation of atherosclerosis lead to the progression of atherosclerotic 
plaque downstream of the lesion [92]. In a study by Ku et al. [102], the 
effects of pulsatile flow conditions on hemodynamic forces to intimal plaque 
deposition in human carotid bifurcations was examined. A laser Doppler 
velocimetry was used to calculate the WSSs in the bifurcations and 
comparison made between the WSS and intimal plaque thickness. Results 
from the study showed strong correlation between intimal plaque thickness 
and low WSS and oscillations in the WSS direction. This led to support the 
hypothesis that low WSSs and OSS could be key predictors of 
atherosclerotic plaque formation and localisation. 
It is worth noting however that although significant correlation between low 
WSS and atherosclerosis development has been generally accepted and 
presented in most literature, recent study by Peiffer et al. [103] has 
concluded otherwise. In a systematic review of literature that compared 
hemodynamic forces with atherosclerotic plaques, Peiffer et al. reported that 
the evidence of the aforementioned hypothesis was less robust. It was also 
stated that interpretations of data from the different studies to support the 
current consensus were subjective; hence diverse techniques have been 
used to characterise the lesion distribution and the hemodynamic factors that 
might have caused them. To attest to this statement, Peiffer took five studies  
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that made a quantitative point-by-point comparison between lesion location 
and low WSS and OSS into account. The use of a point-by-point analysis 
was considered as a rigorous method for quantifying this relationship. 
Results achieved from the studies did reveal no significant connection 
between the low and oscillatory stresses and intimal thickening [104-108]. It 
should be made clear that although these findings are interesting revelations 
and heterodox to the established theory of low and oscillatory stresses, the 
level of significance is very much dependent on the statistical method used. 
Wentzel et al. [109] reached a conclusion that the significance level of the 
correlation between WSS and atherosclerotic lesion predilection sites in 
coronary arteries were affected depending on whether or not stresses data 
were averaged in the axial artery direction.    
 
2.4        TREATMENT OF CAD 
 
Treatments of CAD have involved coronary-artery bypass grafting (CABG), 
percutaneous coronary intervention (PCI) and/or medical treatments.  
 Medical Treatments: Over the past years, medical treatments of 
CAD have improved because of the availability of new and more 
potent drugs that lower the risks factors and development of CAD. 
The availability and use of cholesterol-lowering drugs such as statins, 
blood pressure lowering drugs, calcium blockers and anti-platelet 
agents have helped lower the risk of CAD development in high risk 
patients [110]. 
 
 Percutaneous Coronary Intervention: PCI treatments of CAD have 
improved in the past decades and thus revolutionised the 
management of CAD. The use of stents, - bare metal stents (BMS)  
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and drug eluting stents (DES) together with dual anti-platelet therapy 
has reduced CAD morbidity and mortality associated with PCI and 
made PCI safer [111]. 
 
 Coronary Artery Bypass Graft: Studies of CABG treatment in high 
risk CAD patients- patients with diabetes and patients with multi-
vessel disease revealed that CABG significantly reduced the rate of 
mortality and increased the rate of complete revascularisation in these 
groups [112-114]. 
PCI and CABG are both established treatment modalities of invasive 
revascularisation for CAD patients; however the debate on which treatment 
modality is best is still on-going [115-117]. Most of the conclusions reached 
on this debate have hugely been based on some factors such as the 
morphology and location of the lesion in the artery in addition to the medical 
conditions of the patient. Other factors such as complications and risk factors 
associated with each treatment have also been taken into account. 
Nonetheless, these factors used in comparing the efficacy and safety of 
CABG and PCI have sometimes led to conflicting data. Optimal treatment of 
CAD has therefore not been achieved and hence more needs to be done.  
The use of PCI has increased over the years becoming, one of the most 
common medical interventions being performed [118, 119]. Further studies 
by Mack et al. [120], Ulrich et al. [121] and Gerber et al. [122] have all shown 
data which revealed increase in PCI treatment and decrease in CABG 
treatment for CAD between the years 1987 to 2004. In a recent national audit 
of PCI procedures published in 2014 by the British Cardiovascular 
Intervention Society it is reported that about 4 in 5 CAD patients are treated 
with PCI whilst 1 in 5 CAD patients are treated with CABG [123]. On the 
account of CAD treatment modalities presented, it is clear that PCI has been 
and still is very relevant in the management of CAD.  
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Although PCI has been suggested as the most preferred treatment choice for 
CAD, it is necessary to clarify that optimal treatment with PCI has not been 
achieved. However, there have been great improvements over the years to 
make PCI treatment more efficient. These improvements, successes and 
limitations in the use of PCI for CAD treatment is discussed in the next 
chapter. 
 
2.5        THE NEED FOR CORONARY ARTERY STENTS 
 
The initial method of performing PCI involved “plain old balloon angioplasty” 
(POBA) where an inflatable balloon with the aid of a catheter is inserted into 
the clogged artery to open it. However, its success was hampered by many 
problems such as restenosis, acute vessel closure and coronary artery 
dissection [124-126]. To reduce these complications the coronary stent was 
invented. The stent was to serve as a scaffold to hold open the occluded 
lumen and prevent vessel closure after PCI. The “Wall” stent was the first 
coronary stent to be implanted in a human and this was done by Sigwart et 
al. [127] in 1986. 
In 1993, the use of coronary stents during PCI became widely accepted after 
the publication of two benchmark trials; the Belgium Netherlands Stent 
Arterial Revascularisation Therapies Study (BENESTENT) and the North 
American Stent Restenosis Study (STRESS) which provided evidence of the 
safety of stenting and also significant improvements in angiographic 
outcomes [128, 129].  These studies established the use of coronary stent 
implants during PCI as the standard of care and also drove the Food and 
Drug Administration to approve bare metal stents (BMSs) to treat occluded 
blood vessels [130]. 
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2.5.1     THE SUCCESS AND COMPLICATIONS OF BMS 
 
By 1999, 84.2% of PCI procedures involved the use of BMS [131] due to the 
positive results published in the above mentioned benchmark trials. In the 
STRESS trial, it was reported that restenosis decreased from 42% to 32% 
and in the case of BENESTENT trial, restenosis decreased from 32% to 22% 
[130]. Also, in a further study on POBA and coronary stents, it was reported 
that the restenosis rate with the use of BMS was about 20% - 30% which 
was better compared to POBA which had restenosis rate of about 30% - 
60% [126]. 
Despite the reported advantages of BMS implantation during PCI, for 
instance the decreased rate of restenosis; the BMS restenosis rate is still 
considered clinically unsatisfactorily high due to the exponential increase in 
the use of BMS during PCI. In addition, BMS restenosis is very prominent in 
high risk patients. Subsequent trials on BMSs also showed that there were 
some risk factors and concerns related with this procedure. These trials 
reported that BMS implants resulted in acute and sub-acute stent thrombosis 
(ST) rates of 16%-24% and also in-stent neointimal hyperplasia (NIH) [44, 
132-135].  The rise of some of these problems as a result of BMS 
implantation were directly related to the abnormal proliferation and migration 
of vascular smooth muscle cells (VSMCs) at the stented site of the artery 
[136].  Additionally, injury to the endothelial layer of the artery due to stenting 
initiated inflammatory responses which also contributed to the event of 
restenosis [137, 138]. The initial use of BMS during PCI has led to more 
problems compared to the use of POBA alone as more incidents of ST, 
myocardial infarction (MI) and death were reported [128, 129].  Ultimately, 
the advent of BMS implantation during PCI which was thought to be the 
breakthrough in reducing restenosis and thrombosis now seemed elusive. 
However, subsequent practices and management during and after BMS  
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implantation such as optimising the collocation of the stent struts to the 
vessel wall and using dual-antiplatelet therapy after the stent implantation 
have led to significant reduction of ST [139-142]. These improvements in the 
management of BMS implants nonetheless did not reduce the occurrence of 
restenosis. BMS were still associated with a 20% to 30% rate of restenosis 
within 6 months of implantation [136] and an increased rate of target lesion 
revascularisation (TLR). Some literatures reported that repeat 
revascularisation occurred in about 60% - 80% of restenotic lesions [143-
145]. 
Reports on the advent of BMS ISR had been previously perceived as a 
benign event since clinical presentation of ISR had been silent [146]. 
However, Chen et al. [147] concluded from their study on the benignity of 
BMS ISR that clinical ISR was more severe than assumed. The study 
showed cases of unstable angina (36%) and myocardial infarction (MI) were 
the manifestation of ISR and that patient with unstable angina required 
hospitalisation. Nonetheless, depending on the classification applied to what 
clinical cases were considered as the acute coronary syndrome of BMS ISR, 
the statistics of the benignity of ISR could differ. Walters et al. [148] classified 
acute coronary syndrome as a combination of rest angina and acute MI and 
hence in the report stated  68% of acute coronary syndrome accounted for 
BMS ISRs.  
POBA, atherectomy, brachytherapy and repeat stenting have been some of 
the re-intervention mechanisms employed to prevent ISR [149-151]. 
However as reported by Yokoi et al. [150] and Lemos et al. [151] some of 
these treatments such as POBA increased the rate of restenosis to 85% and 
also treatment failure occurred in about 30% of cases after brachytherapy. It 
is thus concluded that restenosis is the bane of PCI treatment with BMS. 
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2.6        UNDERSTANDING THE ONSET/PROGRESSION OF ISR 
 
Since ISR remains the main complication associated with the use of BMS 
during PCI, many studies have tended to focus on understanding factors that 
initiate the onset and/or progression of ISR. These studies could be grouped 
into two main sections namely experimental studies and computational 
studies. 
 
2.6.1     EXPERIMENTAL STUDIES 
 
The mechanisms of restenosis have been under investigation since this 
disease was realised to limit the efficacy of POBA in treating CAD patients. 
Pathological studies by Nobuyoshi et al. [152]  on the causes of restenosis 
after POBA treatment in 20 CAD patients proposed three major mechanisms 
of restenosis. These mechanisms were; thrombus formation due to 
endothelial denudation, intimal proliferation of VSMCs as a result of plaque 
splitting and elastic recoil due to the expansion of the vessel wall. Out of the 
three mechanisms, intimal proliferation of VSMCs was considered to be the 
main mechanism of restenosis. The conclusion reached by Nobuyoshi et al. 
tend to agree with earlier studies by Garth et al. [153] which also examined 
the pathological changes in the coronary arteries of three CAD patients who 
died after POBA intervention. The report demonstrated that these patients 
had prominent proliferation of SMCs on the neo-intimal and intimal surfaces 
of the coronary arteries. These intimal proliferations of SMCs were attributed 
to cause restenosis in the patients after POBA. However, Clowes et al. [154] 
investigation into a rat ballooned carotid artery to demonstrate the 
contribution of SMCs migration to injury induced intimal thickening (IT) 
showed that SMCs migration alone without proliferation accounted partly for  
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the accumulation of intimal SMCs. The study therefore suggested that SMCs 
migration could play an important role in cells response to injury.  
Nonetheless, this dogma of SMCs proliferation and migration being the main 
mechanism responsible for the onset/progression of restenosis after POBA 
have been suggested as false in later studies. 
Clinical and animal studies have questioned the dogma which suggested 
SMCs proliferation and migration to be the predominant mechanism of 
restenosis after POBA [155-157]. This was because arterial remodelling 
rather than SMCs proliferation and migration was found to be the dominant 
factor responsible for restenosis after POBA.  This may explain the reason 
for the failure in strategies that were employed to prevent restenosis which 
were based on limiting SMCs proliferation after POBA treatment. An 
intravascular ultrasound (IVUS) study by Mintz et al. [158] pointed out that 
restenosis after POBA was determined predominantly by the direction and 
magnitude of arterial wall remodelling.   
 
2.6.1.1  ISR IN BMS 
 
Meta-analysis of ISR after stent placement with various coronary artery stent 
types by Kastrati et al. [159] highlighted that main predictors of restenosis be 
explored among lesion and procedural parameters. The knowledge of these 
factors would aid in predicting the risks of the disease. Indeed whereas 
restenosis in POBA has been shown to be mainly due to arterial remodelling, 
ISR after BMS implantation have been attributed primarily to neointimal (NI) 
tissue proliferation/migration and extracellular matrix (ECM)  accumulation 
[160, 161]. Arterial remodelling involves the expansion of the media and 
external expansion membrane during plaque development [162]. The plaque 
is located within the media and does not develop into the lumen. However,  
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the lumen area tends to diminish when the plaque growth reaches above 
40% area stenosis. On the other hand, NI tissue proliferation/ migration 
involves smooth muscle cells within the medial layer of the artery migrating 
into the intima where they continue to proliferate [163]. Continuous migration 
and proliferation of these smooth muscle cells consequently cause intimal 
thickening which also results to luminal size reduction.  Hoffmann et al. [160] 
in a study predicting the pattern and mechanisms of ISR using IVUS 
confirmed that intimal hyperplasia was the main mechanism of late lumen 
loss after BMS implantation. Results from the study also demonstrated that 
stents were able to resist remodelling forces that otherwise may have 
contributed to restenosis and hence arterial remodelling was not the major 
mechanism of ISR. Subsequent studies from Hoffmann et al. [164] on 
chronic arterial responses to stent implantation showed that BMS induced 
tissue proliferation both within the endo-luminal surface of the stent and in 
the tissue layers surrounding the stent struts. It has been postulated that 
there could be no parallels drawn between NI proliferations with injury period 
despite evidence that NI development is closely linked with medial dissection 
during stent placement [15]. It is therefore suggested that NI formation is a 
product of complex mechanisms which might also involve the axial 
displacement of the primary stenotic lesion to neighbouring arterial segments 
during stenting.      
In other studies, arterial injury and inflammation have been linked to ISR [45, 
165]. Animal studies by Karas et al. [44] and Schwartz et al. [166] into the 
relationship between arterial injury and NI thickness in stented porcine 
coronary artery released data which established proportional relation 
between artery injury and intimal SMCs proliferation. This relation of intimal 
SMCs proliferation due to arterial injury was similar to that seen in human 
restenosis. Farb et al. [45] performed an experimental investigation into the 
relationship between arterial injury, inflammation and NI tissue growth after    
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stenting in human coronary artery. In the study it was concluded that the use 
of coronary stents during PCI may result in medial damage or the stent struts 
may penetrate into a lipid core which induces arterial inflammation which is 
linked with increased NI tissue growth. Figure 2.4 shows the association of 
arterial injury with increased NI tissue growth. In a related study by Komatsu 
et al. [167] it was observed that there were extensive accumulations of 
macrophages which are known to be types of inflammatory cells at site of 
stent restenosis.   
 
Figure 2.4 Photomicrographs (A and B) and bar graph (C) showing the link 
between arterial injury (medial fracture, arrow in A) with increased NI 
thickness against stents in which the arterial media was undamaged (B). 
Medial fracture length as a percentage of the circumference of the internal 
elastic lamina was more in restenotic stents compared with stents without 
restenosis (D). A and B, Movat pentachrome stain. Scale bars = 0.23mm in A 
and 0.30mm in B. [45] 
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Continuous advancements in the study of ISR have led to the understanding 
that the mechanisms leading to ISR is complex and not as simple to be 
related to one event. In a study by Mitra et al. [168] the complex mechanisms 
of ISR was divided into two phases namely the early phase and the late 
phase. Figure 2.5 shows the sequential order of mechanisms leading to ISR 
at the early and the late phase. 
 
 
Figure 2.5  Sequential order of mechanisms of ISR at early phase and late 
phase [168]. 
 
As shown in figure 2.5, endothelial injury during stenting leads to a cascade 
of cellular events which finally causes the onset of restenosis. 
 
 
 35 
 
CHAPTER 2 BACKGROUND 
 
2.6.1.2  LIMITATIONS IN EXPERIMENTAL STUDIES 
 
Many comprehensive experimental studies on the mechanisms of restenosis 
and ISR have been carried out in order to provide an integrated view of the 
pathophysiology of restenosis that explains the central role of SMCs 
proliferation/migration, arterial remodelling and/or inflammation. Needless to 
say, these studies have provided better understanding and evaluation 
techniques of each disease which has led to the development of more 
efficient treatments/prevention methods of ISR and restenosis [169-171]. 
Nonetheless, there is an uncertainty that exits over the exact cause of ISR 
and restenosis.  One of the reasons why the exact cause of ISR has still not 
been known is due to the fact that cellular and molecular pathways involved 
in each of the mechanisms leading to ISR have not been fully identified 
[168].    
Many animal models of restenosis have also provided great insights into 
human restenosis and allowed the development of better treatments. For 
instance, profound platelet inhibition with GP I1B/IIIa antagonist has been 
revealed to minimise NI proliferation in both animals and clinical restenosis in 
humans [172].  Unfortunately however, this is one of the few breakthroughs 
made in relation to using a specific treatment application which has proved 
successful in reducing mechanisms leading to restenosis in animals to also 
reduce clinical restenosis in humans. Reason for the lack of breakthroughs 
may be due to the fact that the pathophysiology of restenosis in animals is 
not exactly similar to that of humans and hence application of treatments to 
restenosis in humans may be to some extent limited.    
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2.6.2     COMPUTATIONAL STUDIES 
 
Absolute comprehension of the mechanisms of restenosis and ISR is very 
important for the future development of therapies to prevent and/or treat 
these clinical diseases. The fact that restenosis and ISR are prominent in 
arteries which are tortuous, bifurcated and angulated makes it more difficult 
to achieve experimental data to quantify processes involved in the 
onset/progression of disease [18, 173-175]. However, the use of 
computational models to simulate stenotic arteries has provided alternate 
method to investigate the factors which causes restenosis and ISR in 
arteries.  
Many computational studies into restenosis in blood vessels have been 
driven by the hypothesis that pathological changes are in part associated to 
WSS changes that result to activation of mechanisms of the disease [18, 19].  
Hence CFD models have been elicited to investigate the blood flow 
dynamics within stented arteries [27, 176, 177] and also the interactions 
between stents and the arterial wall that leads to ISR [178, 179].   
Experimental studies by Ku et al. [8], Zarins et al. [9], and Friedman et al. 
[10] into factors that contribute to the increased rate of restenosis have 
suggested strong correlations between intimal thickening  increase and 
WSSs. It has also been reported that WSS could alter the orientation and 
morphology of the endothelial cells which may increase the susceptibility of 
the arterial walls to restenosis and atherosclerosis [180, 181].   
Due to the substantial evidence linking WSSs to NI hyperplasia in arteries 
which have been reported in many literatures, early numerical and 
experimental studies into ISR and/or restenosis in stented arteries have tend 
to focus primarily on the influence of WSSs to the onset of ISR [7, 182, 183]. 
Needless to say other mechanical forces within the stented artery which may  
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equally be major predictors of restenosis might have been overlooked. 
Furthermore, on a macro-scale, the presence of the stent struts results in 
local geometric changes of the artery with flow conditions within the stented 
regions being characterised by flow separation, flow recirculation and 
disturbed shear stresses [184]. Thus the hemodynamic milieu within the 
stented artery is marked by complex and co-existing mechanical factors 
which might also contribute to the development of restenosis. A study by 
Rouleau et al. [11] used CFD analysis to quantify ECs response to both WSS 
and SWSSG. In the study it was reported that ECs subjected to only WSSs 
elongated and aligned in the direction of flow whilst ECs subjected to 
combined SWSSG and WSSs did not exhibit preferred alignment and 
elongation. Sakamoto et al. [185] also reported similar observations from 
their studies on the effect of SWSSG on the morphological changes of ECs 
and suggested that SWSSG may act as a suppressor to ECs morphological 
response to flow. These results are indicative of ECs responses at stented 
arterial regions where flow is highly disturbed both in vivo and in vitro [186, 
187]. Also, in an investigation into the effect of WSSs on intima hyperplasia 
in a rabbit carotid artery, Wang et al. [188] used CFD to provide quantitative 
data of the flow field distribution and WSS in the artery. Results from their 
studies showed that blood flow was severely disturbed at the stenosed 
region of the artery. Additionally increased intima hyperplasia was observed 
at regions with high SWSSG and thus led to a proposal that SWSSG may 
play significant role in endothelial dysfunction.    
The use of CFD modelling has not only elucidated the effects of combined 
mechanical forces on ECs functioning but also helped to optimise stent 
designs and to determine stent’s mechanical parameters which could 
influence disease progression.  Blouza et al. [176] and Dehlaghi et al. [27] in 
a study to analyse WSS in stented artery used CFD simulations to obtain 
optimal parameters of stent that could lead to reduced rate of restenosis. In  
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both studies, it was concluded that the blood flow pattern and WSS 
magnitude were significantly influenced by the stent thickness, strut shape 
and strut spacing.  Hence, to minimise the risk of restenosis due to changes 
in fluid dynamics and associated mechanical factors created by the presence 
of stent; these stent parameters are needed to be taken into consideration.  
 
 2.6.2.2  LIMITATIONS IN COMPUTATIONAL STUDIES 
 
The surge of technological advancements has led to the increase of 
computational studies in analysing CADs and the treatment options to 
determine how to optimise the safety and efficacy of these treatments. 
However, it is important to note that these computational simulations are built 
on some assumptions and fixed parameters. The assumption that blood 
could be considered as a Newtonian fluid when simulating blood flow in 
coronary arteries is very common in many literatures. Although this 
assumption might not be totally flawed, it nonetheless does not give very 
accurate account of blood behaviour. This is because the rheology of blood 
is non-Newtonian and considering the fact that the human coronary artery is 
of a complex shape, results achieved from assuming blood to be Newtonian 
to determine predictors of CADs could differ greatly from that achieved from 
a non-Newtonian simulation and/or experiment.  Rodkiewicz et al. [189] 
investigated Newtonian and non-Newtonian flow through a curved tube and 
highlighted differences between the Newtonian and non-Newtonian flow 
patterns.     
On the other hand, non-Newtonian blood models used in CFD are obtained 
by parameter fitting to experimental viscosity data attained under steady 
state conditions and at a certain shear rate [190-192]. However, it is mostly 
assumed that the steady flow conditions are analogous to pulsatile flow  
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conditions and hence results achieved should show exact representation of 
blood behaviour. This assumption is however implausible since the 
reformation of red blood cell rouleaux is different under each of the flow 
conditions [193]. It is therefore worth stating that physiological blood flow 
phenomena have not been fully understood. Hence computational simulation 
of blood flow to understand the onset of ISR is still an on-going process. 
Finally, most CFD studies have restricted to using simple computational 
geometries such as straight tubes for the analysis of fluid dynamics in 
stented coronary artery as modelling the exact shape of the artery could 
involve very complex procedures [176, 178, 179, 194]. However, a study 
showed that the effect of hemodynamic forces and stresses acting on a 
blood vessel may differ depending on the shape of the blood vessel [195]. 
This means that using simple CFD models could limit our knowledge on 
factors that influence ISR.    
 
2.7        DRUG ELUTING STENTS (DES) 
 
The effort to minimise and/or prevent in-stent NIH ultimately led to the 
development of DES [196]. Inhibiting leukocyte infiltration and SMCs 
proliferation by coating BMS with anti-proliferative agents such as sirolimus 
and paclitaxel, cardiologists hoped this would solve the problem of restenosis 
[196, 197]. The DES consisted mainly of three elements:  
 a stent platform  
 a polymer that served as a drug carrier  
 an anti-proliferative drug.  
The initial stent platform of DES was made of 316L stainless steel; same 
metal alloy used for BMS. This was because 316L stainless steel was radio- 
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opaque and provided enough radial strength with minimal recoil [111]. Drug 
eluting stents were first approved in Europe in 2002 whilst in the USA, the 
FDA for the use of sirolimus-eluting stent (SES) (Cypher®, Cordis 
Corporation) was granted in April 2003. Paclitaxel-eluting stent (PES) 
(Taxus®, Boston Scientific) was later granted FDA approval in March 2004. 
Randomised controlled trials on the implant of both SES and PES in patients 
with de novo coronary lesions showed that both DESs were very potent in 
reducing restenosis and NIH at 6-12 months when compared to BMS [198-
205]. Furthermore, studies on clinical safety and efficacy of the use of SES 
and PES revealed that both the DESs minimised late lumen loss [206, 207]. 
A meta-analysis of 16 randomised clinical trials of SES versus PES which 
included 8,695 patients with CAD showed major reduction in TLR with the 
use of SES [208]. Due to the positive results achieved from the use of DES, 
in 2005 it was reported that 85% of all stents implanted in the USA and 
Europe were DES [209].  
 
2.7.1     STENT OPTIMISATION 
 
Continuous experimental studies into ISR have led to the revelation that 
maintaining endothelial cell integrity (coverage and quality) is important in 
reducing the adverse clinical events after stent implantation [210, 211]. This 
is because damaging the endothelial cell layer could initiate blood 
coagulation which may consequently lead to thrombosis [212]. So to 
minimise damage to the endothelial monolayer, research has tend to focus 
on optimising the stent parameters. More so, the research on stent 
optimisation has mostly been focused on DES since many of the stent 
implantations during PCI has now involved the use of DESs.  Furthermore, 
advances in CFD modelling and finite element analysis of fluid-structure 
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interaction has led to more robust and efficient way of analysing mechanical 
interactions between stents and the arterial wall. These have therefore led to 
better stent optimisation techniques. Some criteria used in determining DES 
performance are: acute recoil, tissue stresses, hemodynamic disturbance, 
drug delivery, uniformity of drug distribution and flexibility of the stent [213]. 
Hence stent design optimisation has been concentrated in these areas.  
Briguori et al. [41] investigated the impact of stent strut thickness in relation 
to the rate of restenosis. Results achieved from the investigation led to the 
conclusion that thinner stent struts reduced the rate of restenosis. This result 
tend to agree with experimental findings which suggested that stent strut 
thickness could affect strut tissue coverage and therefore could lead to a 
delay in endothelialisation [42]. Figure 2.6 shows the rate of restenosis in 
lesions treated with two different stents: one stent having a strut thickness of 
<0.10mm and the other stent having a strut thickness of >0.10mm. 
 
Figure 2.6  Restenosis rate in lesions treated with stent strut thickness 
>0.10mm (Thin Group) and stent strut thickness of <0.10mm (Thick Group) 
[41].  
Many studies have numerically demonstrated that the geometry of the stent 
struts could influence the perturbation of the flow fields [28, 30, 43, 183, 214]. 
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This as a result creates recirculation and flow separation characterised by 
unphysiological mechanical forces at the peri-strut regions which have been 
postulated to serve as nidus for procoagulant molecules entrapment and 
precipitate thrombus formation [215-217]. It has therefore been predicted that 
strut-induced flow disruption could be further attenuated if cross-sectional 
strut shape is streamlined (semi-circular arc shape) than non-streamlined 
(rectangular shape) [43]. Mejia et al. [30] quantified the effect of both 
streamlined struts and non-streamlined struts on WSSs within the peri-strut 
regions and affirmed that 4% of the regions around streamlined struts were 
exposed to low WSS whilst that of non-streamlined struts was 81%.  
As we appreciate the synergistic beneficial effects of stent strut streamlining 
and thinning as critical determinants for favourable post stent implantation 
hemodynamic milieu, it is also important to note that these factors are limited 
by the need to maintain adequate stent radial strength to prevent recoil. 
 
2.7.2     SECOND GENERATION DES 
 
Progress in stent optimisation led to development of second-generation drug 
eluting stents which has been suggested to be better than first-generation 
DES. Second-generation DESs were composed of cobalt chromium (CoCr) 
as this alloy possessed more radial strength and better radio-opacity  which 
allowed for thinner stent struts as opposed to 316L stainless steel [218, 219]. 
Radial strength is the measure of the stent’s strength and ability to maintain 
the shape of the vessel lumen [220]. Hence adequate radial strength of the 
stent is very important in order to minimise stent recoil. Additional advantage 
of using CoCr as a stent platform is that due to its mechanical strength 
properties, unique stent designs that could facilitate precise drug delivery to 
target lesions could be built [221]. Furthermore, a variety of biocompatible  
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polymers could be built on to these unique stent to serve as drug carriers. 
The use of CoCr led to the creation of different DESs such as Endeavor 
Zotorolimus-eluting stent (ZES) and Xience V everolimus-eluting stent (EES) 
which have been claimed to have better efficacy compared to the first-
generation DES. This claim has been supported by several clinical studies 
which have compared the superiority of ZES (second-generation DES) to 
SES (first-generation DES) and have revealed that ZES had greater 
endothelial coverage of struts, significantly lower in-stent restenosis and TLR 
[222-225]. 
Clinical outcome data has shown that second-generation DESs are better 
than BMS in promoting arterial wall healing [226]. However, this evidence 
has been questioned lately with the emergence of studies which have 
showed varied results in the efficacy of stents. In a study by Joner et al. 
[227], first-generation DESs (PES and  SES), second-generation DESs (ZES 
and EES) and BMS were implanted into the iliac arteries of a rabbit to 
investigate the trends in endothelial coverage and recovery; thus an indicator 
of arterial healing between the stents.  The result of the study affirmed that at 
day 14 there was significantly greater endothelial coverage in EES, followed 
by ZES then PES and lastly SES. However on day 28 there wasn’t any 
statistically significant difference of endothelial coverage amongst the 
different type of stents. It was also postulated that stent struts lacking 
endothelial coverage served as nidus for focal aggregates of platelets and 
inflammatory cells. Results of this study are illustrated in figure 2.7. 
Animal models of stenting may maintain predictive value to some significant 
extent to humans as arterial healing stages are remarkably similar [228]. 
Nonetheless, it is imperative to note that interpretation of animal data is 
highly contingent on factors which might or might not significantly influence 
results as compared to that of humans. In a review study comparing vascular 
healing after DES placement in both humans and animals it was reported  
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that there was characteristic difference in the healing timeline between 
humans and animals [228]. Thus long term follow up of patients with DES 
placement for restenosis is necessary.  
In 2011 and 2012, Boston Scientific unveiled their new stents called 
OMEGA™ and PROMUS Element™ respectively which were both built on a 
platinum chromium platform. Using platinum chromium alloy, stent designs 
could be further optimised to improve conformability, minimise recoil and 
enable precise drug delivery across complex lesions due to the increased 
radio-opacity of the stents [220, 229].  
 
Figure 2.7  Radiographic images of endothelial coverage of stents at day 14 
(top left), Radiographic images of endothelial coverage of stent at day 28 
(bottom left), Scanning morphmetric analysis bar graphs showing 
quantitative analysis of endothelial coverage between stents at day 14 (A) 
and day 28 (B) respectively [227]. 
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2.8        COMPLICATIONS WITH DES USE 
 
Clinical enthusiasm owing to the advantages of DES over BMS was 
lessened due to concerns over ST after DES implantation [230].  
One of the main criticisms of the first-generation DES was that initial clinical 
investigations into ISR with the use of first-generation DESs during PCI were 
only concentrated on patients who had stable de novo lesions. As a result of 
the biased patient selection, data achieved from the clinical trials about the 
efficacy of DES were positive. Early studies on DES by Spaulding et al. 
[231], Kastrati et al. [232], and Stone et al. [233] all involved patients who 
had simple lesions and conclusions from their results were that there were 
no significant mortality and morbidity rates in DES use. These results 
however do not reflect the real world as patients may present with complex 
lesions. Hence clinical outcomes from DES treatment on complex lesions 
could be devastating. Comparative studies of DES use between simple and 
complex lesions have shown higher rates of deaths, MI and repeat 
revascularisation in the latter [234, 235]. 
Additionally, patients may present different medical conditions which mean a 
clinical intervention using DES may not be the appropriate form of treatment 
for a specific patient. Also, although the use of DES reduced restenosis 
compared to BMS, concerns were raised about ST which seemed to be the 
“Achilles heel” of this device. Luckily, ST is rare; however it is an 
unpredictable event that causes high rate of deaths (45% to 75%) and MI 
(25% to 65%) [236-240]. The first cases of late stent thrombosis (LST) were 
reported by McFadden et al. [241] when four patients implanted with DES 
over a year (two with SES and two with PES) developed LST and MI after 
stopping their anti-platelet treatment. Reported treatments after a diagnosed 
case of LST and MI have involved balloon angioplasty, re-continuation of the 
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anti-platelet treatment and intra-aortic counter-pulsation [242, 243]. Although 
these treatments have proved successful in managing ST and MI, 
complications associated with these treatments however could lead to death. 
Waters et al. [242] investigated a case study of 4 CAD patients who 
developed LST following treatment of ISR with DES after cessation of anti-
platelet treatment. In the investigation it was affirmed that one case patient 
died after being treated with vasopressor therapy and intra-aortic counter-
pulsation following a diagnosis of MI. The death of the patient was attributed 
to complications associated with cardiogenic shock which was due to acute 
MI. Finn et. al [39] concluded from a study on pathological correlates of late 
DES thrombosis that the lack of re-endothelialisation was the most powerful 
predictor of ST. It was stated the reason for the lack of re-endothelialisation 
was as a result of non-uniform incomplete healing of the arterial wall. The 
causes for the non-uniformity and incompleteness of arterial wall healing 
however remain unknown. It is postulated that the lesions characteristics, 
drug dose and distribution and the biocompatibility of the polymer may have 
important roles to play in the incomplete healing of the artery. Nevertheless 
the influence of each of these factors to cause this problem has not been 
fully understood hence increasing the complexity and difficulty in the study of 
LST with DES. Hwang et al. [244] study on how physiological transport 
forces govern drug distribution for stent-based delivery provided a possible 
explanation for the non-uniform healing with DES.  From the study it was 
understood that the nearness of the lesion to the drug coated stent did not 
guarantee adequate drug distribution. More so, the local concentrations of 
the drug are extremely dependent on the stent strut spacing and therefore 
inconsistencies in the distances between the struts will increase the 
difference in concentrations, leading to non-uniformity of arterial healing and 
subsequently result to LST. Researchers are now looking into the 
physiochemical properties of the drug and geometric stent characteristics to 
help explain the onset of LST in DES implantations. 
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2.8.1     CONCERNS ABOUT DURATION OF DUAL ANTI-PLATELET 
THERAPY 
 
Meta-analysis of randomised and observational clinical outcome data has 
demonstrated that patients with DES implantation have reduced rates of 
death and MI with the extended use of aspirin and clopidogrel [245-248]. 
Nonetheless, the optimal duration of continuous dual anti-platelet therapy 
after DES implantation remains a central issue. This is because the 
administering of aspirin and clopidogrel to DES patients has been associated 
with some side effects. In the CURE trial, CAD patients who were on both 
clopidogrel and aspirin medication were observed to have major bleeding 
[249]. Previous studies into the side effects of clopidogrel and aspirin therapy 
demonstrated that the bleeding was not life-threatening and that the clinical 
benefits of dual anti-platelet therapy outweighed the side effect [249-251]. 
However, in the Global Registry of Acute Coronary Events (GRACE) registry 
by Moscucci et al. [252] major bleeding was reported as life-threatening as 
patients who had severe bleeding were reported to be at a higher mortality 
risk.  
Lastly, there exist some discrepancies in data showing the potential adverse 
effects of prolonged dual anti-platelet therapy in CAD patients. In an 
observational cohort study on the influence of extended use of clopidogrel 
after DES implantation by Park et al. [253], it was reported that continued 
clopidogrel use beyond 1 year did not reduce ST and adverse clinical events. 
In the TYCOON (Two-Year ClOpidOgrel Need) registry however, 
investigation into the effectiveness of dual anti-platelet therapy use in 
preventing ST showed positive results [254]. In the study, 447 CAD patients 
were treated with DES and out of the 447 patients, 173 of the patients were 
put on dual anti-platelet therapy for 12 months and the rest of the patients 
were put on dual anti-platelet therapy for 24 months. Follow-ups on the two 
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patient groups revealed no difference in adverse clinical events; however, 
there were reported 5 cases of ST in the 12 month group and in the 24 
months group 1 case of ST. The conclusion therefore reached on the study 
was that prolonged anti-platelet therapy does not affect clinical events but 
significantly reduces the rate of ST. From these conflicting data, it could 
therefore be concluded that it remains still unclear if prolonged dual anti-
platelet carry better prognosis after PCI.       
The unexpected discoveries of the complications associated with the DES 
use have ultimately generated an uncertainty about its efficacy and safety.  
 
2.9        PROGNOSIS OF ST 
 
Prognosis of ST still remains very poor as there are no known exact causes 
of this disease. However, many studies and registries have identified 
implicating factors that may increase the risk of ST. 
 
2.9.1     PATIENT FACTORS 
 
One of the independent predictors of ST is the patient factor. ST is more 
likely to occur in high risk patients; thus patients with renal failure and 
diabetes. Spaulding et al. [231] and Karvouni et al. [255] reported incidents 
of very LST in diabetic patients after SES implantation. Also, though studies 
on the relation between renal insufficiency and ST is limited, initial studies 
have suggested that chronic kidney disease is associated with stent 
thrombosis in patients who have undergone PCI with DES [256]. 
The management and treatments to prevent and/or minimise the risk of LST  
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in patients could sometimes lead to the opposite effect. For instance 
brachytherapy or PCI for acute coronary syndrome, left ventricular ejection 
fraction and ST segment elevation myocardial infarction can lead to episodes 
of LST [257, 258]. The strongest independent predictors of ST are the early 
discontinuation of dual antiplatelet therapy. A rate of 7.8% in ST was 
recorded in patients who had prematurely discontinued taking clopidogrel, 
aspirin or both in a report study by Park et al [259]. Kuchulakanti et al. [260] 
reported an increase in LST in patients who discontinued taking clopidogrel 
compared to those who kept up with the clopidogrel therapy; thus suggested 
that clopidogrel compliance was vital in high-risk patients. 
 
2.9.1.1  CLOPIDOGREL RESISTANCE 
 
The benefits of clopidogrel in the prevention of ST are well established but it 
emerged that some patients treated with clopidogrel show signs of resistance 
[261, 262]. Clinical trials have led to the suggestion that patients who are 
non-responsive to clopidogrel may be at a greater risk of thrombotic 
outcomes [263, 264].  The principal mechanisms leading to clopidogrel 
resistance are not completely elucidated, but are thought to probably occur 
through clinical, cellular factors and/or pharmacokinetics of clopidogrel in the 
patient’s system [261, 265].  Further studies are therefore needed to provide 
better understanding on the impact of individual response variability to 
clopidogrel that could lead to better treatment management.  
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2.9.2     LESION CHARACTERISTICS 
 
Examples of lesion characteristics that could influence the onset of ST and 
adverse clinical events include lesion length, calcified and complex lesion in 
the artery [141, 266]. 
Hougaard et al. [267] in a randomised study assessed the influence of lesion 
length on clinical outcomes amongst patients treated with EES and SES. In 
the study, 383 patients with short lesions and 890 patients with long lesions 
were treated with EES. Also, 417 patients with short lesions and 900 patients 
with long lesions were treated with SES. Results obtained from this study 
revealed significant adverse cardiac events in the patient group who long 
lesions (8.8%) compared to patients who had short lesions (6.2%). 
Conversely, there was not any significant difference in adverse cardiac 
events between patients with long lesions treated with either EES (8.6%) or 
SES (9.1%). These results therefore attest to the fact that lesion 
characteristic as suggested by many studies is a predictor of adverse clinical 
outcomes and ST. 
 
2.9.3     BIOLOGICAL FACTORS 
 
In addition to the above predictors mentioned, biological factors such as 
hypersensitivity reaction and drug resistance have been reported to 
contribute to the development of early/late ST [238, 268, 269]. 
In a clinical investigation study by Virmani et al. [238] it was shown that 
localised hypersensitivity reactions after DES implantation plays a probable 
role in the pathogenesis of LST. The study involved a 58 year old man who 
died of LST 18 months after having two SESs implantation for unstable  
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angina. Findings presented after angiographic and ultrasound showed no 
incidence of NI formation, however, an autopsy showed the stented arterial 
regions with severe localised hypersensitivity reaction consisting mainly of T 
lymphocytes and eosinophils. Conclusion therefore reached on this study 
tended to suggest that pharmacokinetic elution profile of SES might have 
caused an adverse reaction in the artery which might have led to the 
development of LST. 
 
2.9.4     MECHANICAL AND TECHNICAL FACTORS 
 
Inadequate stent expansion and stent malapposition are predisposing factors 
for ST. A study by Kenichi et al. [38] to investigate factors that contributed to 
ST after SES implantation concluded that stent under-expansion was one of 
the associated factors. Additionally, malappositioning of stents in arteries 
especially ones with significant tortuosity have been suggested to play a role 
in the pathogenesis of LST [40].   Stent design parameters could also be 
critical to influence ST and restenosis; hence studies have also been focused 
on stent optimisation. In a report by Gurbel et al. [270] stent designs were 
affirmed to influence the degree of platelet activation which contributed to the 
pathophysiology of ST. 
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2.10      THE DEBATE: BMS VERSUS DES 
 
2.10.1   MORTALITY/ MI 
 
The controversy over either BMS or DES being the better stent intensified as 
publication of 4 studies raised concerns about the increased mortality rate 
associated to DES use. 
 Nordmann et al. [271], performed an evaluation on the effect of DES 
and BMS treatment on patients with CAD on cardiac and non-cardiac 
death. In the randomised trials, sirolimus-DES and paclitaxel-DES 
treatment for CAD did not reduce the mortality rates when compared 
to BMSs. Interestingly however; preliminary results suggested that 
sirolimus-DES use led to significant increase in non-cardiac mortality.  
 In the BASKET (Basel Stent Kosten Effektivitats Trial) study by 
Pfisterer et al. [272] which assigned randomly 746 patients to either 
DES or BMS and treated them with clopidogrel reported that there 
was no difference in the rate of 18 months cardiac mortality/MI 
between DES and BMS patients. Nonetheless, a discontinuation of 
clopidogrel resulted to 4.9% of cardiac death/MI for DES patients as 
compared to 1.3% which occurred in BMS patients. Figure 2.8 shows 
the statistical data of clinical outcomes with the use of BMS and DES.  
 Camenzind et al. [230] analysed a pooled data of mortality rates from 
the Cypher and Taxus randomised trials and compared with that of 
BMS to come to a conclusion that mortality rates were higher with 
first-generation DES compared to BMS. 
 Comparative study on mortality/MI rate between two study groups; 
one group being patients treated with BMS and the other group being  
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patients treated with DES using data from SCAAR (Swedish Coronary 
Angiography and Angioplasty Registry); Lagerqvist et al. [273] 
presented results which associated increased mortality rate with the 
use of DES.  
 
 
Figure 2.8  Statistics of late clinical outcomes (7 – 18 months) after BMS 
(blue colour bar) and DES (red colour bar) implantation [272] 
These studies have triggered research into investigating the general 
comparison between DES and BMS in terms of mortality and morbidity at 
short- and long-term follow-up. A meta-analysis comparing the safety and 
effectiveness of DES and BMS in patients conducted by Stettler et al. [274] 
reported that sirolimus-eluting stents were clinically better than BMS and 
paclitaxel-DES. Additionally, the rates of mortality for patients treated with 
paclitaxel-DES, sirolimus-DES and BMS were similar.   Kirtane et al. [275] 
and Kastrati et al. [232]  concluded on the safety and efficacy of DES and 
BMS; that is, there were no substantial differences observed in the rates of 
mortality/MI after DES or BMS use.  
BMS 
DES 
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2.10.2   ENDOTHELIALISATION 
 
Delay in endothelialisation because of the anti-proliferative agents of DES 
could cause stent struts to remain thrombogenic which consequently 
increases the risk of ST which is associated to 45% of mortality [39, 241]. 
Conversely BMSs have been demonstrated to facilitate complete 
endothelialisation  after implant  thus minimising the onset of stent 
thrombosis [39]. 
 
2.10.3   SUMMARY 
 
It is clear that coronary stents are an indispensable component of modern 
PCI, although associated with some adverse clinical events such as 
restenosis and ISR. The understanding of mechanisms that lead to these 
diseases after stent implantation is however unclear as pathophysiology of 
each disease is complex and influenced by many cellular and molecular 
events. Therefore identification of good therapeutic targets is complicated.  
Researchers have performed a lot of studies to disclose mechanisms leading 
to restenosis and ISR both experimentally and computationally. Nonetheless 
substantial evidence to suggest the main predictors of ISR and restenosis 
has still remained elusive.  
The use of computational modelling tool such as CFD has helped to quantify 
the mechanical milieu predicted to be experienced by cells within artery. 
Cellular responses that lead to initiate ISR within stented artery can therefore 
be mapped onto these quantified local mechanical stimuli. Hence possible 
mechanisms that may initiate ISR can be identified. In the next chapter, CFD 
is used to quantify the mechanical forces within a stented artery. 
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CHAPTER  3 
COMPUTATIONAL FLUID DYNAMICS (I) 
 
Figure 3. Graphical chart showing the processes involved in CFD simulation 
There are three main processing phases involved in CFD simulation namely; 
the pre-processing, solution and post-processing phase as shown in figure 3. 
It is essential that caution is taken when performing each processing phase 
involved in the CFD simulation. This is because CFD results obtained have 
been shown to be operator specific and thus each phase that is poorly 
simulated can lead to final results being highly misleading [276].  
In this chapter, CFD simulation of blood flow dynamics within a stented artery 
is analysed. However, before this analysis was performed, the appropriate 
blood rheological model to use for the flow simulation was established.     
 
3.1        ESTABLISHING APPROPRIATE BLOOD RHEOLOGICAL MODEL 
 
3.1.1     INTRODUCTION 
Vascular endothelial cells are known to play an important role in the 
homeostatic functions in response to several chemical and mechanical 
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stimuli due to blood flow. To investigate these mechanical stimuli and its 
potential effects on cell function, researchers have employed both 
experimental and numerical methods. Numerical methods however have 
been the preferred choice by researchers especially when analysing a wide 
range of hemodynamic parameters. 
Evidence relating shear stresses to NIH has led to investigating the influence 
of stents on the local blood flow dynamics and associated stresses that lead 
to stenosis within stented arteries [8-10]. Blood plays an imperative role 
transporting oxygen and nutrients throughout the body. Its circulation is 
dictated by its rheological properties and the characteristics of the blood 
vessel it flows through [277].  It is commonly known that blood is thixotropic 
and exhibits non-Newtonian characteristics. However above shear rate of 
100s-1 blood is considered to exhibit Newtonian characteristic in large 
arteries [31-34]. Ignoring the non-Newtonian effect of blood based on the 
aforementioned argument is plausible especially if artery is healthy and of 
regular size [278]. Nonetheless, this argument weakens when complex 
arterial geometry and transient blood flow which may involve reverse flow 
directions or stops are considered. Thus the non-Newtonian effects could 
become significant in this case.   
Current consensus suggests WSS as the dominating mechanical stimulus in 
stent performance as stated by Mejia et al. [279]. So, the constitutive blood 
model chosen must take into account the local shear rate dynamics at the 
stented arterial region. In predicting the effects of different constitutive blood 
models on resulting transient WSSs in a stented coronary artery; Mejia et al. 
[279] compared Newtonian blood model against non-Newtonian blood model 
under normalised cardiac waveform. Two Newtonian blood models were 
simulated; the first using a Newtonian viscosity of 3.5 cP which is the lower 
viscosity limit of blood. The second Newtonian model used a calculated 
characteristic viscosity of 4.7 cP. For the non-Newtonian blood model, a  
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Carreau-Yasuda viscosity model was employed. Three different time points 
of the cardiac cycle were selected for analysis; two of the time points 
corresponded to ascending and descending flow with instantaneous 
Reynolds number of 190 respectively and the third corresponded to the peak 
flow rate. Results obtained at these time points all showed the two 
Newtonian viscosity blood models to have under-estimated the WSSs within 
the stented artery when compared to the non-Newtonian model. Thus 
prediction of the risk of restenosis in stented arteries could be over-estimated 
when Newtonian models are used. The use of characteristic Newtonian 
viscosity here to compensate for the under-estimation of viscosity observed 
with the Newtonian model and to produce quantitatively similar WSSs when 
compared to Carreau-Yasuda model just as reported by Benard et al. [29] 
did not produce expected results. The WSS levels of the characteristic 
Newtonian model although higher than the Newtonian model still were 
substantially lower than the non-Newtonian model. The authors of this study 
argued that the discrepancies between results achieved and that reported by 
Benard et al. was likely to be due to the different flow models used. Whilst 
Benard et al. simulated the flow dynamics in the stented artery under steady-
state conditions; Mejia et al. simulated a transient flow condition. Additionally, 
this discrepancy observed is supported by the investigations of rheological 
blood models by Soulis et al. [35] which suggested that blood viscosity model 
is dependent on flow conditions amongst many other factors. Careful 
interpretation of CFD simulations is therefore required as results obtained 
are operator specific and also poorly executed simulations could potentially 
produce highly misleading data.   
It is suggested that validating CFD simulations against experimental data will 
prevent misleading interpretations of CFD analysis. Hence in this section, 
different constitutive blood viscosity models is compared against 
experimental blood rheology to determine the blood model that best fits the  
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experimental blood data. Using the best fit blood viscosity model as a bench 
mark, quantitative assessment of the WSSs difference between the best fit 
model and other blood viscosity models in a helical stented artery under LAD 
physiological flow would be determined. 
 
3.2        ANALYTICAL METHOD 
 
3.2.1     VALIDATION OF CFD VISCOSITY BLOOD MODEL 
 
In the LAD, ECs are predicted to experience a mean WSS of 1.38±0.1 Pa to 
maintain normal homeostatic functions [280]. So in determining the most 
suitable rheological blood model to mimic blood dynamics in the artery, it 
was important to also determine the nature of blood viscosity under these 
stresses as viscosity influences greatly the blood flow phenomena. 
Haematocrit levels also play important role in determining the behaviour of 
blood. Haematocrit is the percentage volume of red blood cells (RBCs) in 
blood. Blood fluidity at a specific shear rate and temperature is determined 
by haematocrit; hence alterations of haematocrit could influence greatly 
haemorheological variations in disease [281]. Also paucity of blood fluidity 
may affect vascular tissue perfusion and subsequently result in vascular 
tissue dysfunction [281].  
Newtonian model and non-Newtonian models based on Carreau and non-
Newtonian Power Law were therefore validated against experimental blood 
rheology data of normal haematocrit level of 45% [282, 283]. The three 
different rheological blood model under investigation thus; Newtonian model, 
non-Newtonian Power Law and Carreau models were analysed using the 
analytical formulation presented in table 3.1.    
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Table 3.1  Formulations of rheological blood models 
Blood model Viscosity Parameter 
Newtonian model 
[278] 
𝜏 = 𝜇?̇? 
𝜇 = 0.0035 𝑃𝑎. 𝑠  
Carreau model [282] 
                              
𝜇 =  𝜇∞ + (𝜇0 − 𝜇∞)[1 + (𝜆?̇?)
2]( n – 1) / 2 
𝜆 = 3.313𝑠, 𝑛 = 0.03568,  𝜇∞ = 0.00345 𝑃𝑎. 𝑠, 
𝜇0 = 0.056 𝑃𝑎. 𝑠 
Non-Newtonian Power 
Law model [284] 
 
𝜏 = 𝑘𝛾 ̇ ( n – 1) 
𝑛 = 0.7, 𝑘 = 0.017𝑘𝑔 𝑠
𝑛−2
𝑚⁄ , 𝜇0 = 0.0001 𝑃𝑎. 𝑠, 
𝜇∞ = 0.1 𝑃𝑎. 𝑠 
 
 
3.2.2     ANALYTICAL MODELLING 
 
Given the analytical equation for WSS in a pipe, assuming the shape of the 
artery is analogous to a pipe: 
 
𝜏 =  𝜇?̇?   3.1 
where 𝜏 is the WSS, 𝜇 is the dynamic viscosity and ?̇? is the shear rate. 
and flow is laminar, spatially and temporally fully developed throughout the 
artery, then the use of computational modelling is obviated. Thus the use of 
analytical modelling to assess the relationship between the shear rate and 
viscosity of each constitutive blood model is appropriate.  
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Figure 3.1  Comparative analysis of blood viscosity between experimental 
data and computational rheology blood data. 
 
It is observed in figure 3.1 that the Carreau viscosity model fits best the 
experimental rheological blood data of Cho et al. and Chien et al. 
respectively. Hence it is proposed that Carreau model is the best amongst 
the other analysed constitutive blood model in capturing the non-Newtonian 
viscosity of blood and consequently the effects of flow hemodynamic in the 
LAD. Nonetheless as discussed earlier in this section, many studies have 
suggested Newtonian model to mimic the non-Newtonian characteristics of 
blood above shear rate of 100s-1. Taking the mean WSS in LAD is 1.38±0.1 
Pa, then using equation 3.1 and viscosity of 0.0035 Pa.s, the calculated 
mean shear rate respective to the physiological mean WSS is 394.3s-
1±28.6s-1. Thus in the LAD, the mean shear rate is above 100s-1 and so 
based on the above deductions, Newtonian viscosity model is an appropriate 
alternative model to use in simulating flow hemodynamic in the LAD.  
 61 
 
CHAPTER 3 COMPUTATIONAL FLUID DYNAMICS 
 
Additionally, the data produced in figure 3.1 tends to support this consensus 
and more so if the dynamic Newtonian viscosity is modified to 0.004 Pa.s 
instead of 0.0035 Pa.s as suggested by [285] then a much better agreement 
could have been observed between the Newtonian and Carreau model. 
 
3.3        COMPUTATIONAL METHOD 
 
3.3.1     STENTED LAD ARTERY (PRE-PROCESSING PHASE) 
 
In section 3.2 the use of analytical method to determine the relationship 
between viscosity and shear rate of different constitutive blood models is 
sufficient as the geometry of artery and flow is considered simple. In the case 
of a stented artery however, the presence of the stents results in local arterial 
geometric changes and complex flow with subsequent changes in local 
shear rates as previously discussed. Thus the effect of non-Newtonian blood 
viscosity on hemodynamics in the stented artery could be more complicated 
than in a simple artery. Additionally, although blood viscosity is considered 
virtually constant at high shear rate condition [282], the instantaneous shear 
rate for example in the LAD varies significantly over a cardiac cycle. So the 
artery is predicted to experience an immensely different viscosity over a 
cardiac cycle which consequently could affect its mechanical milieu; more 
especially in that of a stented artery.  
Taking into consideration the above stipulations, it is clear that CFD is 
required to accurately analyse the mechanical environment of the stented 
LAD artery and also investigate if the Newtonian viscosity model still remains 
an acceptable alternative able to capture correctly the hemodynamics in the 
stented artery. 
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3.3.2     GEOMETRICAL CONDITIONS  
 
A 3D straight stented LAD was designed with an arterial diameter of 3mm 
after a fully deployed helical stent implantation. The LAD artery was 
assumed to be straight with a rigid wall. This assumption was supported by 
evidence in literatures which emphasised that artery curvature decreased 
after stent implantation. In a comparative study by Zhu et al. [54] on coronary 
artery dynamics pre- and post-stenting, a stent length of 18𝑚𝑚 was 
implanted in a LAD artery. Results attained from the stented artery affirmed 
that regions of the LAD at which pre-stent mean curvature was at the 
greatest were evidently straightened by the stent. The stent dimensions were 
modelled similar to typical coronary stents; thus stent strut diameter of 
0.15𝑚𝑚 and struts pitch-to-pitch distance of 0.7𝑚𝑚 [30].   
 
Figure 3.2  Geometry of helical stented LAD 
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3.3.3     GOVERNING EQUATIONS 
 
Based on predicted complexity of blood flow dynamics in the stented LAD 
artery and the assumption that blood is incompressible, a finite volume 
method (FVM) is implemented to analyse the flow. FVM is a well-established 
and robust CFD technique which enables the numerically solving of the 
Navier-Stokes (N-S) equation that governs fluid flow [286]. The fluid flow is 
governed by the following equations: 
 
 The N-S equation which describes the momentum conservation of the 
fluid; 
𝜕?⃑⃑?
𝜕𝑡
+ (?⃑⃑? ∙ ∇)?⃑⃑? =  −
∇𝑝
𝜌
+ 𝜇∇2?⃑⃑? +  ?⃑?  3.2 
Writing the Navier-Stokes equations in this form allows for the various uses 
of non-Newtonian blood models. 
 
 The continuity equation which describes the mass conservation of the 
fluid; 
 
𝜕𝜌
𝜕𝑡
+ ∇ ∙ 𝜌?⃑⃑? = 0  3.3 
 
where ?⃑⃑? is the velocity vector, 𝑡 the time, 𝑝 the static pressure, 𝜌 the blood 
density, ?⃑? is other forces, and 𝜇 the kinetic viscosity.  
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A no-slip condition was applied to the artery wall and a fully developed LAD 
pulsatile velocity profile was applied at the inlet boundary of the artery. At the 
outlet boundary, normal diffusive flux for all flow variables was assumed to 
be zero. This outlet boundary condition is used in cases where velocity and 
pressure details of the flow exit are not known prior to solving the flow 
problem. The equation describing this condition is given below: 
 
−𝑝?⃑? +
1
𝑅𝑒
𝜕?⃑⃑?
𝜕?⃑⃑?
= 0  3.4 
where ?⃑? is a unit directional vector normal to the outlet boundary. 
 
3.3.3.1 SOLUTION PROCEDURE FOR GOVERNING EQUATIONS 
 
The governing equations for the fluid motion are highly nonlinear, hence are 
solved using a segregated iterative algorithm built in ANSYS Fluent 13 
software (Ansys inc., Canonsburg, PA, USA). The segregated iterative 
algorithm used to solve the flow problem is the FVM. The use of FVM has 
achieved widespread acceptance because of its accuracy and also as it is a 
thoroughly validated CFD technique. So, in solving a given flow problem 
using this computational numerical algorithm, the following steps are 
involved: 
 Discretisation of flow domain: Based on the reasoning that fluid 
dynamics in the flow domain are governed by N-S equations which are a set 
of partial differential equations and thus couldn’t be solved analytically, the 
entire flow domain is discretised into control volumes 𝐶𝑉 also known as cells 
[286]. Discretising the flow domain as shown in figure 3.3 converts the partial 
differential equations into several algebraic equations; one for each 𝐶𝑉 which 
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is then solved generally using iterative method. Discretising the governing 
equations is mostly demonstrated by considering a steady-state conservation 
equation for transport of a mass.  
 
 
     
 
Figure 3.3  Discretised flow domain 
 
 Integration of governing equation:  After discretisation of the flow 
domain, the momentum and continuity equations shown in equations (3.2) 
and (3.3) respectively are integrated over a constant volume 𝑉 and enclosed 
surface 𝐴; the 𝐶𝑉. This is shown in the given formulation below [286]: 
 
∫
𝜕(𝜌?⃑⃑?)
𝜕𝑡𝐶𝑉
𝑑𝑉 + ∫ ?⃑?
𝐴
∙ (𝜌?⃑⃑??⃑⃑?)𝑑𝐴 = ∫ ?⃑?
𝐴
∙ (𝜇∇?⃑⃑?)𝑑𝐴 + ∫ ?⃑?
𝐶𝑉
𝑑𝑉   3.5 
 
∫
𝜕𝜌
𝜕𝑡
𝑑𝑉 +
𝐶𝑉
∫ ?⃑?
𝐴
∙ (𝜌?⃑⃑?)𝑑𝐴 =  0  3.6 
where ?⃑⃑? is velocity vector, 𝑝 the pressure, 𝑡 the time, 𝜌 the fluid density, 𝜇 
the kinetic viscosity, and ?⃑? a directional vector normal to surface 𝐴. 
Discretisation of equations 3.5 and 3.6 over time and space produces  
Control Volume  Face  Node  Boundary node 
 66 
 
CHAPTER 3 COMPUTATIONAL FLUID DYNAMICS 
 
algebraic equations describing transport of mass and momentum through the 
𝐶𝑉 at each time step [287]. In the case of a transient simulation, it becomes 
necessary for the governing equations to be discretised in both time and 
space. Spatially discretising time-dependent equations are similar to that of a 
steady-state case. On the other hand, temporal discretisation involves 
integration of every term in the partial differential equation which yields a set 
of algebraic equations at each 𝐶𝑉 describing the transport of mass and 
momentum over a time step ∆𝑡 [287]. 
 Iteration of algebraic equations: The algebraic equations from the 
flow discretisation are then finally solved by iteration with a selection of a 
convergence criterion which ensures that there are no significant changes in 
results when further iterations are performed [287]. Solutions were therefore 
judged to have met convergence criterion when scaled residuals for 
continuity and all three velocity components; (x-, y-, and z-velocity) have 
fallen to below 10–5.     
 
3.3.4     MESH GENERATION AND MESH INDEPENDENCE 
 
Achieving mesh independence of a model although not a sufficient condition 
to ensure complete accuracy of results is nonetheless an essential 
requirement in validating CFD results [288]. Solutions are termed to be mesh 
independent when to they are independent of grid density, simulation time 
and further computational iterations performed.    
The flow domain of the stented LAD was discretised using a CutCell 
algorithm in Ansys Workbench 13. This algorithm is a mesh generator which 
results in meshes having a high proportion of hexahedral cells as illustrated 
in figure 3.4.  Mesh refinements studies where then performed by using the  
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WSS results attained from the simulation of stented LAD model after each 
successive refinement as a measure for determining the convergence 
behaviour of results. Thus increasing the cell number over the entire flow 
domain generates finer meshes: (coarse mesh: 61159, 244651; medium 
mesh: 460271, 621698; and finest mesh: 936716, 1070554, hexahedral cells 
respectively). For each successive mesh generated, an increased cell 
density was imposed at immediate regions around the stent strut where most 
complex flow dynamics is anticipated. Mesh independence is considered to 
be achieved when relative WSS error percentage between two successive 
meshes is ≤ 5%.  
 
Figure 3.4 Hexagonal Meshing of stented LAD. The dashed line is a center 
line showing axisymmetric stented artery and the arrows show flow direction  
 
Figure 3.5a shows the WSS distributions and magnitude across a selected 
section of the stented LAD for each mesh. A general agreement exists in the 
WSS distributions for all the meshes; however a detailed examination of the 
WSS magnitudes reveals that there is an appreciable difference between the 
different meshes at the peri-strut regions as shown in figure 3.5b. Thus to 
quantify these WSS magnitude differences, the mean WSS magnitude of the  
Flow inlet 
z-axis x-axis 
y-axis 
Flow outlet 
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region where flow at the peri-strut region was deemed to have recovered 
was taken. Table 3.2 shows result of the mean WSS from the coarsest to the 
finest mesh simulations. 
 
 
Figure 3.5  Comparison of WSSs in stented LAD between all meshes. 
(Figure 3.5a) shows a general WSS distribution within the stented model and 
(Figure 3.5b) is the WSS at a zoomed in section of the peri-strut region. 
 
Table 3.2  Mean WSS of recovered flow at peri-strut region 
Mesh Refinement Number of Cells  Mean WSS (Pa) 
Coarsest 61159 1.92 
 244651 1.82 
460271 1.76 
621698 1.73 
936716 1.64 
Finest 1070554 1.62 
 
3.5a 3.5b 
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The results here tend to suggest that mesh with insufficient spatial resolution 
could yield over-estimated WSS levels. Considering the finest mesh obtained 
as a “gold standard”, the relative percentage WSS error [289] between 
successive meshes, where 𝑖 is the order of mesh number and 𝜏6 is the WSS 
of the finest mesh is calculated to be 18.5%, 12.3%, 8.6%, 6.7%, 1.2% 
respectively. It is therefore demonstrated that mesh independence is 
established at 936716 cells and that this density was sufficient enough to 
provide acceptable accurate CFD results as further mesh refinement 
(1070554 cells) yielded an insignificant change to the WSS magnitude. The 
mesh of 936716 hexahedral cells represents a compromise between result 
accuracy and computational costs, and so this mesh density is used in the 
simulation of the flow dynamics with error < 5% expected in results. The 
computational cost in running simulations for the different mesh densities is 
shown in table 3.3. A Viglen Omnino all-in-one desktop pc with a random-
access memory of 4.00 GB was used for the CFD simulation.  
 
Table 3.3  Computational costs for different mesh densities 
Mesh Density Computational Cost 
 Hours Minutes Seconds 
61159 0 4 49 
244651 0 24 20 
460271 0 33 48 
621698 1 26 23 
936716 2 23 3 
1070554 2 52 54 
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3.3.5     SIMULATION (SOLUTION PHASE) 
 
With the convergence criterion established to ensure that results are 
insensitive to mesh density, integrations of the fluid flow governing equations 
thus equations 3.5 and 3.6 are then solved by iterations. Since the pressure 
term of the discretised Navier-Stokes equation is unknown and fluid flow 
cannot be determined if flow pressure field is neglected, a method to couple 
pressure and velocity is needed. Thus Semi-Implicit Method for Pressure-
Linked Equations (SIMPLE) algorithm was used for velocity-pressure 
coupling [290].  Simulations were therefore executed using a pressure based 
Navier-Stokes solver on a double precision solver FVM platform. Pressure 
and momentum were discretised using a second order scheme as this 
provided for a second order accurate numerical solution in space.   
Flow boundary conditions controlling the model included no slip at the tube 
walls and velocity inlet and outlet boundary conditions. A user defined 
function (UDF) was written to apply a physiological pulsatile LAD inlet 
velocity flow waveform derived by Marcus et al. [58] at the inlet boundary of 
the model. This flow waveform is shown in figure 3.6. Also, the flow velocity 
waveform imposed at the inlet boundary was assumed to be parabolic. At the 
outlet boundary, a constant pressure value was specified and a zero normal 
derivative was also specified for the velocity. To eliminate start up effects, 
three cycles of the LAD flow waveform was performed with only the results 
from the third cycle taken for analysis.  
Since the present study is based on transient LAD physiological flow, it 
becomes imperative to perform a time step convergence in addition to the 
mesh convergence done in order to ensure better accuracy of results. Thus 
temporal discretisation should be sufficient enough to produce accurate time 
evolution of velocity component of a transient flow. This is necessary  
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especially as there are significant time dependent flow dynamics within the 
LAD flow cycle. So simulation of each LAD pulse cycle was discretised into 
300 time steps of size 0.005s which was used for final CFD analysis as 
further discretisation of time step produced negligible results but only 
increased computational cost. Solutions for each time step were deemed to 
have converged when the normalised scaled continuity residuals and x-, y-, 
and z- velocity components had fallen to below 10–5 or after 200 iterations. 
Blood was assumed incompressible with a density, 𝜌 of 1057𝑘𝑔/𝑚3and an 
average inlet velocity, 𝑉 of 0.265𝑚/𝑠 [291]. Considering blood flow to be 
Newtonian with dynamic viscosity 𝜇 of 0.35 𝑚𝑃𝑎. 𝑠 through the LAD of 
internal diameter, 𝐷 of 3𝑚𝑚 the mean Reynolds number, 𝑅𝑒 is calculated to 
be 240. Blood flow is therefore considered laminar as 𝑅𝑒 calculated is less 
than 1000 [292]. Re is defined as [43]: 
𝑅𝑒 =  
𝜌𝑉𝐷
𝜇
   3.7                  
Taking a normal resting heart rate of an adult to be 70 beats/min (i.e 𝜔 =
7.3), Womersley number, 𝛼 that defines the unsteady nature of the LAD 
flow is calculated to be 2.4. Wormersley number is defined as [293]: 
𝛼 =  
𝐷
2
√
𝜔𝜌
𝜇
  3.8 
Thus flow is laminar and satisfies physiological LAD flow dynamics [294].  
 
Figure 3.6  LAD flow waveform 
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3.3.6     QUANTIFICATION OF BLOOD MODEL DIFFERENCES  
 
A quantitative measure of WSSs within the stented model with the use 
different constitutive blood models was introduced to determine the WSS 
differences between each model in the analysis of blood flow dynamics. So 
for the quantitative analysis different time points of the LAD cardiac cycle; 
thus 𝑡1 = 0.1𝑠, 𝑡2 = 0.2𝑠, 𝑡3 = 0.3𝑠, 𝑡4 = 0.4𝑠, 𝑡5 = 0.5𝑠, 𝑡6 = 0.6𝑠, 𝑡7 =
0.7𝑠, 𝑡8 = 0.8𝑠, 𝑡9 = 0.9𝑠 𝑎𝑛𝑑 𝑡10 = 1𝑠  were taken. Data produced from 
using Carreau model in the flow simulation was considered as the target data 
as this model was shown to best fit the experimental rheological blood data. 
The Newtonian and non-Newtonian Power Law models were compared to 
the Carreau model to find the agreement between each set of data. 
Quantitative analysis of the disagreement between Carreau model and the 
Newtonian and non-Newtonian Power Law models were performed by the 
formulation given below:  
𝜀 = 100 × 
(|𝐴(𝑠;𝑡)− 𝐵(𝑠;𝑡)|)
0.5×(𝐴(𝑠;𝑡)+𝐵(𝑠;𝑡))
  3.8 
  
where 𝜀 is the measure of error between two different constitutive blood 
models.  𝐴 and 𝐵 are the acquired and target averaged WSS data 
respectively produced from the flow simulation at instantaneous time point 𝑡 
and at specific region 𝑠 within the stented artery. The specific region 𝑠,  
is a 0.2mm square area taken at the inlet, outlet and peri-strut regions where 
flow is assumed to be most stable. In the case of the peri-strut region, the 
most stable flow region is where flow is deemed to have recovered; thus 
have similar WSS magnitudes as that of the inlet and outlet regions. The fit 
of the agreement WSS data produced by the two rheological models was 
considered good if 𝜀 was less than 0.1 and excellent if less than 0.05. 
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3.4        RESULTS 
 
3.4.1     DATA ANALYSIS (POST-PROCESSING PHASE) 
 
Pulsatile LAD flow computation of three different constitutive blood models 
(Newtonian, non-Newtonian Power Law, Carreau) within a stented artery 
was performed and the WSS data in the stented model from each blood 
model was analysed. Figure 3.7 shows the WSS distributions within the 
stented artery at specific instantaneous time points of the LAD flow 
waveform.  
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Figure 3.7 shows an xy-plane of WSS distribution (Pa) contour plots within 
stented LAD artery at time points of 0.1s, 0.2s, 0.3s, 0.5s, 0.7s and 0.9s. 
Flow direction is indicated by arrow (left to right). WSS magnitude shown on 
the colour bar legend ranges from 0.008 Pa (indicated by the colour dark 
blue) to 23.9 Pa (indicated by the colour red).    
The grooves shown in figure 3.7 represent the stent position within the 
artery. It is noticed that at time; t5 = 0.5s, the WSS magnitudes recorded at 
these grooves are the highest (~19 Pa) comparatively to the WSS 
magnitudes recorded at other time points. Additionally, lower WSS 
magnitude across the LAD stented artery were recorded at time t1 = 0.1s, t2 
= 0.2s and t3 = 0.3s  
t3 = 0.25s t4 = 0.35s 
t3 = 0.3s t5 = 0.5s 
t7 = 0.7s t9 = 0.9s 
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Figure 3.8 shows the WSSs generated along the centre plane of the stented 
artery by the different constitutive blood models at instantaneous time points 
of a complete LAD cardiac cycle. 
 
 
 
 
 
 
 
t1 = 0.2s t2 = 0.2s 
t3 = 0.3s t4 = 0.4s 
t1 = 0.1s 
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t7 = 0.7s t8 = 0.8s 
t5 = 0.5s t6 = 0.6s 
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Figure 3.8  Line Graph of WSSs (Pa) in stented LAD artery using different 
constitutive blood models and at different time points.  
As seen from figures presented in figure 3.8, WSS magnitudes experienced 
on the stents are higher compared to the WSS magnitudes at regions around 
the stent. This phenomenon is similar to that shown in figure 3.7. It is also 
noted that at t4 = 0.4s to t10 = 1s, the first stent strut in relation to the flow 
direction (thus from left to right) experiences high WSS compared to that of 
the consecutive stent struts. Plausible reason for this occurrence is that flow 
over the first ridge is faster than the subsequent struts and from Bernoulli’s 
equation the pressure at the first strut would be lower than the subsequent 
struts. As pressure is high at the immediate regions of the strut due to low 
fluid velocity, this creates a pressure difference across the strut. This 
pressure difference leads to increase WSS magnitudes. 
Newtonian, non-Newtonian Power Law and Carreau models are seen to 
produce similar WSS pattern along the centre plane of the stented LAD as 
shown in results figure 3.8. Nonetheless, WSS magnitudes at selected time 
points of the LAD waveform amongst the three models are different. This 
result was expected and consistent with similar studies of Benard et al. [29]. 
From this study we could appreciate that non-linear and linear flow models 
t9 = 0.9s 
t10 = 1s 
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generate differences in near wall viscosity behaviour which results in the 
alteration of WSSs recorded. It is also observed that increased flow rate led 
to an emphasis of fluid perturbation within the stented region of the artery 
and yielded a WSS rise. Minimal WSS levels are experienced at immediate 
peri-strut regions and with peak WSS levels experienced on top of stent 
struts. WSS levels are also observed to increase with increase in flow 
recovery within inter-strut regions. Quantitative analysis of WSS error 
between the different blood rheological models at different time points within 
the stented artery is shown in Table 3.4.  
 
  
Table 3.4 Quantitative measurements of WSSs (Pa) error between different 
constitutive blood models and at varied regions and time points. 
 Measure of Error between  WSS data 
Time: t1 = 0.1s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0595 0.1744 
Inter-strut 1 and 2  0.0248 0.0753 
Inter-strut 2 and 3 0.0242 0.0858 
Inter-strut 3 and 4 0.0258 0.0977 
Inter-strut 4 and 5 0.0201 0.0768 
Outlet 0.0190 0.194 
 
Time: t2 = 0.2s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.1724 0.2514 
Inter-strut 1 and 2 0.0642 0.0655 
Inter-strut 2 and 3 0.0642 0.0719 
Inter-strut 3 and 4 0.0766 0.0837 
Inter-strut 4 and 5 0.0631 0.0648 
Outlet 0.0881 0.1182 
Inlet Outlet 
Strut 1 Strut 2 Strut 3 Strut 4 Strut 5 
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  Measure of Error between  WSS data 
Time: t3 = 0.3s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.4099 0.1086 
Inter-strut 1 and 2 1.0557 0.1745 
Inter-strut 2 and 3 1.6118 0.2771 
Inter-strut 3 and 4 2.1068 0.3624 
Inter-strut 4 and 5  2.0252 0.3527 
Outlet 2.7880 0.4632 
 
Time: t4 = 0.4s 
 Newtonian Vs. 
Carreau 
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0390 1.3473 
Inter-strut 1 and 2 0.0209 0.4165 
Inter-strut 2 and 3 0.0221 0.4321 
Inter-strut 3 and 4 0.0253 0.4736 
Inter-strut 4 and 5 0.0194 0.3582 
Outlet 0.0202 0.4812 
 
Time: t5 = 0.5s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0229 1.9033 
Inter-strut 1 and 2 0.0148 0.6036 
Inter-strut 2 and 3 0.0166 0.6287 
Inter-strut 3 and 4 0.0194 0.6735 
Inter-strut 4 and 5 0.0158 0.5311 
Outlet 0.0178 0.74 
 
Time: t6 = 0.6s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0280 1.6904 
Inter-strut 1 and 2 0.0169 0.5461 
Inter-strut 2 and 3 0.0187 0.5703 
Inter-strut 3 and 4 0.0215 0.6167 
Inter-strut 4 and 5 0.0172 0.4810 
Outlet 0.0194 0.6853 
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 Measure of Error between  WSS data 
Time: t7 = 0.7s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0316 1.5635 
Inter-strut 1 and 2 0.0190 0.5123 
Inter-strut 2 and 3 0.0211 0.5367 
Inter-strut 3 and 4 0.0244 0.5841 
Inter-strut 4 and 5 0.0195 0.4538 
Outlet 0.0224 0.6516 
 
Time: t8 = 0.8s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0367 1.4095 
Inter-strut 1 and 2 0.0217 0.4687 
Inter-strut 2 and 3 0.0243 0.4942 
Inter-strut 3 and 4 0.0283 0.5409 
Inter-strut 4 and 5 0.0226 0.4188 
Outlet 0.0267 0.6097 
 
Time: t9 = 0.9s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0416 1.2851 
Inter-strut 1 and 2 0.0247 0.4350 
Inter-strut 2 and 3 0.0279 0.4612 
Inter-strut 3 and 4 0.0327 0.5072 
Inter-strut 4 and 5 0.0263 0.3922 
Outlet 0.0319 0.5768 
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 Measure of Error between  WSS data 
Time: t10 = 1s 
 Newtonian Vs. 
Carreau  
Carreau Vs. non- 
Newtonian Power Law 
Inlet  0.0563 1.0140 
Inter-strut 1 and 2 0.0327 0.3504 
Inter-strut 2 and 3 0.0370 0.3752 
Inter-strut 3 and 4 0.0437 0.4162 
Inter-strut 4 and 5 0.0353 0.3209 
Outlet 0.0447 0.4874 
 
From the WSS error data presented in Table 3.4, Newtonian is noticed to 
compare more closely to Carreau model than non-Newtonian Power Law 
compared to Carreau model.  
 
3.5        DISCUSSION 
 
Numerical transient simulations were applied to a straight helical stented 
artery under LAD pulsatile flow conditions for Newtonian and two non-
Newtonian viscosity blood models. The WSS distribution trends within the 
stented artery are observed to be same for all the blood viscosity models 
investigated at the selected cardiac time points; however the WSS 
magnitudes differed from one viscosity model to another.   
Based on the CFD results presented, the WSS distributions within the 
stented LAD artery can be seen as highly non-uniform. During the flow 
deceleration phase (t1) characterised by a negative flow rate, the WSS 
magnitudes produced by Carreau model and Newtonian model are seen to 
be very similar throughout the entire stented arterial region. The agreement 
between these two constitutive blood models at this phase was considered 
excellent within the areas of interest thus; inlet and outlet regions of the 
stented artery and inter-strut regions, 𝜀 < 0.05. The agreement between the 
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non-Newtonian Power Law and the Carreau model within the inter-strut 
regions was considered good as 𝜀 < 0.1. Conversely, the agreement 
between these two latter constitutive blood models at the inlet and outlet 
regions was considered poor as 𝜀 > 0.1. On the top of the stent struts, WSS 
magnitudes produced by the non-Newtonian Power Law model was 
observed to be lower compared to the Newtonian and Carreau models which 
recorded very similar WSS magnitudes. 
At the acceleration phase (t2) characterised with a forward flow rate, the 
WSS magnitudes produced by the Newtonian and the non-Newtonian Power 
within the inter-strut regions are shown to have good agreement with that of 
the WSS magnitude produced by Carreau model within the same regions; 
thus 𝜀 < 0.1.  At the inlet and outlet regions, there was a poor agreement 
between the non-Newtonian Power Law and Carreau model (𝜀 > 0.1). Also, 
the agreement between Newtonian and Carreau model at the inlet region 
was poor, however at the outlet region the agreement between the two 
models was good. It is suggested that the difference of WSS error seen 
between these two regions may be as a result of the local dynamic nature of 
flow at the respective regions which could influence the impact of both 
constitutive blood models. 
At deceleration phase (t3), flow rate is predicted to be very minimal and this 
is marked by the very low WSS magnitudes as shown in figure 3.8. However, 
the WSS magnitudes produced by all the blood models being investigated 
were seen to be incongruent to each other at the regions of interest. The 
measures of error difference between the three rheological models were very 
poor (𝜀 > 0.1) and thus the error difference considered very significant. It is 
noted however that Newtonian model at this phase compared worse to 
Carreau model as opposed to non-Newtonian Power Law compared to 
Carreau model.  
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During the continuous acceleration phases (t4, t5) and deceleration phases 
(t6, t7, t8, t9 and t10) with each phase having a forward flow rate and 
considerable high flow rate magnitude, the WSS magnitudes produced by 
the Newtonian model and Carreau model are seen to be more comparable 
throughout the entire region of the stented artery. The agreement between 
the Carreau and Newtonian models were also considered to be excellent as 
𝜀 < 0.05. Conversely the agreements between the non-Newtonian Power 
Law and Carreau models at these different phases were observed to be very 
poor 𝜀 > 0.1. Additionally, non-Newtonian Power Law model was observed to 
under-estimate the WSS magnitudes produced within the stented artery 
during these phases. 
From the results analyses it is noted that Newtonian model is able to capture 
very closely most of the non-Newtonian blood viscosity’s (Carreau model) 
effect on WSS magnitudes within the stented LAD model. For instance at 
cardiac time points of (t1, t2, t4, - t10) the agreement between WSS data 
produced by Newtonian model and the Carreau model at regions of interest 
were considered excellent and thus the error difference in WSS data 
between these two rheological models used for the LAD flow simulation 
considered insignificant. Therefore the assumption that Newtonian model 
could serve as an acceptable rheological model to analyse the non-
Newtonian blood characteristics within straight stented LAD is justifiable.  
At time point (t3) of the cardiac cycle however, the Newtonian model is noted 
not able to mimic the behaviour of the non-Newtonian rheological blood 
model. Whilst this result is indicative of the fact that Newtonian model is not 
able to fully capture the behaviour of the non-Newtonian rheological blood 
model over a complete cardiac waveform of the LAD, general results 
nonetheless show that Newtonian model agrees very well with the non-
Newtonian rheological blood model over 80% of the LAD cardiac cycle. Thus 
the Newtonian model and Carreau model is observed to show a good 
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agreement quantitatively in the WSSs during the LAD cardiac cycle. On the 
contrary, non-Newtonian Power Law model is found to produce much lower 
WSS values. This observation is consistent with other observations made by 
Soulis et al. [35], Liu et al. [295] and Johnston et al. [296] in the investigation 
of non-Newtonian blood flow in the human coronary artery. It should be 
noted however that although observations made on the effect of non-
Newtonian Power Law model on WSS correlated to that reported by Soulis et 
al., Liu et al., and Johnston et al; each study reported was carried out under 
different flow condition. Liu et al., investigated into the influence of non-
Newtonian model on WSS in right coronary artery under non-physiological 
unsteady flow conditions whilst Soulis et al., and Johnston et al., performed 
their investigation simulating steady flow conditions. On the other hand, 
investigation on the impact of non-Newtonian blood models on WSS reported 
in this thesis was conducted using physiologically realistic LAD pulsatile flow 
conditions. Also, in the investigation by Soulis at el. [35] it was reported that 
at mid- to high strain rates Carreau model tends to behave like Newtonian 
model. The centre-line velocity used in the simulation of the constitutive 
blood models in this thesis is 0.53 𝑚/𝑠 and at mid- to large velocity centre-
lines (around 0.1 𝑚/𝑠 ≤ ) it has been reported by Liu et al. [295] and 
Johnston et al. [296] that WSS magnitude for Carreau and Newtonian 
models are similar whilst Power Law model produces very low WSSs. This 
therefore tends to explain further the reason why the WSS magnitudes of the 
Carreau and Newtonian models observed are similar and that of non-
Newtonian Power Law model are much lower.      
A CFD analysis by Razavi et al. [297] into stenotic flow dynamics using six 
non-Newtonian viscosity models; (i.e. Power Law, Carreau Yasuda, Carreau, 
Generalised Power Law, modified Casson, Walburn–Schneck) and a 
Newtonian model suggested Carreau model as a suitable model for the 
analysis of stenotic fluid flow dynamics in a carotid artery under pulsatile flow 
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conditions. In the study it was suggested that the cut-off value for global non-
Newtonian importance factor; IG = 1 for which blood flow could be assumed 
to exhibit non-Newtonian behaviour. IG defines the relative difference 
between Newtonian viscosity value and non-Newtonian viscosity value over 
an entire fluid model [192]. So in the analysis of IGs of the non-Newtonian 
models it was observed that Carreau and Carreau Yasuda models predicted 
moderate IG values whilst the other models predicted either high or low IGs. 
Using either high or low IG models could lead to overestimation or 
underestimation of non-Newtonian behaviour respectively. This consequently 
could dominate the effect of the mechanical parameters such as WSS 
magnitudes being recorded and therefore could produce a false 
representation of the mechanical milieu present in the artery. The use of 
Carreau model on the other hand produced a moderate non-Newtonian 
behaviour which therefore showed better representation of the mechanical 
environment in the artery. This conclusion from Razavi et al. [297] thus tend 
to further support the reason why Carreau model was considered as the 
benchmark for comparing the Newtonian and non-Newtonian Power Law 
effects on WSSs within the stented LAD artery in addition to having shown in 
figure 3.1 that Carreau model best fitted experimental blood rheological 
models.  
 
3.5.1     LIMITATIONS 
 
One limitation of this study was that a straight stented tube was used as a 
model for the stented LAD artery. This simplified geometry of the artery 
constitutes another assumption because the anatomical shape of the artery 
is tortuous and curved. Additionally, stenosis is more prone to arterial regions 
which are curved and bifurcated because of the strong relation existing  
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between recirculation regions induced by the effect of curvature and 
atherogenesis process. Seo et al. [214]  investigated into the flow fields 
within straight and curved vessels and revealed that the extent of flow 
disturbance and flow separation is dependent on angle of arterial curvature.   
Also, a simplified helical stent design was modelled to investigate the effect 
of stent on flow characteristics. Whilst the hemodynamic data achieved helps 
us appreciate the effects of stent on fluid flow dynamics it is however known 
that not all stent designs alter hemodynamic parameters in the same manner 
and probably analysis of different constitutive blood models on complex 
stents may not be comparable. Comparative studies of different stent 
designs but of identical stent parameters within arteries have shown 
disparities in local hemodynamic milieu which have been likely attributed to 
the difference in stent design [298, 299]. It is also reasoned that most 
standard commercial stents have stent connectors which links two struts 
together. These connectors increase the complexity of the stent designs and 
depending on their length and the alignment to fluid flow could affect the 
hemodynamic environment [300]. Therefore analysis from our simplified 
stent geometry may not be sufficient enough to capture different flow 
dynamics that may be present in a real case. 
It is therefore not clear how Newtonian and Carreau models would compare 
when more complex arterial and stent geometries are examined. 
 
3.6       CONCLUSION 
 
In summary, the choice of rheological viscosity model used for analysing 
blood flow behaviour and in assessing its impact on WSS in stented LAD 
artery as afore discussed can significantly affect WSS magnitudes. This 
subsequently influences our judgment in predicting accurately stented  
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arterial sites more prone to restenosis. Endothelial transport properties have 
been reported to alter as a result of endothelial structural and functional 
changes mediated by WSS [301]. Hence it is important to quantify accurately 
the WSS that may induce ECs functional and structural changes.  
As discussed in section 3.5 of this chapter, the use of non-Newtonian Power 
Law in simulating blood flow in a stented coronary artery led to under-
estimation of WSS magnitudes. Conversely, the use of Carreau model and 
Newtonian model showed similar WSS magnitudes under realistic pulsatile 
LAD flow condition simulation. So, the choice of rheological blood model 
used to simulate blood flow could under-estimate or over-estimate WSS 
predicted in arterial models. From the WSS data presented in this chapter, 
the use of Newtonian model other than Carreau model in the analysis of 
WSSs in a straight stented LAD, is a better alternative option. This 
proposition is made based on the reasons that: 
 75% of total coronary blood flow occurs during the diastolic period 
[302] and at this period Newtonian model is seen to be able to mimic 
the non-Newtonian rheological blood model based on Carreau model.  
 
 Additionally, the 10% which constitutes the total percentage of which 
Newtonian model is not able to mimic the non-Newtonian rheological 
blood models behaviour occurs during systolic where flowrate is very 
low. It is postulated that taking into account a complete cardiac cycle 
(1s), the failure of the Newtonian model to capture the non-Newtonian 
blood behaviour for a tenth of a second may result in an insignificant 
effect in the general analysis of blood flow dynamics on EC response.  
Finally, as illustrated in figure 3.8, the use of different rheological blood 
models in blood flow simulation within stented artery resulted in 
comparatively different WSS magnitudes; however WSS distributions were  
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similar. Interestingly, WSS magnitude recorded on the first stent strut 
respective to the flow direction was the highest compared to the subsequent 
stent struts which showed relatively lower WSS magnitudes. Explanation to 
this observation was that fluid flow tends to reduce in speed as it flows 
across successive struts. So, employing Bernoulli’s equation, it is deduced 
that pressure on the first stent strut would be the lowest compared to the 
subsequent struts. Additionally, flow speed at the very immediate regions of 
stent strut is very low and thus pressures at these regions are high. The 
pressure difference gives rise to the WSS magnitudes which therefore 
implies that the lower the pressure on top of the strut, the higher the WSS 
magnitude. 
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CHAPTER  4 
 
FLOW BIOREACTOR 
 
4.1        EFFECTS OF STRESSES ON ECs RESPONSE 
 
Numerous studies have established relationships between ECs structure, 
transport properties and gene activity changes to mechanical stresses [51, 
303-308]. The mostly reported ECs alteration when subjected to fluidic WSS 
has been in its morphological change. When ECs are not stimulated thus by 
stress they are shown to be cobblestone-like and disposed to a random cell 
alignment nature. However when they are exposed to appropriate 
physiological fluidic WSS levels, they have been shown to elongate and align 
in the direction of flow in a time dependent manner [308]. It should be made 
clear however that ECs in vivo are not only subjected to fluidic WSS but also 
tensile hoop strain as a result of cyclic stretching and contraction of arterial 
walls [309]. These shear stress and tensile strain coexist and may impact the 
function of ECs to the onset of arterial disease [310]. In the case of a 
diseased artery, the arteries are said to be stiffer [311]. Thus the cyclic 
stretching and contraction action of arteria walls are reduced or become 
negligible. From the above discussion it could therefore be assumed that 
WSS play dominant role influencing ECs response within diseased arteries. 
So, the effect of tensile hoop strain on ECs could be ignored based on 
arterial stiffness.  
It is agreed that CFD analysis of local hemodynamics within stented artery 
based on the assumptions of rigid arterial wall and fixed stent may affect  
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WSS and fluid flow dynamics results. So performing fluid-structure 
interaction analysis of the local hemodynamics within the stented artery 
which takes into account arterial wall compliance may produce further 
hemodynamic data that CFD simulations may fail to capture. Nonetheless, a 
study by Chiastra et al. [312] on the necessity of modelling fluid-structure 
interaction for stented coronary arteries revealed that CFD analysis based on 
the assumption of rigid arterial wall for fluid-structure interaction simulations 
are adequate when analysing WSSs.      
When ECs are stimulated under hydrostatic pressure in the absence of 
fluidic stresses, the cells are shown to elongate with time but have a random 
cell alignment disposure [313]. Further investigations into the independent 
effects of hydrostatic pressure and fluidic stress on EC response have shown 
increase in cell proliferation and a formation of a multi-layered cell structure 
when the cells are exposed to only hydrostatic pressure [313]. When cells 
are exposed to a physiological laminar WSS however, proliferation is 
inhibited and cells form a monolayer structure [314]. Interestingly, White et 
al. [24] have suggested that temporal gradient but not spatial gradient shear 
stress stimulates EC proliferation. Also disturbed WSS is predicted to 
influence EC proliferation [315]. Investigations into the response of ECs to 
combined hydrostatic pressure and shear stress have shown ECs to 
elongate and align to the flow direction and also exhibit a monolayer 
structure [316]. It is therefore postulated that shear stress has an over-riding 
effect on ECs morphology when the cells are subjected to combined shear 
stress and hydrostatic pressure. Studies by Bond et al. [317, 318] into the 
morphological changes of EC nuclei indicated that nuclei elongated and 
aligned with applied shear stress. This implied that there is a parallel 
behaviour between morphological changes of EC and its nucleus. However 
one needs to be very careful when making assumptions of nuclei behaviour 
based on that of EC behaviour as there is quiet a weak correlation  
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between nucleus elongation and stress. Thus other factors such as pulsatility 
of flow or arterial wall stiffness may influence nucleus elongation [317]. 
Understanding ECs morphology can be beneficial in predicting arterial sites 
which are healthy and those prone to diseases. It is suggested that arterial 
sites having ECs of cobblestone morphology are more atheroma prone 
whereas sites with elongated ECs are athero-protected [92, 181, 319].  
Endothelial morphological changes and functions mediated by mechanical 
stresses are regulated by very complex molecular signalling cascades [320]. 
A study by Warboys et al. [305] into the effect of chronic and acute stresses 
on ECs function demonstrated that chronic shear stress reduced ECs 
permeability to macromolecules. It was suggested that this ECs response 
was achieved as constant shear stress induced nitric oxide (NO) synthesis 
through production of phosphatidylinositol 3-OH (P13K) and soluble guanylyl 
cyclase. Increase permeability of endothelium layer to macromolecules such 
as lipoprotein over a period of time has been suggested to trigger 
atherosclerosis [92], thus this stress-NO phenomenon could help explain the 
athero-protective nature of ECs subjected to shear stress.   
 
4.2        TYPES OF STRESSES ON ECs  
 
Several studies have produced compelling evidences to suggest a link 
between WSSs and the disposure to an arterial site being prone to disease 
[12, 109, 321-323]. Whilst these evidences are acceptable, they are still not 
sufficient and therefore it is not prudent to exclude other factors that may 
influence the anatomic state of an artery. Hence, other additional theories 
have been postulated based on either temporal (TWSSG) or spatial 
(SWSSG) rate of change of the WSS or oscillatory shear index (OSI) [11, 
324-326]. These additional theories allow for the consideration of the 
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physiological pulsatile blood flow behaviour in the arteries and also the 
complex geometrical structure of the artery. 
 
4.2.1     TEMPORAL WALL SHEAR STRESS GRADIENT (TWSSG) 
 
The dynamic nature of blood flow with respect to the cardiac cycle gives rise 
to TWSSG. White et al. [50] postulated that TWSSG induced increased 
endothelial turnover by stimulating ERK 1/2 activation. This effect has been 
implicated to contribute in the development of atherosclerotic lesions [327]. 
TWSSG is calculated by the mathematical formulation given below: 
𝑇𝑊𝑆𝑆𝐺 = 
𝜕𝜏𝑤
𝜕𝑡
  4.1   
where 𝜕𝜏𝑤 is the change in WSS and 𝜕𝑡 is the change in time. 
 
4.2.2     SPATIAL WALL SHEAR STRESS GRADIENT (SWSSG) 
 
The complex geometric shape of the artery could cause local spatial 
variation of the stresses acting on ECs. It has been implied that these local 
changes of stresses acting on the EC could induce intercellular junction gaps 
which consequently would lead to uncontrolled permeability of 
macromolecules [328, 329]. SWSSG is calculated by the mathematical 
equation given below: 
𝑆𝑊𝑆𝑆𝐺 =  
𝜕𝜏𝑤
𝜕𝑠
   4.2 
where 𝜕𝑠 is the change in distance.  
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4.2.3     OSCILLATORY SHEAR INDEX (OSI) 
 
OSI is the measure of deflection of the WSS vector from the main directional 
blood flow; thus an indication of flow disruption during the flow cycle in the 
artery as suggested by Ku et al. [102]. A study by Zhang et al. [330] into the 
flow patterns and WSS in the human carotid artery made a correlation 
between elevated OSI with increased risk of stenosis in the artery. This OSI 
formulated as: 
𝑂𝑆𝐼 = 0.5 × (1 −
|∫ 𝜏𝑤⃑⃑ ⃑⃑  ⃑𝑑𝑡
𝑇
0 |
∫ |𝜏𝑤⃑⃑ ⃑⃑  ⃑|𝑑𝑡
𝑇
0
)  4.3 
where 𝜏𝑤⃑⃑ ⃑⃑   is the instantaneous WSS vector at a cardiac time point, 𝑑𝑡 is the 
change in the time point over a complete cardiac period 𝑇.  
Substantive evidence to explain the onset and progression of atherosclerotic 
lesions still remains elusive. Hence it begs the questions if current popular 
flow metric; i.e. WSS, SWSSG, TWSSG and OSI are enough to capture 
physiological blood flow physics? And do these metrics accurately quantify 
the essence of ECs response to dynamic flow so commonly suggested in 
many literature? Chakraborty et al. [331] demonstrated that directionality of 
shear significantly affected ECs response when the effects of biaxial 
oscillatory shear stress on ECs were investigated. Thus it was implied that 
directional oscillatory shear index could play a critical role in atherogenesis. 
 
4.3   FLOW BIOREACTOR SYSTEMS FOR SUBJECTING ECs TO 
FLUIDIC STRESSES 
 
As discussed in sections 4.1 and 4.2, ECs undergo morphological and 
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functional changes under mechanical stress and there have been numerous 
experimental evidences to demonstrate these phenomena. The use of flow 
bioreactors to simulate measured mechanical stimuli on cells has proved 
critical in quantifying of cells response to different dynamic stresses [24, 49, 
51, 304].  Some of these studies are summarised in table 4.1.   
 
Table 4.1  Flow bioreactor subjecting ECs to mechanical stimuli 
  Mechanical Stresses  
Ref. 
 
WSS  SWSSG  TWSSG  OSI Pressure  Flow  ECs 
Ohashi 
[332] 
Yes No No No Yes Steady BAEC 
Galbraith 
[308] 
Yes No No No No Steady BAEC 
Vara 
[333] 
Yes No Yes No Yes Physio
-logical 
HUVEC 
Conklin 
[334] 
Yes No Yes Yes Yes Physio
-logical 
PCCA 
(ex vivo) 
Estrada 
[48] 
Yes No Yes Yes Yes Physio
-logical 
HAEC 
Dolan 
[335] 
Yes Yes No No Yes Steady BAEC 
Punchard 
[336] 
Yes No Yes No Yes Physio
-logical 
HUVEC 
Dardik 
[337] 
Yes Yes Yes No No Orbital BAEC 
Lane 
[338] 
Yes No No No No Steady HUEPC 
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White [24] Yes Yes Yes Yes Yes Steady HUVEC 
Frangos 
[47] 
Yes No No No Yes Steady HUVEC 
 
HUVEC = Human Umbilical Vein Endothelial Cell, BAEC = Bovine Aortic 
Endothelial Cell, HAEC = Human Aortic Endothelial Cell, PCCA = Porcine 
Common Carotid Artery segment, HUEPC = Human Umbilical Endothelial 
Progenitor Cell. 
 
4.3.1     INTEGRAL PARTS OF FLOW BIOREACTOR SYSTEM 
 
4.3.1.1  FLOW CHAMBER 
 
In flow bioreactor systems, the design of the flow chamber is one of the most 
integral part of the bioreactor system [339]. The flow chamber houses the 
ECs and also influences the mechanical environment being experienced by 
the cells. One of the most widely used and well characterised flow chambers 
is the parallel plate flow chamber (CytoDyne, La Jolla, CA) [47]. This flow 
chamber is a simple and re-usable device which houses ECs seeded on a 
substrate; mostly on glass microscope slides to be subjected to predicted 
flow dynamics. The parallel plate flow chamber (PPFC) allows for a uniform 
distribution of WSSs on cells. In other studies, the PPFC has been modified 
to allow for a wide range of mechanical stimuli which the conventional PPFC 
is not able to achieve. One such example was illustrated by DeVerse et al. 
[340] who housed ECs in a cone-and-plate shearing device; thus subjecting 
the cells to both steady WSS and oscillatory shear stress to investigate and 
characterise the inflammatory state of the ECs. Other flow chambers used by 
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researchers are the compliant cylindrical grafts which facilitate cells to be 
subjected to shear stress and hoop stretch [336, 341] and the converging 
flow chambers which cause spatial variation of shear stress to be 
experienced on the cells [335, 339]. 
 
4.3.1.2  FLOW CIRCUIT PUMP 
 
A simple flow circuit pump is normally used to apply steady flow of culture 
media to subject cells to measured steady stress. However, the physiological 
nature of blood flow in arteries is transient and so there is temporal variation 
of stress suspected to be experienced by ECs in vivo. To capture this 
temporal stress dynamics, researchers developed programmable syringe 
pump which would vary the flow rate produced with respect to time and thus 
produced pulsatile flow instead of a steady flow waveform [24, 342, 343]. 
This application led to cultured ECs experiencing temporal variation of shear 
stress. Whilst data achieved from the afore-mentioned references helps us 
appreciate the independent effects of temporal shear stress variation on 
cells, conclusions made from the results may highly not be applicable to the 
physiological response of ECs in vivo. This is because the syringe pump was 
programmed to apply non-physiological flow parameter on the cells. More so, 
there was no constant recirculation of culture media to the cells thus 
experimentation period was short. This as a result could influence our ability 
to accurately predict ECs response in vivo as short-term and long-term 
exposure to either independent or combined mechanical stimuli could cause 
ECs to respond differently [305].  To overcome these limitations, other 
investigators have developed new pulsatile perfusion systems which could 
produce physiological flow parameters over a continuous long period of time 
[336, 344, 345]. As noted in sections 4.3.1.1 and 4.3.1.2 the flow chamber 
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and flow circuit pump are important parts of the flow bioreactor system that 
aid in achieving desirable flow metrics and creating predicted mechanical 
environment for cells. Furthermore, it is also of equal importance when 
conducting cell experimental studies with the bioreactor system that the 
system is able to be kept under good sterile conditions and provide the ECs 
with the appropriate temperature, CO2, pH and oxygen. Additionally, the flow 
tubing used for the system should be non-compliant to yield accurate and 
repeatable mechanical stresses on the cells over the desired period of time.   
 
4.4        DESIGNING FLOW BIOREACTOR SYSTEM 
 
In designing the flow bioreactor system, one of the main objectives set out to 
achieve was for the system to be able to produce a LAD physiological 
waveform with its associated WSS waveform as illustrated in figure 4.2. Also 
the system was to be simple, cheap and able to produce similar flow 
dynamics in a stented LAD artery as discussed in section 3.4.  
 
4.4.1     DESIGNING FLOW CIRCUIT  
 
The design of the flow circuit system was based on that of Conklin et al. 
[334]. Conklin et al. developed a pulsatile perfusion system which consisted 
of a peristaltic pump that yielded a steady flow and a custom designed cam-
driven physiologic flow simulator to superimpose physiologically relevant 
pulsatile flow waveform on top of the steady flow. An advantage of this 
system was that the cam-driven physiologic flow simulator could be easily 
detached from the system when only steady flow is desired. Additionally the 
system allowed independent control of flow rate and pressure subjected to 
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the cells. The disadvantage to this system however was that accuracy of the 
pulsatile flow waveform reproduced to that targeted was poor.  El-Kurdi et al. 
[346]  designed a similar flow perfusion system to that of Conklin et al. but 
with an added advantage of the system being able to produce a pulsatile flow 
waveform that was more comparable to the targeted waveform. Whilst it 
would appear to be of a better judgement to therefore base the design of the 
flow bioreactor system to that of El-Kurdi et al., it is noted that El-Kurdi’s flow 
system is highly complicated compared to that of Conklin et al. and also 
likely to be relatively more costly to establish. Hence it was deemed 
appropriate to base the flow design on that of Conklin et al. as the design 
was simple and relatively cheap to build. It is proposed that the limitation of 
the flow system by Conklin et al. could be overcome by including a feedback 
control system to the flow simulator to keep a constant angular velocity of the 
camshaft and thus improve the accuracy of the flow waveform produced 
throughout the flow cycle. Additionally, it is noted that Conklin’s flow system 
was designed to study intact vascular segments however it is anticipated that 
this system could be easily modified to incorporate any type of flow chamber 
to investigate ECs response to various mechanical stimuli.  
Illustrated below is a schematic diagram of the flow bioreactor system. The 
bioreactor system works by drawing culture media from a reservoir (A) by the 
use of a peristaltic pump (B) through a non-compliant tube. A compliance 
chamber (C) is connected to the tube to dampen oscillations that may arise 
from the use of the peristaltic pump. The desired pulsatile flow waveform is 
then superimposed onto the flow through the action of the cam-driven 
pulsatile flow simulator (E) and to ensure that this pulsation effect is not 
dampened by the compliance chamber, a one-way flow check valve (D) is 
connected to the tube. The pulsatile flow now passes through a test flow 
chamber (H) were cells cultured on a substrate are housed. To build 
pressure in the system, a flow resistance valve (J) is used to lower the 
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outward flow rate thereby causing a build-up of media in the compliance 
chamber which consequently leads to an increase change in pressure. The 
flow waveform and pressure are quantified using the flow sensors (F) and 
pressure sensors (G) connected to analogue to digital converters. A sterile 
filter (K) is connected to the media reservoir which allows for gaseous 
exchange.       
 
 
 
Figure 4.1 Shows a schematic diagram of flow bioreactor system setup. 
Components housed in the incubator are shown within the dashed line 
square. The arrows show culture media pathway during flow experiment.   A 
= media reservoir, B =peristaltic pump, C = compliance chamber, D = one-
way flow check valve, E = cam-driven pulsatile flow simulator, F = flow 
sensor, G = pressure sensor, H = test flow chamber, J = flow resistance 
valve, K = filter.    
A 
B 
C 
D 
E 
F G 
H 
J 
K 
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Figure 4.2  LAD waveform; Flow rate (L), WSS (R) [58]. 
 
4.4.1.1  FLOW AND PRESSURE SENSORS 
 
To ensure accurate recordings of the flow and pressure data in the system, it 
was crucial that the sensors used to take the measurements were able to: 
 Record sufficient data points to ensure reproducibility of predicted 
flow and pressure waveforms. 
 Sensitive enough to detect any slight changes that may occur in the 
flow and/or pressure at low and high levels. Thus higher accuracy in 
the measurements is obtained.    
 Maintain sterility of flow experiment.   
To achieve the above stipulated requirements, it was suggested that 
ultrasonic flow sensors be used. This is because these sensors have no 
contact to the flow media as they are clamped onto the flow tubing and 
measurements are taken via the acoustic nature of the fluid flow. Hence the 
sterility of the fluid flow experiment is maintained. The flow sensor selected 
for the flow measurement was the Em-Tec SonoTT Clamp-On transducer 
(www.em-tec.com/index.php?topic=produkte&subtopic=emtecProducts). The  
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flow data were then taken on a flow computer (BioProTT) that controlled the 
sensor.  To calibrate the flow sensor for our system, a peristaltic pump was 
used to produce a referenced steady flow rates through a 3.2𝑚𝑚  internal 
diameter tubing. The flow sensor was used to measure the flow rate 
produced by the peristaltic pump using the BioProTT flow computer.  To also 
verify that the peristaltic pump was producing the required flow rate, 
analytical measurements were made by timed collection of the steady flow 
volume exiting the tube over at least 60 seconds. Figure 4.3 and table 4.2 
shows the agreement of flow rates between that measured with the flow 
sensor and also from the analytical measurements to that produced by the 
peristaltic pump. All measurements were repeated at least three times and 
performed under similar conditions that the cell experiments would be 
conducted such as keeping the fluid flow at a temperature of 37℃. 
 
 
 
 
 
 
Figure 4.3  Calibration of flow sensor and peristaltic pump 
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Table  4.2  r2 values and gradient of best fit line (m) for  correlation between 
flow rates measured analytically or from a SonoTT clamp-on flow sensor to 
flow rate from a peristaltic pump.  
Flow Measurement Device m r2 
SonoTT Clamp-On Flow Sensor 0.9011 0.9997 
Analytical Measurements 0.9115 0.9996 
 
 
To also measure the physiological pressure in the system whilst still keeping 
the flow experiment under sterile conditions, a piezoelectric pressure sensor 
(Physiological Pressure Transducer, AD Instruments; MLT844) was used. 
This pressure sensor is used in combination with appropriate signal amplifier 
equipment (Bridge Amp, AD Instruments; ML221) and a PowerLab 4/25T, 
AD Instruments; ML845 which serves as an analogue to digital converter. 
The pressure signals from the pressure transducer are read on a PowerLab 
LabChart software (LabChart 6, AD Instruments) installed on a computer. 
The LabChart is set to convert the signals which are in voltages to pressure 
unit mmHg. It is important that the pressure transducer is able to measure 
accurately a wide range of pressure; for example of relevant physiological 
pressure levels and at a sampling rate at least as high as for the fluid flow. 
To calibrate the pressure transducer, different referenced amount of distilled 
water at temperature of 37℃ is put into a centimetre calibrated column and 
the pressure transducer used to record the pressure in unit voltage exerted 
by each referenced amount of distilled water. Figure 4.4 shows the 
calibration graph of the pressure transducer. Table 4.3 shows the correlation 
between pressure (mmHg) and the voltage measured. 
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Figure 4.4  Calibration of pressure transducer 
 
Table  4.3  r2 values and gradient of best fit line (m) for  correlation between 
pressure and measured voltage of pressure sensor. 
Pressure Sensor Device m r2 
Pressure Transducer 0.0347 0.9999 
 
 
4.4.1.2  CAM DRIVEN PULSATILE FLOW SIMULATOR 
 
The cam driven pulsatile flow simulator shown in figure 4.5 was built in-
house and can power different cams independently to simultaneously 
produce different flow waveforms.  However since the interest of this project 
was to investigate the LAD flow, only the LAD cam was used. The LAD cam 
is attached to a shaft which is connected to a power motor (V5253, Rotalink, 
UK) at one end and at the other end a bearing which constrained its rotation. 
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A proportional-integrated-differential (PID) control system (RedDrive 10A, 
Rotalink, UK) was also connected to the motor to ensure that constant 
angular speed throughout the flow cycle was maintained. A push rod with 
one end attached to a carbon filled polytetrafluoroethylene (PTFE) cap was 
kept constantly in contact with the cam by the use of a stainless steel spring. 
The other end of the push rod which had a no head screw was connected to 
a plunger of a syringe whose barrel is held fixed. When the motor is powered 
on, the shaft tends to rotate which causes the cam to consequently rotate 
and also cause a forth and backward motion of the plunger in the syringe 
barrel. The shape of the cam and angular speed with which the shaft rotates 
determines the velocity of the plunger and also the flow rate at which fluid 
exits out the syringe barrel. In the case of producing a physiological 
waveform, the shaft is caused to rotate at 60𝑟𝑝𝑚 (revolution per minute) to 
give a pulse frequency of physiological level. 
 
 
Figure 4.5  Cam driven pulsatile flow simulator 
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The design of a cam to produce a particular pulsatile waveform can be 
achieved by having define the flow rate in the periodic waveform over a 
complete time period, 𝑇. Thus given a function 𝑔(𝑡) that defines the flow 
rate, the pulsatile component of the waveform could be calculated as 
follows:  
 
1. Firstly, subtract the mean flow rate from the function 𝑔(𝑡) to get the 
oscillatory component: 
𝑔𝑜𝑠𝑐𝑖(𝑡) = 𝑔(𝑡) − 
∫ 𝑔𝑑𝑡
𝑇
0
𝑇
  4.4 
 
2. Based on the cross sectional area of the syringe barrel (𝑎) and the 
oscillatory component of the flow rate 𝑔𝑜𝑠𝑐𝑖(𝑡), the velocity of the 
plunger 𝑢(𝑡) is determined: 
𝑢(𝑡) =  
𝑔𝑜𝑠𝑐𝑖(𝑡)
𝑎
 4.5 
 
3. Integrate 𝑢(𝑡) with respect to time to get the particular position of the 
plunger (𝑥) as a function of time with respect to an arbitrary datum: 
𝑥(𝑡) =  ∫ 𝑢(𝑡)𝑑𝑡  4.6 
 
4. Add a constant, 𝑐 to the above calculated step: 
𝑥′(𝑡) =  𝑥(𝑡) + 𝑐  4.7 
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5. Define the angle at which the cam turns on a cycle: 
𝜃(𝑡) = 2𝜋𝑡  4.8 
 
6. To finally produce the shape of the cam, plot 𝑥′ against 𝜃 in polar 
coordinates: 
 
The plotted coordinates from the above calculations are then exported for 
CNC machining. Figure 4.6 shows a cam profile of a LAD flow waveform. 
 
 
Figure 4.6  Cam profile of LAD waveform 
 
4.4.1.3  PERISTALTIC PUMP AND TUBING 
 
It was important to use a peristaltic pump which could provide a given flow 
rate required to produce a predicted WSS especially in the case where  
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physiological WSS levels are being considered. Hence the peristaltic pump 
selected to use for the flow system was a Masterflex LS 115/230 drive from 
Cole-Parmer, UK which could deliver very high flow rates (~348 ml/min).  
Also the tubing used for the flow system was required to have acoustic 
properties suitable for use with the flow sensor, ability to withstand the fluid 
flow forces and made of materials suitable for cell culture applications. 
Hence PharMed tubing of internal diameter 3.2𝑚𝑚 and of thickness 1.6𝑚𝑚 
from Fisher Scientific, UK which satisfies the above stated characteristics 
was used.      
 
4.4.2     DESIGNING FLOW CHAMBER  
 
A parallel plate flow chamber was developed to house the ECs cultured on a 
custom designed glass substrate. In designing the parallel plate flow 
chamber, notice was taken of the fact that the dimensions of the flow 
chamber and the flow media viscosity do affect the magnitude of WSSs 
associated with the LAD flow waveform produced on the cells. Hence to 
relate the predicted WSS applied to the ECs to the flow rate of the media and 
the flow chamber, a constant K is defined. This constant, K is given by the 
mathematical formula: 
 
𝐾 =  
6𝜇
𝑏ℎ2
  4.4 
𝜏𝑤 = 𝐾𝑄  4.5 
where 𝜇 is the media viscosity, 𝑏 and ℎ is the width and height 
respectively of the flow chamber, 𝑄 is the flow rate and 𝜏𝑤 is the  
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predicted WSS. The constant K, from the above equation 4.4 signifies that 
fluid viscosity is considered Newtonian. 
As flow in the coronary artery is laminar, it is expected that the Re of flow in 
the flow chamber is sufficiently low to ensure that fluid flow is laminar. Thus 
particular consideration must be taken when choosing the constant K.  To 
verify the condition that flow is laminar and Re is satisfied, the below 
mathematical equation is employed. 
 
𝑅𝑒 =  
𝜌𝑄𝐷ℎ
𝜇𝑏ℎ
  4.6 
𝐷ℎ =  
4𝑏ℎ
2(𝑏+ℎ)
  4.7 
where 𝐷ℎ is the hydraulic diameter. The Reynolds number of the designed 
flow chamber with height of 0.48𝑚𝑚 and fluid density of 1000𝑘𝑔/𝑚3 is 
366.2 at a flow rate calculated to obtain a mean WSS of 2 𝑃𝑎. Flow with Re 
< 1000 is considered laminar. Thus our flow condition is laminar as Re 
is 366.2.  
 
4.4.2.1  DESIGNING ECs SUBSTRATE  
 
As the aim of this project is to investigate cells response to mechanical 
stimuli in a stented artery, it was imperative that the mechanical environment 
experienced on cultured cells is similar to that of a real case. It was therefore 
one of the main objectives in this project to design a flow system capable of 
subjecting a wide range of mechanical stresses such as WSS, SWSSG, 
TWSSG and OSI which are predicted to be present within a stented artery on  
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the cells. To achieve this objective it was necessary to establish a flow 
chamber which could create such desired combined mechanical stimuli to be 
experienced on the cells. A simple generic stented LAD artery model which 
was to be investigated would have five independent semi-circular rings as 
shown in figure 4.7. The generic stented artery had dimensions of 3𝑚𝑚 
internal artery diameter, stent strut diameter of 0.15𝑚𝑚 and inter-strut 
spacing of 0.625𝑚𝑚. Thus the flow and WSS dynamics applied to the 
cultured cells is similar to WSS dynamics in a helical stented LAD artery as 
described in section 3.4.1. So, the choice to use a parallel plate flow 
chamber to create the mechanical stimuli needed only subjected cultured 
cells to spatially uniform WSS [47] and not to both spatial and temporal 
gradients in stress which have been suggested to be present within stented 
arteries [4]. However, this parallel plate flow chamber is of a very simple 
design and applies uniform WSS proportional to the flow rate onto cells 
which is one of the main stresses to be investigated in this project. It is 
therefore proposed that in order to use the parallel plate flow chamber, the 
substrate for the cultured cells should be modified so as to create the other 
mechanical stresses of interest i.e. SWSSG and OSI.                  
 
           Figure 4.7  Generic stented artery model 
A glass microscope glass slide which served as the substrate for the cultured 
cells was therefore suggested to be modified into a shape that represented a 
2D shape of the generic stented LAD artery model as shown in figure 4.8. 
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This was expected to create the desired mechanical milieu predicted to be 
subjected to ECs in the stented artery. The dimensions of the semi-circular 
ridges on the glass microscope slide are of the exact dimensions of the stent 
struts and stent spacing of the generic stented artery model. The 
combination of the parallel plate flow chamber and the modified glass 
microscope glass slide is termed as a cell-structure interaction experimental 
model. Detailed development and CFD analysis of the mechanical 
environment within the cell-structure interaction experimental model will be 
discussed in chapter 5.   
 
Figure 4.8  2D shape of the generic stented artery model 
 
4.5        CHARACTERISING CELL CULTURE MEDIUM PROPERTIES 
 
As discussed in chapter 3, viscosity affects the shear rate of a fluid especially 
if it is of non-Newtonian characteristics. More so, viscosities of fluids are 
temperature dependent, hence it was important that the viscosity of culture 
medium at a temperature required for the medium to sustain cell viability be 
quantified.  Additionally, the WSS being experienced in the flow chamber 
could be accurately determined if the viscosity and density of the culture 
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medium flowing through the flow bioreactor system are quantified. 
The cell culture medium used for the flow experiment is made of the 
following compositions; M199 culture media (Sigma-Aldrich) containing 20% 
foetal calf serum (BioSera, UK), 30𝑢𝑔/𝑚𝑙 endothelial cell growth factor 
(Sigma-Aldrich, UK), 30𝑢𝑔/𝑚𝑙 heparin (Sigma-Aldrich, UK), 2𝑚𝑀L-
Glutamine (Sigma-Aldrich), 100𝑢𝑔/𝑚𝑙 Penicillin Streptomycin (Sigma-
Aldrich). Since the flow chamber is placed in an incubator at a temperature of 
37℃, the viscosity of the culture medium was determined at that temperature 
using a vibro viscometer (A&D Vibro Viscometer SV-1A).   
To determine the density of the culture medium, a known volume of the 
medium in a graduated cylinder was weighed on a high precision balance. 
To ensure that measurement of the cell culture medium density recorded 
was accurate, the density of distilled water at  20℃ was also determined and 
compared to that reported by Calvert et al. [347]. 
 
 Table  4.4  Measurements of viscosity and density of cell culture medium at 
37℃ and distilled water at 20℃.   
Fluid  Viscosity (mPa.s) Density (kg/m3) 
Culture Medium 0.64 1005 
Distilled Water 1 998 
Referenced Distilled Water [347] 1.002 1000 
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4.6        CHARACTERISING THE FLOW CIRCUIT 
 
The flow circuit was set up as shown in figure 4.1 with the appropriate flow 
parameters set on the peristaltic pump and the cam driven pulsatile flow 
simulator to produce the desired LAD flow waveform as shown in figure 4.2 
and at a physiological pressure of 120/80mmHg. The flow waveform 
recorded was then compared with the target flow waveform to analyse the 
deviation between them. Analytical measurement of this deviation was 
performed by calculating the mean squared error (𝑀𝑆𝐸) between the two 
waveforms i.e. the measured and the target waveforms, normalised against 
the variance of the of the target waveform as shown in the equation given 
below. 
𝑀𝑆𝐸 =  
∑ (𝑄𝑖− ?̅?𝑖)
2𝑁
𝑖=1
𝑁𝜎𝑄
2   4.8 
where 𝑄𝑖 and ?̅?𝑖 are the measured and target flow rate respectively at 
sampling point 𝑖 on the flow waveform, 𝑁 is the number of sampling point 
and  𝜎𝑄
2 is the variance of the target flow waveform.  
Chetwynd et al. [348] used this equation to quantify the difference between a 
neural network predicted output and the true target output. How the two 
outputs compared was considered good if 𝑀𝑆𝐸 was less than 0.1 and 
excellent if 𝑀𝑆𝐸 was less than 0.05. Figure 4.9 shows the measured flow 
waveform compared with the target waveform and figure 4.10 shows the 
pressure at which the flow data was obtained. The inclusion of a feedback 
control system to the cam-driven pulsatile flow simulator ensured angular 
velocity of camshaft was kept constant throughout the flow cycle. This 
therefore helped improve the accuracy of the target flow waveform 
reproduction. Table 4.5 shows the quantitative data of the deviation between   
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the measured and target flow waveform. 
 
Figure 4.9  Measured vs target LAD flow waveform.  
 
 
Figure 4.10  Physiological pressure at 120/80mmHg 
 
Table 4.5   Measure of deviation between measured and target flow data  
Waveform 𝑴𝑺𝑬 
LAD 0.031 
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It is observed that the flow bioreactor system designed is capable of 
producing the desired physiological LAD flow waveform at a physiological 
pressure of 120/80mmHg. Additionally quantitative analysis performed to 
determine how well the flow waveform produced from the system agreed 
with that of the target showed a very good agreement (𝑀𝑆𝐸 = 0.031). It is 
however acknowledged that for the system to produce a different type 
of waveform, a new cam is needed to be designed. Nonetheless it is 
reasoned that the designed flow system can allow for possible 
modification of flow waveform achieved if desired without requirement 
for new apparatus.   
 
4.7        CONCLUSION 
 
A modular flow bioreactor system has been designed which allows for easy 
addition of new features. This flow system is thus highly versatile and permits 
for a wide range of experiments to be performed with it. As discussed in this 
chapter, the flow bioreactor system is capable of running a parallel steady 
flow and LAD pulsatile flow experiment simultaneously. Also with the addition 
of the feedback control system to the in-house built cam-driven pulsatile flow 
simulator, higher accuracy of target flow waveform is constantly reproduced.    
The flow circuit, culture medium and features used in recording flow and 
pressure parameters have been characterised and calibrated accordingly to 
ensure accuracy of results. The main requirement set out in this chapter was 
that the bioreactor system is capable of producing LAD flow waveforms and 
hydrostatic pressure at physiologically relevant levels and this requirement 
was able to be met. Thus WSSs, OSIs, SWSSGs and TWSSGs experienced 
by the cells when subjected to this flow condition in the designed flow 
bioreactor would be of physiologically realistic levels.    
 115 
 
CHAPTER 5 CELL-STRUCTURE INTERACTION MODEL 
 
CHAPTER  5 
 
CELL-STRUCTURE INTERACTION MODEL 
 
5.1        INTRODUCTION TO STEREO-LITHOGRAPHY 
 
As briefly discussed in section 4.4.2.1 a glass microscope slide which was 
considered as a cell substrate was to be modified to represent a 2D artery 
with five independent semi-circular rings which served as stent as shown in 
figure 4.8. So, to fabricate these stent-like structures on the glass 
microscope slide, a two photon stereo-lithography technique was employed.   
 
5.1.1     STEREO-LITHOGRAPHY 
 
Stereo-lithography is an additive manufacturing technique that involves 
fabricating 3D structures by selectively curing photo-curable polymer based 
resins in a layer-by-layer form [349]. These photo-curable polymer resins 
which are initially of a liquid state are sensitive to specific range of laser 
wavelengths and thus upon exposure to these wavelengths the resins 
change to a solid state. Typically the chemistry involved in this process is 
that the initiator component in the resin gets excited to an unstable state 
when a laser of a specific wavelength is beamed onto the resin. At this 
unstable state, the initiator tends to cleave into its radical components which 
as a result cause a chain of crosslinking reaction with the monomer units. 
Thus a solid polymer network is formed.  Limitation to this technique however 
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is that resolution achieved is dependent on the wavelength used and 
diffraction of light within the polymer based resin which is dictated by Beer 
Lambert Law [350] .  
An advanced technique to the standard stereo-lithography technique is the 
two-photon polymerisation (TPP) [55]. TPP technique can be used to 
fabricate complex bespoke structures with improved resolution and accuracy 
since as it involves curing a pin-point position of the resin at a time as 
opposed to curing the resin in bulk [351].  The main procedure involved when 
using TPP technique to fabricate structures is the absorption of two photons 
simultaneously which enables direct laser writing within photo-curable 
polymer resins. This direct laser writing is based on the quadratic relationship 
between laser excitation wavelength and the two photon absorption cross 
section [352].  Conditions to this relationship are only satisfied at a focal point 
of a laser objective where there is sufficient amount of photon flux. This pin-
point location at the focal spot of the objective in an area known as a voxel 
[353] is of an elliptical volumetric space and acts like a single building block 
for creating complex structures. The laser beam outside this region has 
negligible effect on the photo-curable resin. Thus by translating this focal 
point relative to a curable resin, complex structures could be fabricated in a 
direct laser write approach within a bulk resin [354]. A self-smoothing effect 
of the 3D structure fabricated can be achieved when the voxel overlap is 
sufficiently close [355]. This fabricating technique has been found useful in 
multiple tissue engineering applications and in the preparation of medical 
devices with micro-scale properties [356-358]. TPP technique has also been 
employed to fabricate microfluidic channels as well as structures within 
microfluidic channels [359, 360].  
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5.2        FABRICATING SEMI-CIRCULAR RIDGES ON GLASS SLIDE 
 
5.2.1     GLASS MICROSCOPE SLIDE FUNCTIONALISATION 
 
The surface of a glass microscope slide with dimensions of 70𝑚𝑚 𝑥 25𝑚𝑚 
(Corning, USA) was initially functionalised before fabricating the semi-circular 
ridges on them. Piranha solution using a 3:1 mixture of sulphuric acid 
(𝐻2𝑆𝑂4) and hydrogen peroxide (𝐻2𝑂2) respectively was prepared and the 
glass microscope slide submerged into the mixture for at least 1 hour. This 
solution is a powerful oxidizing agent which exposes the hydroxyl groups 
(−𝑂𝐻) on the surfaces of the glass microscope slide and also removes any 
dirt or organic residue from the slide. After an hour, the glass slide is washed 
in deionised water and dried prior to it being submerged into 10𝑤𝑡% 
methacryloxypropyltrimethoxysilane (𝑀𝐴𝑃𝑇𝑀𝑆) solution in toluene for a 
minimum of 24 hours. Submerging the glass slide into 𝑀𝐴𝑃𝑇𝑀𝑆 solution in 
toluene causes methacrylate groups from the 𝑀𝐴𝑃𝑇𝑀𝑆 solution to bind to 
the −𝑂𝐻 groups exposed on the glass slide. This step allowed for better 
adhesion of polymer-resin during the polymerisation process of fabrication of 
the semi-circular ridges [361]. 
 
5.2.2     FABRICATION OF SEMI-CIRCULAR RIDGES 
 
The fabrication process of the semi-circular ridges firstly involved preparing a 
photo-curable polymer based resin by mixing poly(ethylene glycol) diacrylate 
(PEGda) of molecular weight 700𝑔/𝑚𝑜𝑙 with a 4𝑤𝑡% of photo-initiator 2-
Hydroxy-2-methylpropiophenone (Sigma Aldrich, UK). This polymer resin is 
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then able to be cured in a 266𝑛𝑚 region from the absorption of two photons 
produced by the TPP using a Nd:YAG microchip laser emitting at 532𝑛𝑚.  
To start fabricating the semi-circular ridges, a well of the prepared 
photo-curable polymer resin was created at a region on the 
functionalised glass slide where the structures were desired as shown 
in figure 5.1. This sample glass slide was then affixed to a glass slide 
holder attached to a motorised xyz- stage. The motorised stage was 
controlled by computer-based software which translated the sample 
glass slide relative to the focal point of a stationary 20𝑥 laser objective 
lens. The focal point was positioned just below the polymer/glass slide 
boundary prior to fabrication and for reproducibility all glass 
microscope slides used were needed to be of 1𝑚𝑚 thickness. The 
fabrication setup for patterning the desired structures is illustrated in figure 
5.2. 
 
 
Figure 5.1 shows a well of photo-curable resin on microscope glass slide 
 
 
Well of photo-curable 
polymer resin 
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Figure 5.2 shows the fabrication setup for TPP. The glass slide is mounted 
on the motorised stage (A). The objective lens (B) focuses the laser beam 
(C) onto the mounted glass slide for fabrication process to begin.  
The structural dimensions and positions of the semi-circular ridges are 
entered into a computer-controlled proprietary software called 𝑁 𝑉𝑖𝑒𝑤. This 
software converted the entered data into the xyz- stage movements and 
concurrently controlled the polymerising focal spot. In an initial attempt to 
fabricate the semi-circular ridges,   the xyz- stage was programmed to trace 
a semi-circle oscillatory waveform with reference to the dimensions of the 
semi-circular ridges along the width of the glass slide (z- position) relative to 
the fixed objective lens. Thus a semi-circular arc is created at the end of a 
traced oscillatory waveform at a region along the z- position. The spacing 
between each created semi-circular arc was set at 1𝑢𝑚 to ensure sufficient 
attachment to the previously cured arc. This process was repeated along the 
width of the glass slide to produce a ridge of length 25𝑚𝑚. After the 
specified length of the semi-circular ridge had been produced, the above 
processes were repeated again to create subsequent ridges at specified 
positions on the glass slide. Fabricating a ridge of a length of 25𝑚𝑚 
however took 7 hours and so fabricating 5 ridges on a glass slide took over a 
day. This method of fabricating the semi-circular ridges was therefore 
C 
B 
A 
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deemed not time efficient. To overcome the problem of time spent to 
fabricate the desired structures, a quicker method was employed. In this new 
method, the ridge structure was produced by translating straight polymerised 
lines in a back and forth motions over the 25𝑚𝑚 distance and with each line 
offsetted in the x- and y- position by 1𝑢𝑚 to create a semi-circular shape. 
The high confinement of polymerising region with TPP although 
advantageous for micro-structuring over a few 𝑚𝑚, over long distances such 
as 25𝑚𝑚, any micron tilt of sample; in this case the glass slide, could be 
detrimental. This is because there could be significant variation of height of 
the ridges produced as the tilted glass slide moved relative to the fixed 
position of the polymerising focal spot. Upon finding out that the sample 
holder attached to the stage was at a slight angle to the objective lens, it was 
reasoned that the problem forecasted could occur. To overcome this 
limitation, the glass slide had to travel at an angle to offset the angle at which 
the glass slide was being held. To do this, the polymerising focal spot at both 
ends of the width of the glass slide was first determined. The glass slide was 
then repeatedly scanned over a localised region while gradually changing the 
height of the stage. At a point region on the glass slide where polymerisation 
occurred, a ripple light effect was observed. These ripple light effects helped 
determined the exact polymerising height at different regions of the glass 
slide. It was therefore calculated that the height difference with reference to 
the start and end position of the polymerising region along the 25𝑚𝑚 
length was 24𝑢𝑚. 
So to fabricate a uniform straight line, the stage was set to translate the 
glass slide along the objective lens with an increase angle of 0.055° 
which compensated for the tilt of the glass slide with a laser scan speed 
of0.6𝑚𝑚/𝑠. After polymerisation, the glass slide was gently submerged into 
a 50:50 solution mixture of 4 − 𝑚𝑒𝑡ℎ𝑦𝑙 − 2 − 𝑝𝑒𝑛𝑡𝑎𝑛𝑜𝑛𝑒 and 2 − 
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𝑝𝑟𝑜𝑝𝑎𝑛𝑜𝑙 to wash away the uncured polymer resins. The advantage to this 
method was that the total time taken to fabricate 5 ridges, each of length 
25𝑚𝑚 was 8 hours. Figure 5.3 shows the fabricated semi-circular ridges on 
the glass microscope slide. 
 
Figure 5.3  Microstructure semi-circular ridges (A) fabricated on microscopic 
glass slide (B) 
 
5.2.3    CALLIBRATION OF FABRICATED SEMI-CIRCULAR RIDGES 
 
To determine the optimal starting height position to fabricate the micro-
structure ridges via TPP, different starting positions of the polymerising focal 
spot was calibrated. Thus for each consecutive single ridge structure 
fabricated, the initial focal spot height position was gradually increased 
by10 𝑢𝑚 through lowering the glass slide towards the objective lens by 
10 𝑢𝑚. This process also allowed for testing the stability of the ridge 
fabricated against collapse within the design parameters and during the post-
polymerisation washing stage. Scanning electron microscopy (SEM) images 
were taken of the ridges fabricated at different starting focal spot height as 
shown in figure 5.4 and it is observed that the last ridge on the right has 
started to detach from the glass slide surface. Explanation for the 
B 
A 
 122 
 
CHAPTER 5 CELL-STRUCTURE INTERACTION MODEL 
 
detachment of the ridge is reasoned to be as a result of there being only a 
small part of the ridge base attached to the glass slide due to very high 
starting focal spot position. The starting height of the polymerising focal spot 
therefore chosen for the ultimate fabrication of the semi-circular ridges was 
33.1 𝑢𝑚 to ensure ridge fabricated was very stable.   
 
Figure 5.4  SEM images of  fabricated semi-circular ridges of 1mm length, 
from left to right; starting height is increased by 10um.  
 
5.3        PDMS PREPARATION AND STAMPING 
 
5.3.1     PDMS PREPARATION 
 
Patterning the semi-circular ridges design via TPP enables us to control the 
design dimensions with micron accuracy. However the directly structured 
ridges were unsuitable for direct experimentation for numerous reasons that 
polydimethylsiloxane (PDMS) replication addresses. The fragile hollow 
nature and the glass/polymer boundary of the fabricated structures made it 
unsuitable for direct use in the fluid flow experiment as they were easily 
washed off. Therefore a soft lithography approach for replication of the 
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surface ridges was adopted.  A negative PDMS elastomer mould was 
created of the patterned surface of the microscope glass slide, and was 
subsequently used to reproduce the fabricated structure features via PDMS 
stamping for experimentation.  To make the negative PDMS elastomer 
mould, Sylgard 184 silicone elastomer was mixed in a 1:10 weight ratio with 
the base silicone elastomer curing agent (Dow Corning, UK). The mixture 
was then degassed under vacuum in a desiccator to release trapped air 
caused by the mixing process, thus resulting in a clear viscous liquid. The 
glass microscope slide with the fabricated micro-semi-circular ridges (master 
slide) was placed in an aluminium rectangular-shaped box and the degassed 
silicone elastomer mixture was then poured over the master slide gently 
without introducing any air bubbles. In the case where air bubbles were 
introduced into the mixture whilst pouring the mixture onto the master slide, 
further degassing was done to remove the trapped air. The now aluminium 
box containing the master slide and the silicone elastomer mixture was 
heated to 60℃ in an oven for at least 3 hours to cure and become solid. 
Figure 5.5 shows the silicone elastomer mould with in the negative imprint of 
the fabricated micro-structure semi-circular ridges on the master slide. 
 
 
Figure 5.5  A negative imprint of master slide silicone mould used for the 
reproduction of test slides through PDMS stamping. 
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5.3.2     PDMS STAMPING 
 
After curing of the silicone elastomer mixture into a mould, the mould was 
then carefully removed from the master slide to get an exact negative of the 
micro-structure features of the master slide onto the silicone mould. This 
silicone mould was used to re-create replicas of the master slide patterns via 
PDMS stamping. The simple technology and ease of use behind PDMS 
stamping makes it both a low cost and effective tool for reproducing the 
desired surface pattern. Also, PDMS stamping has been shown to reproduce 
surface features with high accuracy [362].  To create a PDMS stamp, a pre-
polymer PEGda with molecular weight 250𝑔/𝑚𝑜𝑙 (Sigma Aldrich, UK) was 
mixed with a 2 𝑤𝑡% of photo-initiator 2-Hydroxy-2-methylpropiophenone 
(Sigma Aldrich, UK). The choice of PEGda (250𝑔/𝑚𝑜𝑙) use for the PDMS 
stamping process was because this polymer had low swelling rate which 
ensured firm attachment of the polymer when cured onto the glass substrate. 
Figure 5.6 shows the poor attachment of PDMS stamped PEGda (700𝑔/
𝑚𝑜𝑙)  as compared to that of PEGda (250𝑔/𝑚𝑜𝑙) after been submerged 
into a phosphate buffered saline (PBS) solution for 24 hours. Also, for cell 
culture experimentation purposes, it has been reported that PEGda with 
lower molecular weight helped promote better cell adhesion as compared to 
PEGda with higher molecular weight [363]. So, few drops of the PEGda 
(250𝑔/𝑚𝑜𝑙) mixture with the photo-initiator were placed on the silicone 
mould and then a functionalised glass slide was placed into the negative 
imprint of the mould. During this process, it was ensured that there was no 
air interface between the polymer mixture and the glass slide and that there 
was a uniform coverage of the PEGda mixture over the entire surface of the 
glass slide. The silicone mould with the glass slide was then placed under an 
ultra-violet light with the intensity of the light gradually increased from 1% to 
100% to cure the PEGda polymer mixture. To facilitate easy removal of the 
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PDMS stamped glass slide and also ensure that the silicone elastomer 
mould was hydrophobic to the polymer mixture, the mould was pre-treated 
with tridecafluoro − 1H, 1H, 2H, 2H − tetrahydooctyl trichlorosilane, 97% 
(Sigma Aldrich, UK) which is a silanizing agent before being used for PDMS 
stamping. Replication of the fabricated micro-structure semi-circular ridges 
via this technique improved the structural strength of the micro-structures 
due to the bulk curing process during PDMS stamping. Thus the PDMS 
stamped glass slides were more suitable to use for fluidic flow 
experimentations. Figure 5.7 shows the PDMS stamped microscope glass 
slide with the micro-structure semi-circular ridge features.  
 
a)   b)    
Figure 5.6  PDMS stamped glass slides with different molecular weight 
PEGda: 700 g/mol (A) and 250 g/mol (B) respectively after 24 hours 
submersion in PBS  
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Figure 5.7  PDMS stamped microscope glass slide for flow experiment  
 
5.4      CALIBRATION OF THE SEMI-CIRCULAR RIDGES FABRICATED 
VIA TPP AND PDMS STAMPING 
 
To confirm that the micro-structure semi-circular ridges fabricated via the 
TPP technique met the design parameter requirements, SEM images were 
taken of the micro-structures as shown in figure 5.8. To prepare the sample 
for SEM imaging, the sample was first mounted on a stud using a carbon 
adhesive and gold coated using a gold sputter coater (Edwards S150b, 
Crawley, UK). Gold coating of the sample helped to prevent charge build-up 
at areas of the sample which were non-conductive. SEM images of the 
sample were then generated using Philips XL-20 SEM (Philips, Eindhoven, 
Netherlands).  The surface profile of the ridge was also determined using a 
profilometer (Dektak Profilometer, Veeco, USA) with a stylus force of 3 𝑚𝑔, 
a scan resolution of 0.056 𝑢𝑚/𝑠𝑎𝑚𝑝𝑙𝑒 and a scan speed of 10 𝑢𝑚/𝑠. 
Figure 5.9 shows the surface profile of a fabricated ridge compared that of a 
semi-circle shape calculated analytically. Using equation 4.8, the deviation 
between the target shape of the ridge and that produced via TPP was 
measured and this measure of error is shown in table 5.1.  
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Figure 5.8  SEM images of fabricated ridges via TPP. Left: A close-up of one 
of the ridges. Right: All 5 semi-circular ridges on the glass slide.  
 
Figure 5.9  Profilometer scan of the surface of the semi-circular ridge 
fabricated via TPP compared to target semi-circle perimeter. 
 
Table  5.1  Error between measured and target surface perimeter 
 Surface Perimeter  𝑴𝑺𝑬 
Semi-Circular Ridge 0.085 
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The agreement between the target shape of the ridge to that fabricated via 
TPP is shown to be relatively good as 𝑀𝑆𝐸 < 0.1. However, it is presumed 
that the initial method employed to fabricate the ridges as discussed in 
section 5.2.2 could have produced better semi-circular ridge shape but this 
method was not very time efficient. A probable solution to this problem could 
be in the use of synchronised multiple focal points to fabricate many 
structures at a time; thus cut down the time spent on fabricating the 
structures but this method has not been established.    
A surface scan across the entire length of the PDMS stamped semi-circular 
ridges was also performed using the profilometer to determine how each 
ridge height varied from the other. As shown in figure 5.10, each ridge height 
was in between ± 1.5𝑢𝑚 of the desired height which is 75𝑢𝑚. It therefore 
could be concluded that the above discussed processes used to 
develop the desired structure of five independent semi-circular ridges 
on a microscope glass slide has been achievable with relatively minor 
deviations from the target structural design.   
 
Figure 5.10  Profilometer scan of the surface of five semi-circular ridges 
spaced 550um apart. 
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5.5        RIDGE SHEATH FABRICATION 
 
As stated in the introduction section, ECs may become denuded during the 
process of stent implantation. Hence at the immediate regions of the stent 
strut and on the stent strut, there might not be the presence of healthy ECs. 
To mimic this in vivo condition in the cell-structure interaction experimental 
model, a thin ridge sheath was fabricated. This thin sheath is used to cover 
the ridges before cell seeding and thus prevented cells from being seeded 
onto the ridges before subjecting the cells to the flow experiment.   
The ridge sheath was fabricated using photo-stereo lithography in a direct 
laser write method. The fabrication process involved a passively Q-switched 
DPSS microchip laser (Pulselas P-355-300, Alphalas, Gottingen, Germany) 
with a wavelength 532𝑛𝑚 to emit a laser beam. An ultra-violet light was then 
isolated from the laser beam emitted using a Pellin Broca Prism (ADB-10, 
Thorlabs, Germany). This ultra-violet light was expanded using a Galilean 
beam expander to around 8𝑛𝑚 before being reflected via a silver coated 
mirror into a x10 objective lens (Carl Zeiss, EC Plan-Neofluar 10x, Numerical 
Aperture 0.3) to initiate polymerisation of a liquid polymer resin. The 
exposure of the laser beam emitted was controlled automatically by a 
mechanical shutter (LS6ZM Uniblitz Electronics). The polymer resin sample 
was held to a motorised xyz- stage which was controlled by two types of 
computer-based software which worked concurrently; thus Aerotech 
ANT130XY and PRO115 software that controlled the xy- translation and z- 
translation of the stage respectively.   
The polymer resin used for the sheath fabrication process was PEGda 
(700 𝑔/𝑚𝑜𝑙) mixed with a 4𝑤𝑡% 2-Hydroxy-2-methylpropiophenone photo-
initiator. A well of this polymer-based resin was created on a non-
functionalised microscope glass slide to allow easy detachment of the  
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fabricated sheath from the glass slide. The glass slide sample was then 
affixed to the stage and was translated relative to the focal point of the 
objective lens via the xyz- stage to begin the fabrication of the ridge sheath 
process.  Figure 5.11 shows the fabricated ridge sheath of 1𝑚𝑚 thickness.  
 
Figure 5.11  A 1mm thick ridge sheath  
 
5.6        ASSEMBLY OF CELL-STRUCTURE INTERACTION MODEL 
 
Assembling the cell-structure interaction model involved mounting the test 
glass slide with fabricated microstructure semi-circular ridges into a parallel 
plate flow chamber. The parallel flow chamber is formed of three main parts; 
namely, a top plate, bottom plate and a silicon gasket as illustrated in figure 
5.12. The plates were machined in-house. The model was assembled by first 
carefully placing the PDMS stamped microscope glass slide with seeded 
ECs into the groove on the bottom plate. The silicone gasket was then 
placed to fit the perimeter of the groove and finally the top plate was placed 
on top of the bottom plate. The two plates were held tightly together by 
machine screws. One end of a 2 way, 1/8 NPT – barbed connectors (Cole-
Parmer, UK) was screwed into both ports of the top plate and the other end 
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connected to the rest of the flow circuit system. Figure 5.13 shows the 
complete experimental set-up of parallel plate flow chamber connected to the 
flow circuit system and placed inside an incubator. 
 
 
Figure 5.12. A schematic diagram of a parallel plate flow chamber for 
housing the PDMS stamped test glass slide.  
Barbed connectors are attached to the top plate (A) to allow fluid flow to and 
out of the flow chamber. The dashed lines displayed on the top plate show 
the flow domain of the parallel plate flow chamber. The test glass slide sits 
within the groove of the bottom plate (B). The silicon gasket is sandwiched 
between the two plates to prevent fluid from leaking out of the flow domain. 
 
 
Barbed connector 
Top plate 
  Flow pathway 
  Silicon gasket 
  Bottom plate 
  Groove in plate 
A 
B 
C 
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Figure 5.13 A complete set-up of test flow chamber and flow circuit system. 
The assembled parallel plate flow chamber encasing the test glass slide (test 
flow chamber) is represented within the red dashed line square. The test 
chamber is placed within an incubator of 37℃, 5% 𝐶𝑂2 and also connected 
to the flow circuit system.     
 
5.7        SUMMARY 
 
In summary, a cell-structure interaction model was designed so that in 
combination to the flow circuit discussed in Chapter 4, cultured ECs on the  
Test flow 
chamber 
Flow 
circuit 
Flow media 
reservoir 
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modified microscope glass slide could in respect to cell position on the 
modified glass slide experience different magnitude of WSSs, SWSSGs and 
OSIs concomitantly. The model consisted of three main parts: 
 A parallel plate flow chamber. This flow chamber is made of two 
plates; thus a bottom flat plate with a groove which houses the ECs 
cultured on the modified microscope glass slide and a top flat plate 
with inlet and outlet ports. The top and bottom plate produces a gap 
of a known height when put together and thereby allows fluid flow 
through the flow chamber   
 A modified microscope glass slide. This is a PDMS stamped 
microscope glass slide with semi-circular micro-structure ridges. ECs 
are seeded on this glass slide.   
 A silicone gasket. The gasket is fitted in between the two plates to 
ensure fluid does not leak out of the parallel plat flow chamber. 
Application of TPP technique enabled for the fabrication of desired micro-
structures on the glass slide and PDMS stamping enabled for a quick and 
easy replication of the fabricated structures on the master microscope glass 
slide onto other glass slides. Calibrations of the semi-circular ridge structures 
fabricated were observed to have deviated slightly from the desired structure 
dimensions but were within an acceptable range of error margin. Thus CFD 
analysis of the ideal cell-structure interaction model could be applicable to 
the cell-structure interaction model fabricated within accepted error margin.    
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CHAPTER  6 
 
COMPUTATIONAL FLUID DYNAMICS (II) 
 
In this chapter, the mechanical forces present within the cell-structure 
experimental model described in chapter 5 is investigated and quantified. To 
investigate these mechanical forces, the fluid flow domain of the cell-
structure model is simulated using CFD. 
 
6.1        CFD ANALYSIS 
 
As discussed in chapter 3, CFD analysis based on FVM method has been 
proved to enable numerical solving of complex fluid flow dynamics with high 
accuracy. So, flow simulations within the cell-structure interaction model 
were performed using FVM built in ANSYS Fluent 13 software (Ansys inc., 
Canonsburg, PA, USA). The fluid domain of the cell-structure interaction 
model in which simulations were performed is illustrated in figure 6. 
 
A 
Inlet port 
Outlet port 
Test flow chamber 
Rounded rectangular cavity  
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Figure 6. Geometry in which simulations were performed (Not to scale). The 
isometric view (A) of the modelled geometry shows the inlet and outlet flow 
positions and the test flow chamber where flow dynamics are subjected onto 
cells. The bottom view (B) shows the position of the fabricated semi-circular 
ridges within the test flow chamber. The semi-circular ridges are placed 
sufficiently far away from the inlet so that flow is developed before influenced 
by the presence of the ridges. 
Fluid flow is simulated to pass through the inlet port of diameter 3 mm, then 
through a rounded rectangular cavity of length 17 mm, semi-circular width of 
4mm diameter and height of 6 mm. The fluid then passes through the test 
flow chamber of length 71 mm, width of 20 mm and height of 0.48 mm then 
finally through the outlet port of same inlet port dimensions. The height of the 
test flow chamber was chosen to be 0.48 mm so as to achieve instantaneous 
WSS of 2 Pa within the flow chamber at a flow rate of 144 ml/min. This 
calculation is based on equation 4.5.        
The fluid properties used for the CFD simulations were based of on the cell 
culture media which would be used during the experimental stage of 
investigation ECs response to complex flow dynamics. Thus the density of 
the flow used is 1005 𝑘𝑔/𝑚3 at a viscosity of 0.64 𝑚𝑃𝑎. 𝑠. As cell culture 
media is suggested to be Newtonian [364], the flow was simulated to 
Semi-circular ridge features 
B 
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behave as a Newtonian fluid. Using Newtonian fluid as a 
representation of blood flow characteristics for this model is deemed 
adequate. Reason for this suggestion was highlighted in chapter 3 as 
Newtonian fluid was showed to capture the non-Newtonian blood 
characteristic based on Carreau model within a straight stented artery.   
Flow boundary conditions were imposed at the inlet and outlet 
boundary and a no slip condition set at the walls of the model. A UDF 
script was written to apply pulsatile LAD inlet velocity flow waveform at the 
inlet boundary. This flow waveform used is derived by Marcus et al. [58]. This 
written UDF defines the time evolution of the velocity distribution at the inlet 
boundary, assuming velocity profile to be parabolic and matching the volume 
flow rate to that described of the target LAD flow waveform shown in figure 
4.9. At the outlet boundary, a zero normal velocity derivative was specified. 
Meshing of the model was done using the same CutCell algorithm used in 
section 3 to discretise the spatial flow domain of the cell-structure interaction 
model into many hexahedral cells as illustrated in figure 6.1. To ensure CFD 
results were independent of the mesh density, mesh refinement studies of 
the model were carried by performing steady flow simulations on different 
mesh densities as shown in figures 6.2a and 6.2b. Although steady flow was 
simulated, it was expected that there may be some time dependent features 
due to the flow dynamics across the semi-circular ridge structures in the 
model. Therefore the flow was modelled as an unsteady flow with time steps 
lasting 0.005s. To ensure that a steady state solution had been reached, 
sufficient time steps were calculated. The WSSs recorded at the inlet of the 
model with the spatial flow domain discretised into 612,097 and 865,281 
hexahedral cells were 1.97 𝑃𝑎 and 1.98 𝑃𝑎 respectively. The percentage 
WSS error calculated between these two mesh densities was found to be 
< 1% with insignificant changes to the WSS upon further mesh refinements.  
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This therefore demonstrated that mesh independence of CFD result was 
established at mesh density of 612,097 cells. Finer meshes at regions nearer 
to the semi-circular ridges were also ensured to enable detailed flow 
dynamics and WSS to be captured. Simulation settings of the flow were 
similar to those used in section 3, with SIMPLE algorithm used for pressure-
velocity coupling. A second order scheme was used to discretise both the 
pressure and momentum which ensured a numerically second order higher 
accuracy. The computational cost in performing flow simulation with different 
mesh densities is tabulated in table 6.1. 
 
Figure 6.1  Meshed flow domain of cell-structure experimental model. A – A 
shows the meshed region of the semi-circular ridges 
 
Figure 6.2a  WSSs at inlet region of cell-structure model for different mesh 
densities. Mesh convergence is assumed at mesh density of 612097 cells. 
A A 
Q 
A 
A 
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Figure 6.2b  WSSs  at inter-ridge region of cell-structure interaction 
experimental model for different mesh densities. Mesh convergence is 
assumed at mesh density of 612097 hexagonal cells. 
The correlation between increase in mesh density and increase WSS 
magnitude is evident from the mesh refinement studies study although 
further mesh refinements resulted in insignificant WSS changes. Based on 
this evidence it is reasoned that the true WSS subjected on ECs is slightly 
higher than that of CFD analysis predictions.   
 
Table 6.1  Computational costs for different mesh densities 
Mesh Density Computational Cost 
 Hours Minutes Seconds 
62455 0 10 0 
23274 3 5 30 
465009 5 25 27 
529472 9 53 42 
612097 13 59 22 
865281 15 9 40 
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Simulations of each LAD pulse cycle was discretised into 300 time steps of 
0.005s time step size. Three LAD pulsatile waveform cycles were performed 
with results from at least the second cycle used for analysis. This was done 
so as to eliminate analysing data which might have been influenced by 
simulation start-up effects. The simulation at each time step was deemed to 
have reached convergence when the normalised scaled continuity residuals 
and the velocity components had all fallen to below 10–5 or after 200 
iterations. This reasoning was ascertained through the examination of the 
WSS convergence history at different regions of the flow model which 
showed that this condition was adequate enough to produce data which had 
insignificant WSS changes upon further iterations.   
 
6.2        RESULTS 
 
The cell-structure interaction model was designed to apply combined 
mechanical stimuli such as WSS, SWSSG and OSI to seeded cells. Analysis 
of these mechanical stresses distributions within the model are discussed 
below. 
 
6.2.1     WALL SHEAR STRESS DISTRIBUTION ANALYSIS 
 
Figure 6.3a shows a contour plot of the WSS distribution on the entire 
cultured cell surface area of the model and figure 6.3b shows the WSS 
distribution specifically at the region with the semi-circular ridges under 
steady flow simulations to produce a steady shear stress of 2 𝑃𝑎. The 
contour plot of the entire cell culture surface area shows relative spatially 
uniform WSS distribution at regions away from that where the semi-circular 
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ridges are present.  Regions with the semi-circular ridges are however 
observed to have a wide varied range of WSS distribution. WSSs at this 
region tend to follow a complex pattern of alternating peaks and troughs with 
the top of the ridges experiencing very high WSSs and the very immediate 
end base of the ridges experiencing very low WSSs. This WSS distribution 
phenomenon is similar to that observed within the helical stented artery 
discussed in section 3 and also from literature [30].  
 
 
Figure 6.3a  Contour plot of WSS distribution (Pa) on cell culture surface 
area under steady flow simulations. Flow is from left to right. Uniform WSS of 
magnitude ~ 2 Pa is observed at regions far away from the inlet and also at 
the outlet.  
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Figure 6.3b  Contour plot of WSS distribution (Pa) at region with semi-
circular ridges under steady flow simulations. Flow is from left to right. The 
plot shows WSS is highest (~ 5 Pa) at the top of the ridges and at the 
immediate peri-ridges the lowest WSSs (~ 0 Pa) were recorded.   
A 2mm distance from the immediate side walls of the inlet, outlet and length 
sides of the cell culture surface area were negated in the WSS distribution 
analysis. Data at these regions where considered to have been strongly 
influenced by the entrance, exit and side wall effects of the flow chamber.   
Pulsatile flow simulation of the LAD waveform at mean WSS of 2 𝑃𝑎 over 
the cell cultured surface was also computed. Figures 6.4a – 6.4f show the 
WSS distributions of the entire cell culture surface area and regions with the 
semi-circular ridges at different time points of the LAD waveform. It was 
noted that WSS distributions on the entire cell culture surface area at 
different time points of the LAD waveform where similar to that observed 
under steady flow simulations although WSS magnitudes recorded were 
different for each time point.   
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Figure 6.4a  Contour plot of WSS distribution at 0.1s in the LAD waveform on 
entire cell culture surface area (Top) and at region with semi-circular ridges 
of cell-structure interaction model. Flow is from left to right. WSS magnitudes 
across the cell culture surface area are noted to be generally very low. This 
observation is as a result of very low volume flow rate at that instantaneous 
time.    
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Figure 6.4b  Contour plot of WSS distribution at t = 0.2s in the LAD waveform 
on entire cell culture surface area (Top) and at region with semi-circular 
ridges of cell-structure interaction model. Flow is from left to right. WSS 
magnitude across the culture surface area is noted to be low, however WSS 
on the top of the ridges are observed to be relatively high (~ 3 Pa).  
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Figure 6.4c  Contour plot of WSS distribution at t = 0.3s in the LAD waveform 
on entire cell culture surface area (Top) and at region with semi-circular 
ridges of cell-structure interaction model. Flow is from left to right. WSS 
magnitudes across the culture surface area are noted to be low. This is as a 
result of low flowrate at this waveform phase. 
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Figure 6.4d  Contour plot of WSS distribution at t = 0.5s in the LAD waveform 
on entire cell culture surface area (Top) and at region with semi-circular 
ridges (Bottom). Flow is from left to right. Flow rate at this phase is highest 
hence high WSS magnitudes across culture surface area (~5 Pa). High 
WSSs (> 15 Pa) were recorded at the top of the ridges whilst WSSs at the 
peri-ridge regions ranged between 0 Pa to 3 Pa.   
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Figure 6.4e  Contour plot of WSS distribution at 0.6s in the LAD waveform on 
entire cell culture surface area (Top) and at region with semi-circular ridges 
(Bottom). Flow is from left to right. In this figure as well as in figure 6.4d, 
WSS spikes are observed on the ridges whilst lowest WSSs are observed at 
immediate regions adjacent to the ridges. The WSS tend to increase with 
distance from the ridges and at its highest in the region furthest away from 
the ridge, with exception of the WSS on the ridges themselves. 
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Figure 6.4f  Contour plot of WSS distribution at t = 0.9s in the LAD waveform 
on entire cell culture surface area (Top) and at region with semi-circular 
ridges (Bottom). Flow is from left to right. WSSs experienced across the cell 
culture surface show similar WSS distribution trends as illustrated in figures 
6.4d and 6.4e however with relatively lower WSS magnitudes. This 
occurrence is as a result of lower flowrate at this phase compared to that of t 
= 0.5s and t = 0.6s.   
W
S
S
 (
P
a
) 
Ridges Region x- Direction (m) 
Q 
W
S
S
 (
P
a
) 
 148 
 
CHAPTER 6 CFD ANALYSIS OF CELL-STRUCTURE MODEL 
 
One of the main objectives of this project is to be able to map the mechanical 
stresses within the cell-structure interaction model to cells response. Thus 
CFD simulations serve as a tool to quantify these stresses and also help 
make decisions earlier in the experimental set up stages in relation to 
achieving desired results.  
As discussed in chapter 4, there have been many studies which have utilised 
parallel plate flow chamber in the investigation of WSS on ECs. Mostly in 
these studies, WSSs within parallel plate flow chambers have been 
calculated analytically using the formula given in equation 6.1 to obtain WSS 
from flow rate.   
𝜏𝑤 =  
6𝜇𝑄
𝑏ℎ2
  6.1 
where 𝜏𝑤 is the instantaneous WSS, 𝑄 is the flow rate, µ is viscosity of flow 
medium and 𝑏 and ℎ are the width and height of the flow chamber 
respectively. 
The use of this formula therefore obviates the need for CFD modelling. 
However this approach is only valid based on the assumptions that flow is 
fully developed spatially and temporal, laminar, Newtonian, two dimensional 
flow domain and no effect of side wall of the flow chamber on flow. 
Being that the culture fluid used for the CFD simulation is Newtonian, as 
discussed earlier in this chapter, one of the above assumptions is satisfied. 
The assumption that flow domain is two dimensional is however clearly not 
satisfied in regions close to the flow chamber side walls. Nonetheless it has 
been suggested that as long as the width to height ratio of the parallel flow 
chamber is greater than 10:1, then this two-dimensional flow can be 
assumed [365]. The calculated width to height ratio of the modelled test flow 
chamber is approximately 42:1 and thus assumption that flow in the 
modelled test chamber is two-dimensional can be made.  
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From the CFD steady flow simulation presented in figure 6.3a, uniform WSS 
magnitude at inlet and outlet region of flow domain was approximately 2 Pa. 
Hence using the flow and flow chamber parameters already stated in section 
6.1, and substituting those into equation 6.1, one can calculate flow rate, 
(𝑄 = 2.4 𝑥 10−6 𝑚3/𝑠) needed to get a WSS of 2 Pa.  This flow rate would 
result to an average flow velocity of 0.25 𝑚/𝑠. The Reynolds number, Re, 
of the flow can be calculated using the formula below: 
𝑅𝑒 =  
𝜌𝜇𝑙
𝜇
                                                                                                    6.2 
Substituting the average velocity, 𝜇 and taking ℎ as the characteristic 
length scale, the Reynolds number of the fluid is 188.43. This flow is 
therefore classified as laminar as Re < 1000 [292]. Hence the assumption of 
laminar flow in the flow chamber is satisfied.  
To justify that flow is developed spatially and temporally, it is reasoned that 
start up effects quickly dissipate under steady flow, hence flow is developed 
in time after few seconds of an experiment. To ascertain if flow becomes 
spatially developed in the flow chamber, the entrance length, 𝐿𝑒 is defined. 
Using the formula for calculating the entrance length for laminar flows 
between two parallel plates by Schlichting et al. [366] as shown below: 
𝐿𝑒 = 0.01ℎ. 𝑅𝑒                                                                                      6.3 
The entrance length in this flow chamber when the WSS is 2 Pa is therefore 
0.90 mm, which is a negligible proportion of the entire chamber length 
(≈ 70 𝑚𝑚). Flow is therefore assumed to be spatially developed after 
0.90mm of the flow chamber entrance. This assumption is justified in figure 
6.3a as WSSs of the flow domain under steady flow simulation is observed to 
be relatively uniform after few distance from the entrance of the flow 
chamber. It should be noted nonetheless that although analytical methods 
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were used to predict approximately the WSS applied to cells within the test 
flow chamber, this method and assumptions made may not entirely be 
applicable for our custom designed flow chamber. This is because the 
assumption that led to the basis of equation 6.1 is thought to be more 
applicable for flow within a uniform space and non-disrupted flow. Therefore, 
since our custom designed flow chamber is not entirely of a uniform space 
and flow is slightly disrupted within some regions of the flow chamber due to 
the presence of the semi-circular ridges, the extent to which this assumption 
is applicable to our flow chamber is limited. CFD was therefore used to 
predict accurately the mechanical milieu experienced by the cells in the cell 
structure interaction experimental model. 
Correlation between the WSS LAD waveform determined using analytical 
equation 6.1 and that predicted by CFD analysis is shown in figure 6.5. It is 
observed that the WSS data produced from both methods compared 
relatively very close; thus the assumption made of the relationship between 
flow rate and WSS is plausible. Nonetheless, it is noted that there were at 
some time points where the WSS predicted by the analytical equation 
deviated slightly from that recorded by the CFD. This deviation implies that 
for complex flow, analytical equation many not be able to capture accurately 
the fluid dynamic present and thus the use of CFD is needed. 
 
Figure 6.5  Graph showing the correlation between analytical WSS and CFD 
WSS over LAD waveform in flow chamber.      
 151 
 
CHAPTER 6 CFD ANALYSIS OF CELL-STRUCTURE MODEL 
 
6.2.2     SPATIAL WALL SHEAR STRESS GRADIENT ANALYSIS 
 
From the WSS results shown in figures 6.3a – 6.4f it is noted that WSSs at 
the inlet and outlet of the cell-structure model is relatively uniform. However 
at regions with the semi-circular ridges, there were varied WSSs as 
expected. The very high then low WSSs recorded at this region brings about 
a spatial WSS gradient. Figure 6.7 shows the SWSSG predicted to be 
experienced on the cell culture surface under the simulated steady flow and 
figures 6.8a – 6.8d show the SWSSG under the LAD pulsatile flow simulation 
at selected time points of the LAD waveform. 
 
Figure 6.6  Labelled section of the cell culture surface area   
 
Sections of the cell culture surface area were taken to show the SWSSG 
distributions under the two flow conditions. These sections were annotated 
as follows: 
Inlet section is annotated with the letter ‘a’ 
Ridges Region is annotated with the letter ‘b’ 
Outlet Region is annotated with the letter ‘c’ 
Inlet 
Outlet 
Ridges Region 
Q 
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a  
b  
c  
Figure 6.7  SWSSG (Pa/m) distribution under steady flow simulation. From 
this figure, there is no SWSSG (~ 0 Pa/m) at the inlet and outlet regions. 
SWSSG are however at the highest at immediate ridges region ( ≥ 3.0 x 105 
Pa/m). Also, SWSSG tend to decrease as we move further away from the 
ridges. 
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a  
b  
c  
Figure 6.8a  SWSSG (Pa/m) distribution under LAD flow simulation at t = 
0.1s. As seen in this figure, there is on SWSSG across the inlet and outlet 
regions. However there is slight increase in SWSSG at immediate ridge 
regions.  
S
W
S
S
G
 (
P
a
/m
) 
S
W
S
S
G
 (
P
a
/m
) 
S
W
S
S
G
 (
P
a
/m
) 
Outlet x- Direction (m) 
Ridges Region x- Direction (m) 
Inlet x- Direction (m) 
 154 
 
CHAPTER 6 CFD ANALYSIS OF CELL-STRUCTURE MODEL 
a  
b  
c  
Figure 6.8b SWSSG (Pa/m) distribution under LAD flow simulation at t = 
0.3s. As seen in this figure, there is on SWSSG across the inlet and outlet 
regions. However there is slight increase in SWSSG at immediate ridge 
regions.  
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a  
b  
c  
Figure 6.8c SWSSG (Pa/m) distribution under LAD flow simulation at t = 
0.5s. As seen in this figure, there is on SWSSG across the inlet and outlet 
regions. However there is very high SWSSG at immediate regions around 
the ridges.   
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a  
b  
 
c  
Figure 6.8d SWSSG (Pa/m) distribution under LAD flow simulation at t = 
0.9s. This figure shows that at the inlet and outlet regions there are no 
SWSSG. Conversely, there is high SWSSG at immediate regions around the 
ridges.  
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The general observation made with regards to figures 6.7 – 6.8d, is that 
there is zero or relatively minimal SWSSG at the inlet and outlet regions of 
the model under the steady and LAD pulsatile flow simulation performed. 
However, under steady flow simulation, SWSSG spikes are observed on the 
ridge regions and SWSSG valleys are observed at very immediate regions of 
ridges. Thereafter, the SWSSG levels tend to decrease with distance from 
the ridges. Under LAD pulsatile flow simulations, the SWSSG phenomenon 
at the ridges region at time phase t = 0.5s and t = 0.9s is similar to that 
observed under steady flow simulation. The reason for this similarity is that 
flowrate at these time points are comparable to that of the flowrate used for 
steady flow simulations. On the other hand, at time points t = 0.1s and t = 
0.3s of the LAD waveform, flowrate is suggested to be very low. Hence 
SWSSGs magnitude at the ridge regions are not as pronounced as that 
observed with the steady flow simulations and at time phase t = 0.5s and 
0.9s of the LAD pulsatile flow simulation. It is evidently seen in figures 6.8a 
and 6.8b that SWSSGs at the ridge regions are relatively very low. 
   
6.2.3     OSCILLATORY SHEAR INDEX ANALYSIS 
 
OSI, as previously discussed, is a measure that allows evaluating the local 
oscillatory effect within an artery which has been postulated to correlate with 
increased risk of stenotic lesions [330]. OSI values are within the range of 0 
and 0.5 with the lowest value 0, representing a region in which there are no 
flow reversals; hence total instantaneous shear is in one direction. The 
highest value 0.5, indicates the region in which there are opposite flow 
directions and thus the oscillatory shear flow at this region results in a zero 
WSS. Regions of high OSIs have been suggested to be more prone to 
endothelium dysfunction [367]. Figure 6.9 shows the OSI distribution within 
the region with semi-circular ridges during one complete cardiac LAD cycle.  
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Figure 6.9  OSI distribution within ridges (R1, R2, R3, R4, R5) region during 
a complete LAD waveform cycle. 
As shown in figure 6.9, high OSIs (≥ 0.3) are experienced some distance 
after the immediate ridge region which therefore meant that there were 
opposing flow directions at that area.       
 
 
6.3        DISCUSSION 
 
Of clinical relevance are ‘site-specific’ endothelial functional changes 
associated with particular flow dynamics and mechanical stresses that 
develop at arteries with certain geometrical characteristics such as curvature 
and bifurcations [104, 368]. On this premise, the mechanical stresses and 
flow characteristics at stented arteries associated with endothelial response 
are equally of high clinical importance as the presence of stents results in 
local geometric changes of the artery with flow conditions characterised by 
disturbed shear stresses [184]. Increasing evidence has led to the 
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suggestion that the number, shape, width and thickness of stent struts 
influence the arterial floor exposed to increased SWSSGs, TWSSGs, OSI 
and low WSSs that are associated with the spatial and sequential localisation 
of NIH and consequently in-stent restenosis [30, 216, 369-372].    
CFD analysis allowed for evaluation of these individual mechanical stresses 
applied to ECs within a modified cell-structure interaction model which 
represented a simplified stented artery.  The model was designed to apply 
combined stresses thus WSS, SWSSG, TWSSG and OSI to ECs. It is noted 
that at the immediate inlet regions of the model, there are some disturbed 
WSSs. This occurrence is as a result of flow being disturbed as it enters the 
cell-structure model from the flow tubing due to the significant geometrical 
difference between the flow tubing and the entrance of the model. Also, the 
“No Slip’’ condition of the wall of the cell-structure model comes into effect 
when flow initially hits its boundary. Nonetheless, the flow is seen to develop 
quickly downstream from the inlet and have a uniform steady flow and thus 
majority of the ECs at the inlet region are suggested to be subjected to 
uniform WSSs. ECs at the very immediate region of the entrance region will 
not be taken into analysis due to this entrance effects. Figure 6.10 shows a 
line graph of the WSS and SWSSG distribution along the centreline of cell-
structure model under steady flow simulations. Figures 6.11a and 6.11b 
show the WSS and SWSSG distributions respectively along the centreline of 
the cell-structure model under LAD pulsatile flow simulations at selected time 
points of the LAD waveform.  
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Figure 6.10 Line graphs showing WSS (top) and SWSSG (bottom) 
distributions on the centre of the cell-structure model under steady flow 
simulation.  
From figure 6.10, it is observed that areas where ridges were not present 
showed constant uniform WSSs and zero SWSSGs. However, ridge regions 
were characterised with WSS spikes on ridges and WSS valley around the 
immediate regions of the ridges. It is also noted that the first ridge in relation 
to the direction of flow (left to right) showed higher WSS magnitude. On the 
subsequent ridges however, WSS magnitudes reported were comparatively 
lower to that of the first ridge. Explanation to this occurrence is that flow over 
the first ridge is faster than the subsequent ridges. Hence from Bernoulli’s 
equation pressure at the first ridge is lower than that of the subsequent 
ridges. The pressure difference across the ridge causes an increase in WSS 
and thus the lower pressure the higher the WSS produced.   
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Figure 6.11a  Line graphs showing WSS distributions at: (a) Inlet region, (b) 
Ridges region and (c) Outlet region of the cell-structure model under pulsatile 
LAD flow simulation at different time point (0.1s, 0.3s, 0.5s, 0.9s). WSSs at 
the inlet and outlet regions are characterised by uniform WSS whilst WSSs 
at ridge regions are marked by WSS spikes and WSS valleys. 
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Figure 6.11b  Line graphs showing WSS distributions at: (a) Inlet region, (b) 
Ridges region and (c) Outlet region of the cell-structure model under pulsatile 
LAD flow simulation at different time point (0.1s, 0.3s, 0.5s, 0.9s). From this 
figure it is observed that there is no SWSSG at the inlet and outlet regions. 
Conversely, there are high SWSSG at the very immediate ridge regions.  
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Consistent with the literature, it is observed that regions with spatially uniform 
WSS have no SWSSG; (inlet and outlet regions of the model) as opposed to 
regions where WSS is varied due to flow reversal, separation and 
reattachment regions (ridges region of  the model), thus presenting spatial 
WSS gradient [11, 327, 373]. It is also noted that very high WSSs (> 5 𝑃𝑎) 
are recorded on the semi-circular ridges due the ridges disturbing the fluid 
flow and negative or low WSS (< 1 𝑃𝑎) at immediate regions near the 
ridges where recirculation flow vortices and flow separation are predicted. 
Flow is predicted to tend to recover from the flow disruption downstream 
from the location of the ridges as this region is characterised by increasing 
WSSs. This flow recovery is however hampered when flow goes past a 
subsequent semi-circular ridge. As noticed also, the WSS distributions are 
similar across the cell-structure interaction model regardless of the time point 
selected under the LAD pulsatile flow simulation. Conversely, the WSS 
magnitudes recorded are significantly different at the different time points 
selected and this occurrence could be explained by the direct proportionality 
relationship between flow rate and shear stress as indicated in equation 6.1.    
Detailed identification and quantification of local mechanical stresses 
distributions within stented arteries as similarly identified in the designed cell-
structure model helps to predict arterial regions which may be more prone to 
restenosis. As discussed in earlier sections of this report, low and high WSS, 
SWSSG, TWSSG and oscillatory shear stress all have been proposed to 
influence the pathophysiology of diseased artery [97, 101, 327, 329, 330]. 
Although these findings have been validated by experimental data, it must be 
taken into account that it is not known specifically which of these mechanical 
stimuli is mediator of arterial disease. Thus it is thought by some researchers 
that the state of the disease may be as a result of the combined effect of 
these mechanical stimuli. Several studies have reported on the co-existence 
of increased WSS and positive SWSSG in complex arteries and have 
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postulated this co-existence relationship to trigger cerebral aneurysms [374-
376]. Based on this premise, Dolan et al. [373] in a review on high WSS and 
SWSSG in vascular pathology presented findings to illuminate how these co-
existing mechanical risk factors may influence the pathobiology of stenosis in 
arteries. To investigate this relationship of stresses within the cell-structure 
model, the WSSs predicted from the CFD analysis were compared with the 
recorded relative SWSSG and OSI. Figure 6.12 shows the correlation of the 
mechanical stress markers within the designed cell-structure interaction 
model where flow is mostly disturbed.     
 
   
 
 
 
A schematic diagram (not drawn to scale) showing the cell culture surface 
area of the cell-structure interaction model with the five independent semi-
circular ridges annotated by R1, R2, R3, R4 and R5. The arrow shows the 
direction of flow at flow rate, Q. 
 
 
R1 R2 R3 R4 R5 
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Figure 6.12  Line graphs showing the relationships between WSSs and 
SWSSGs (Left) and WSSs and OSIs (Right) within regions with ridges under 
LAD pulsatile flow simulation at time point 0.5s. 
 
From figure 6.12, it can be deduced that within the ridges, OSI is at its 
highest when WSS is relatively zero. Also increase in WSS led to decrease 
in OSI. Comparative analysis of WSS and SWSSG within ridges revealed 
that SWSSG tends to increase at the point where WSS within the ridge 
regions starts to increase. The SWSSG however subsequently decreased 
whilst WSS still increased. 
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The SWSSG and WSS relationship observed within the experimental model 
is similar to that reported by Schirmer et al. [377] in a study investigating the 
spatial and temporal hemodynamic changes within patient specific stenotic 
carotid artery. In the study, WSS increased at the throat of the stenotic artery 
whilst SWSSG changed from positive and negative past the throat of the 
stenotic artery. Furthermore, positive SWSSG was reported post stenotic 
region where endothelial erosion or plaque ulceration has been predicted to 
be most frequent [378, 379]. Rouleau et al. [11] findings of WSS and 
SWSSG distributions from a study on the effect of spatial wall shear stress 
gradient on ECs morphological response in an idealised in vitro stenotic 
artery was also consistent with that reported by Schirmer et al. [377]. It is 
thus interesting that in the cell-structure model similar observations are made 
as WSS is seen to increase at the ridge region and SWSSG changed from 
positive to negative past the ridge section. More so, a positive SWSSG is 
also observed post ridge region. The relationship between WSS and OSI is 
also demonstrated in the cell-structure model as high OSIs are recorded at 
proposed flow separation regions which are characterised by both negative 
and positive WSSs. In addition marked high OSI correlated to the post ridge 
region where positive SWSSG was recorded as shown in figure 6.13.  It is 
proposed that the choice of strut design could influence local flow conditions 
which may be conducive to the development of stent thrombosis or ISR.   
 
Figure 6.13  Line graphs showing the relationship between SWSSG and OSI 
within R4 and R5 region under LAD flow simulation at time point 0.5s. 
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Garasic et al. [301] investigation into the effect of stent and artery geometry 
on intimal thickening independent of arterial injury reported the existence of 
NIH within the centres of diamond shaped stent implanted in rabbit iliac 
arteries. Using a similar stent geometrical design LaDisa et al. [380] reported 
marked elevated SWSSGs and high WSS at these regions which were 
reported by Garasic et al. to have NIH. LaDisa et al. revelation seems to 
contradict the classic hypothesis that high WSS enables the athero-
protective nature of EC [91, 92, 181]. In the study by LaDisa et al., on the 
circumferential vascular deformation after stent implantation, it was reported 
that vascular circumferential straightening as a result of stent implantation 
induced areas of high WSS between stent struts. This phenomenon was 
however absent in stented circular vessels. It was therefore concluded from 
the study that WSS distribution that may be linked to NIH onset may be 
influenced by the geometrical changes of the vessel after stent implantation.  
The cell-structure interaction model designed represents a simplified 
idealised stented LAD artery; thus results presented should be interpreted 
within the constraint of the limitation of the model. The simulation results are 
of stented healthy arterial segment; however results may likely differ if 
simulations were of a stented diseased artery. The assumption of rigid 
arterial wall was made in the simulations presented. A study by LaDisa et al. 
[4] on the alteration of hemodynamic after stent implantation into the LAD 
arteries of 6 dogs reported a reduction of arterial compliance to zero at the 
stented region. Arterial compliance after stent implantation could however 
differ depending on the geometry of the vessel being investigated. Also, the 
arterial compliance of the proximal and distal regions to the stented segment 
could potentially alter vasodilation of the vasculature through the stented 
region. Thus to model this phenomenon would necessitate simulations using 
fluid-structure interactions.  
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6.4        CONCLUSION 
 
The CFD results presented show regions within the cell-structure interaction 
model marked by reverse flow, flow separation and reattachment to have 
varied WSSs, high SWSSGs and OSIs whilst regions marked by relatively 
uniform flow exhibit uniform WSSs and negligible SWSSGs and OSIs. These 
results provide quantitative data that guides our experimental studies and 
understanding of the mechanical milieu within a stented artery and also the 
mechanical forces which might influence the onset of ISR.        
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CHAPTER  7 
 
EXPERIMENTAL ANALYSIS OF ECs MORPHOLOGICAL 
RESPONSE TO PHYSIOLOGICAL RELEVANT FLUID 
DYNAMICS IN STENTED MODEL 
 
7.1        INTRODUCTION 
 
There have been, to the author’s knowledge, no studies on in vitro 
examinations of the morphological and molecular responses of ECs within 
stented artery to a combination of physiologically relevant pulsatile flow 
waveform and pressure. The flow bioreactor system discussed in sections 4 
and 5 is thus suggested suitable to study the effects of combined stresses on 
ECs exposed to physiological flow waveform and pressure. The bioreactor 
system designed is also suitable for the investigation of ECs response to 
steady flow. As the effects of steady flow on ECs responses have been well 
characterised, it is deemed that investigations using the designed bioreactor 
system could be validated by the confirmation of experimental results under 
steady flow being comparable to that reported in literature.   
As discussed in earlier sections of this report, several studies have 
hypothesised the relationship between ECs response (morphological and 
molecular) and mechanical stresses such as WSS. Some of the classic 
hypotheses have been that cells experiencing physiological relevant levels of 
WSS elongate and align parallel to the direction of the fluid flow [11]. The 
degree of the cell alignment however depends up on the magnitude of the 
WSS and the time duration for which the cells have been subjected to the 
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WSS [180]. Conversely cells experiencing low or no WSS are cobblestone 
shaped and do exhibit random orientation [320]. As ECs distinctively alter 
their morphological shape (i.e. either elongated or cobblestone) in response 
to the type and strength of mechanical stimuli being applied to them, it is 
hence proposed that the morphology of the cells may be a focal indicator for 
predicting the arterial site prone to lesion growth. Low WSSs have been also 
postulated to upregulate vascular cell adhesion molecule (VCAM-1); a 
marker for plaque development [381]. Comprehensive in vitro and in vivo 
analyses have revealed a myriad of shear stress regulated genes [382]. Of 
these stress-regulated genes, 70% have been attributed to depend on 
Krüppel-like factor-2 (KLF-2) and nuclear factor erythroid 2-related factor 
(NrF2) which are mechano-sensitive transcription factors and suggested to 
be activated by shear stresses. These transcription factors play crucial roles 
in regulating pro-inflammatory, pro-thrombotic and pro-proliferation gene 
activation of the endothelial [383-385]. 
Despite the successes gained from having been able to map cellular 
responses and molecular responses of the ECs to mechanical stresses in 
vivo and in vitro; thus this knowledge have been used to infer the functional 
state of the artery, there still exist some pertinent challenges in interpreting 
clinical observations of diseased arteries and more especially stented 
arteries. Some of these challenges arise due to the disparities between some 
clinical results and experimental results. In most computational models (i.e. 
CFD) of stented arteries, simplification of the flow dynamics and/or the artery 
constituents are generally made. For example in many computational models 
of the artery, the arterial floor and blood is considered as a continuum thus 
disregarding the varied constituents of the blood (red blood cells, platelets) 
and the artery (smooth muscle cells, ECs) or the intercellular activities within 
constituents [382]. In recent studies however, a multi-scale modelling 
approach whereby mechanical stimuli and biological function at varied spatial 
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and transient scales are combined to provide a framework for analysing 
mechano-biology across scales have been employed in the study of ISR 
development [386-390]. Evans et al. [388] described a detailed formulation of 
a multi-scale model in analysing stenosis in stented coronary artery. This 
framework could potentially reveal the key mediators of clinical ISR and thus 
results achieved could be more comparable to clinical observations. 
However, whilst it is appreciated that multi-scale modelling approach could 
provide detailed insight into the predictors of disease progression in arteries, 
it is noted that most of the frameworks are modelled implicitly. Thus other 
molecular influences and/or reactions might have been neglected in the 
modelling due to the limited knowledge underpinning the relationship blood 
between mechanical stimuli and disease onset. Hence the main cause of 
ISR still remains elusive. Although there are some failings with the 
conventional computational modelling approach in correlating constituents 
and flow dynamics with cells response, this technique is a well-established 
and robust method. Thus it is suggested that if the appropriate processes of 
this technique are observed and results understood within the context of the 
model simulated and limitations of the model, results attained could be 
interpreted with some clinical relevance. 
Many in vitro experimental studies to investigate ECs response to different 
mechanical stresses have mostly been performed under non-physiologically 
realistic flow waveforms (i.e. steady or sinusoidal) albeit physiologically 
realistic pulsatile flow dynamics could have a marked effect on the cells 
response. Although some studies have shown similar morphological changes 
of cells when exposed to physiological pulsatile flow dynamics or steady flow 
[98, 391], molecular and gene expressions of the cells however have been 
reported to differ [98, 392, 393]. Blackman et al. [98] in the in vitro 
examination of the effects of pulsatile arterial stress waveforms on ECs 
reported that ECs exposed to either arterial flow or equivalent steady flow  
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exhibited similar elongation and alignment, but the protein and cellular 
adhesion molecule expressions of the ECs differed with respect to the type 
of flow applied to the cells. It nonetheless should be made clear that the 
suggested similarity in morphological response of cells when exposed to 
either pulsatile or steady flow is only valid to a certain extent. Helmlinger et 
al. [391] investigated the influence of three types of pulsatile flow (i.e. non-
reversing, reversing and pure oscillatory flow) and steady flow on bovine 
aortic endothelial cells (BAECs) shape and elongation. It was confirmed from 
the studies that there were differences in the elongation and also the 
duration it took for the ECs to change shape in respect to the flow waveform 
the cells were exposed to. It is therefore proposed that there is a distinctive 
responsiveness of ECs to any type of flow waveform irrespective of the 
similarities in results that may be observed. Thus to be able to explicitly 
compare in vitro results to in vivo results, then physiological parameters need 
to be employed in the experimental investigations.  
 
7.2        METHOD  
 
7.2.1     PRE-CELL CULTURE PREPARATION 
 
The PDMS stamped glass microscope slides with the micro-structure semi-
circular ridges were submerged into phosphate buffered saline (PBS) for at 
least seven days. This process ensured that uncured polymer resin was 
sufficiently leached out of the stamped glass slides. The stamped glass 
slides were then sterilised in 70% ethanol for at least two hours. The ridge 
sheaths fabricated as discussed in section 5.5 were also sterilised in 70% 
ethanol for at least two hours. 
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7.2.2     CELL CULTURE  
 
T25 flasks were initially coated with sterile 0.1% bovine skin gelatin and 
incubated in a humidified cell culture incubator (37℃, 5% 𝐶𝑂2) for at least 
45 minutes. This process ensured focal adhesion of cells to the base of the 
flasks. Frozen down human umbilical vein endothelial cells; HUVECs 
(Promocell, Germany) were revived at passage number 3 (P3) and seeded 
at sub-confluent density in the coated T25 flasks.  The HUVECs were 
cultured with the cell growth medium M199 (Sigma-Aldrich) containing 20% 
foetal calf serum; FCS (BioSera, UK), 30𝑢𝑔/𝑚𝑙 endothelial cell growth 
supplement; ECGS (Sigma-Aldrich, UK), 30𝑢𝑔/𝑚𝑙 heparin (Sigma-Aldrich, 
UK), 2𝑚𝑀L-Glutamine (Sigma-Aldrich), 100𝑢𝑔/𝑚𝑙 Penicillin Streptomycin 
(Sigma-Aldrich). After every three days, the cell culture medium was 
aspirated from the cells and then after the cells were washed with Hank’s 
balanced salt solution; HBSS (Sigma-Aldrich, UK) containing no calcium and 
magnesium to remove any dead cells before feeding the cells with new 
culture medium. When the cultured cells were about 90 − 100% confluent, a 
routine cell passage was performed but this time the passaged cells were 
used for the flow experiment. Thus HUVECs were used at P4 for 
experiments.    
 
7.2.3     CELL SEEDING 
 
The sterilised PDMS stamped glass slides were washed thoroughly with 
sterile PBS three times to completely remove any ethanol from the slides and 
after the slides were placed in dry petri dishes. The surface of the sterile 
stamped slides with the micro-structure ridges were then each coated  
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with1 𝑚𝑙 of 50 𝑢𝑔/𝑚𝑙 fibronectin solution and incubated for at least 1 hour. 
The fibronectin solution used was a mixture of 50 𝑢𝑙 fibronectin (Sigma-
Aldrich, UK) and 950 𝑢𝑙 HBSS. After 1 hour of incubation, the fibronectin 
were aspirated from the stamped slides. Ridge sheaths were then carefully 
placed on top of the micro-structured ridges on the stamped slides after they 
have been washed thoroughly with sterile PBS. 1.5 𝑚𝑙 of HUVECs at P4 and 
a cell suspension of 330,000 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙 were then seeded onto each 
stamped slides with care taken not to dislodge the ridge sheath from its 
position. This resulted in a cell seeding density of about  26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 
on the stamped slides. The now cell seeded stamped slides were carefully 
returned to the incubator for an added 3 hours to allow the cells to 
completely attach to the substrate, after which the ridge sheaths are 
removed and the cells flooded with 20 𝑚𝑙 of the cell growth culture medium. 
The flooded cells were then incubated for 24 hours to become confluent. In 
all the experimental investigations, HUVECs were seeded at a cell density of 
26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2, used at P4 and incubated in a 5% 𝐶𝑂2 incubator at 37℃ 
unless otherwise stated. 
 
7.2.4     CELL-STRUCTURE INTERACTION EXPERIMENT SETUP  
 
The flow bioreactor system was setup to expose cells to: 
 LAD physiological flow waveform with a mean fluid shear stress of 
2 𝑃𝑎 and a physiological hydrostatic pressure of 120/80 𝑚𝑚𝐻𝑔.   
 Steady flow at a mean hydrostatic pressure of 100 𝑚𝑚𝐻𝑔 and fluid 
shear stress of 2 𝑃𝑎. 
 Hydrostatic pressure of 100 𝑚𝑚𝐻𝑔 and a fluid shear stress < 0.1 𝑃𝑎.   
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Since the mean fluid shear stress applied to the cells were same for both the 
LAD pulsatile flow and steady flow, examinations of cells response under 
pulsatile and steady flow were run in parallel. To run the LAD pulsatile flow 
experiments the flow bioreactor system was assembled as described in 
figure 4.1. To run the steady flow experiments however, the flow bioreactor 
was set up in a similar way to the pulsatile flow system but with the tubing 
connecting to the pulsatile simulator disconnected. The flow bioreactor 
circuits and gaskets were sterilised by autoclaving with the exception of the 
parallel plates of the test chamber which were sterilised using 0.1% 
peracetic acid in PBS for at least a day. Once the flow circuits were 
sterilised, the medium reservoirs were filled with the cell growth culture 
medium. In a sterile cell and tissue cabinet, the culture medium was run 
through the respective flow circuits without the test chambers (that is the cell-
structure interaction model) connected to the flow systems to set the required 
pressure and flow waveform parameters. After the relevant parameters were 
set, the flow circuits were placed in the incubator and the culture medium 
primed throughout the flow circuits at a low flow rate of 10 𝑚𝑙/𝑚𝑖𝑛  for at 
least 2 hours.  
During the priming of the cell culture media, the test chambers were then 
assembled.  To completely mount a test chamber, the stamped slide with the 
seeded HUVECs was initially washed with warm HBSS and then carefully 
placed into the groove of the sterilised bottom plate of the test chamber. The 
gasket was then placed on the bottom plate and carefully 1 𝑚𝑙 of warm 
culture media was pipetted onto the cells without spilling the culture media 
anywhere on the bottom plate. Finally, the top plate of the test chamber was 
placed on top of the bottom plate and firmly and securely affixed with 
machine screws. Warm culture medium was then gently introduced into the 
test chamber whilst making sure that there were no trapped air bubbles in 
the test chamber. After priming of the cell media, the flow circuits were  
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moved back into the sterile tissue cabinet where the test chambers were now 
connected to them. To connect the test chambers to the flow circuits, either 
sides of the tubing where the test chambers would be connected were 
initially clamped. Then after connecting the tubing to the inlets and outlets of 
the test chambers the clamps were removed. The now completed flow 
bioreactor system is moved to the incubator. Before the desired experiments 
were started, the flow rate was gradually increased after every 5 minutes 
starting from 5 𝑚𝑙/𝑚𝑖𝑛 and doubling the flow rate thereafter until the 
required flow rate is reached. Once the required flow rate had been reached 
the cam driven physiologic flow simulator is switched on to add the desired 
pulsatile component onto the flow waveform.   
HUVECs were exposed to either LAD pulsatile and steady flow at a mean 
flow rate of 144 𝑚𝑙/𝑚𝑖𝑛. This resulted in a mean WSS of 2 𝑃𝑎 experienced 
by the cells. In examining HUVECs under only hydrostatic pressure, the cells 
were subjected to a steady flow rate of 7 𝑚𝑙/𝑚𝑖𝑛 which resulted in a WSS of 
approximately 0.07 𝑃𝑎. Initial experiments investigating the hydrostatic 
pressure effects on HUVECs was done at a cell density of approximately 
10,114 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2. It was suggested that fluid flow rate at 7 𝑚𝑙/𝑚𝑖𝑛 to yield 
a shear stress < 0.1 𝑃𝑎 had negligible fluid stress effects on the cells but 
rather allowed for adequate perfusion of cell growth medium to the cells 
[313].  All three main experiments were run for 6, 12 and 24 hours. 
 
7.2.5     CELLS STAINING  
 
After exposure of the cells to the combined pressure and flow stimuli or 
pressure stimulus only for the desired time duration, the flow bioreactor 
system was stopped. The test chambers were then disconnected from the  
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flow circuit in a sterile tissue cabinet and the stamped slides carefully taken 
from the test chambers into petri dishes. The cells were washed once in 
20 𝑚𝑙 of HBSS and then twice with PBS before fixing them in 20 𝑚𝑙 of 3.7% 
formaldehyde for 20 minutes. The cells were then stained for their actin 
cytoskeleton, nuclei and some inflammatory molecules and to ensure good 
staining of the cells this was done in a dark tissue cabinet.  
 
7.2.5.1  STAINING FOR CYTOSKELETON AND NUCLEI  
 
After the cells had been fixed, they were washed three times with PBS for 5 
minutes each. After the third wash, the PBS was aspirated and then the cells 
permeabilised by adding 1% Triton X-100 for 3 minutes. The cells were 
washed again three times with PBS for 5 minutes each after being 
permeabilised. After this step, 1% bovine serum albumin (BSA) in PBS 
solution was added to the cells for 1 hour to block nonspecific binding. The 
staining solution was then made by adding 100 𝑢𝑙 of a 5𝑚𝑔/𝑚𝑙 
concentration FITC conjugated Phalloidin (Sigma-Aldrich, UK) and a 10 𝑢𝑙 of 
0.1 𝑢𝑔/𝑚𝑙 aliquoted DAPI into 10 𝑚𝑙 of  1% BSA in PBS. The BSA was 
aspirated from the cells after the 1 hour and 1 𝑚𝑙 of the stain solution was 
put on the cells for 1 hour. The cells were then washed once with PBS after 
the staining for 1 hour and then preserved in PBS before visualised with a 
fluorescence upright LSM510 Meta confocal microscope. The actin 
cytoskeleton of the cells were stained green when labelled with the FITC 
conjugated Phalloidin. This fluorophore was able to be seen using 488𝑛𝑚 
excitation laser with an emission filter of 500 − 550𝑛𝑚 setting on the 
confocal microscopy. The DAPI stained the nuclei of the cells blue and this 
was also observed by setting the emission filter of the microscopy to 
435 − 485𝑛𝑚.  
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7.2.6     CELLS SEGMENTATION        
 
HUVECs stained with fluorophores after exposure to the mechanical stimuli 
and results obtained with confocal light microscopy system help provide 
qualitative assessment of the changes in cell morphology and orientation. 
This method of obtaining cell results for assessment is relatively better than 
the use of conventional optical microscope as the former provides enhanced 
distinctive features of the cell [394]. Whilst the use of this modern technique 
to produce excellent epifluorescent cell images is well appreciated, it is noted 
that achieving detailed quantitative data with this method can be very 
challenging.  
Previous investigators have quantitatively analysed epifluorescent cell 
images by manually counting and assessing the cell morphological features 
[395]. This type of quantitative analysis is however severely influenced by the 
operator and thus results are highly not repeatable, may not be set to the 
same standards and have high inaccuracies.  To overcome this problem, 
researchers have developed computational image processing programmes    
capable of producing unbiased and repeatable quantitative cell data [396-
399]. It should however be noted that the choice of a cell image processing 
programme could be inadequate for analysing complex data and also the 
robustness of statistical methods of the image programme could influence 
results [396, 400]. Thus care should be taken when choosing appropriate 
image processing programme for cell data analysis.   
A modular image processing software called CellProfiler was used to 
quantitatively analyse the cell data produced in this report. This software is a 
robust, high - throughput and free open-source image analysis programme 
that provides frameworks to measure standard biological assays (i.e. cell 
size and count) and complex morphological assays (i.e. cell shape and  
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protein staining) [396, 401]. The algorithm of this image analysis is built on a 
MatLab platform with the adoption of watershed transform methods which 
allows for accurate cell identification and measurements on crowded cell 
samples [401]. This software has been validated to solve several realistic 
biological problems with high accuracy [402, 403].   
 
7.2.6.1  WORKFLOW OF CELL SEGMENTATION                   
 
Segmentation of the stained cells was performed using a pipeline (a 
sequential set of image analysis algorithms) constructed using CellProfiler 
version 2.1.0 software package. The sequential flow to segmenting the 
stained cells is illustrated in figure 7.1 below.    
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Figure 7.1  Flowchart of cell segmentation. Each cell and its nucleus is colour 
coded to facilitate easy identification quantification of the cell and nucleus.  
The propagation alogorithm was used to identify cells as this method was an 
improvement on the conventional watershed transform method and 
appropriate for cell images with small gaps [404]. The propagation algorithm 
works by considering the identified nuclei as seed points and determines the 
Voronoi region of each given seed point on a Riemann manifold with a metric 
defined in the local image plane [404]. Cells and nuclei touching the image 
boundary are negated in the process of segmenting the cells as they may not 
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be segmented in their entirety and could compromise accuracy of results. 
This is shown with nuclei touching the image boundary outlined with yellow 
hue and the cells touching the image boundary not outlined.        
 
7.2.6.2  QUANTIFICATION OF SEGMENTATION DATA     
 
Once the cells had been segmented, the morphology such as the shape, 
size, aspect ratio and orientation of the cell and nuclei could now be 
quantified. Thus a MatLab script was written to analyse the segmented data. 
Figure 7.2 illustrates some of the morphological parameters obtained from 
the segmentation process.  The maximum ferret diameter (a) and the 
minimum ferret diameter (b) show the length and width respectively of the 
cell. Taking that flow (Q) direction is from left to right; the orientation of the 
cell is calculated by finding the angle (θ) between the major axis of the cell 
and the axis parallel to the flow direction. Nucleus localisation (upstream or 
downstream) in respect to the flow direction was determined by taking the 
distance between the centroid of the cell (C1) and that of the nucleus (C2).     
 
                   
 
 
 
 
 
Figure 7.2  Morphological parameters produced from cell segmentation 
C1 
a 
b 
θ 
C2 
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The aspect ratio of the cell can also be calculated by dividing the minor ferret 
diameter by the major ferret diameter. Calculating the aspect ratio by this 
method produces a conceptual binary result; thus 1 represents a fully 
rounded cell and 0 represents a fully elongated cell. 
 
 
  
 
Figure 7.3  A schematic diagram to explain aspect ratio. The cell is assumed 
to be fully elongated when aspect ratio is 0.0 and cobblestone when the 
aspect ratio is 1.0 
 
7.3        RESULTS  
 
Images of all stained cells taken were at the centre plane of the stamped 
glass slides. This ensured that results were then comparable. Additionally all 
images were taken with a x10 objective lens of the confocal microscopy and 
a standard scale bar of 200 𝑢𝑚 was set on the images. 
 
7.3.1     CELLS EXPOSED TO HYDROSTATIC PRESSURE  
 
Results presented in figure 7.4 shows HUVECs response to 100 𝑚𝑚𝐻𝑔 
hydrostatic pressure only seeded at a cell density of 10,114 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 for 
time durations 0, 6, 12 and 24 hours. 
Rounded 
1.0 0.5 0.0 
Elongated 
Aspect Ratio 
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Figure 7.4  Images of stained HUVECs after exposure to sustained 
hydrostatic pressure 100mmHg and fluid stress of 0.07 Pa for 0, 6, 12 and 24 
hours. Direction of fluid stress is from left to right. 
 
As observed in figure 7.4, local cell density of cell increased with increasing 
time when cells were exposed to sustained hydrostatic pressure.  
    
HUVECs morphological response to the hydrostatic pressure when seeded 
at a cell density of 26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 is shown in figure 7.5 below. Cell 
images shown here are in respect to specific locations on the cell-structure 
interaction model.   
 
0 hours 6 hours 
12 hours 24 hours 
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Figure 7.5 Stained HUVECs after exposure to sustained hydrostatic pressure 
100mmHg and fluid stress of 0.07 Pa for 6, 12 and 24 hours. 
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It is observed in figure 7.5 that HUVECs subjected to hydrostatic pressure 
increase in local cell density with increase in time. Also cells show random 
orientation and are cobblestone shaped. 
 
7.3.2     CELLS EXPOSED TO COMBINED FLUID STRESS AND 
HYDROSTATIC PRESSURE  
 
The results presented in figure 7.6a shows HUVECs morphological response 
when subjected to combined mechanical stimuli that is LAD pulsatile flow 
with a mean shear stress of 2 𝑃𝑎 and physiological hydrostatic pressure of 
120/80 𝑚𝑚𝐻𝑔.  
In figure 7.6b, the stained cell images are of the morphological changes of 
HUVECs when subject to steady laminar flow that yields a shear stress of 
2 𝑃𝑎  and hydrostatic pressure of 100 𝑚𝑚𝐻𝑔.  
The results shown in figure 7.6a and 7.6b were of the experiments with cells 
seeded at a cell density of 26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 and run for different time 
durations of 6, 12 and 24 hours. 
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Figure 7.6a Stained HUVECs after exposure to LAD pulsatile flow and 
hydrostatic pressure 120/80 mmHg for 6, 12 and 24 hours. Cells appear to 
elongate and align more in flow direction at 12 and 24 hours in the inlet and 
outlet regions. Cells at 6 hours appear less elongated at the inlet and outlet. 
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Figure 7.6b Stained HUVECs after exposure to steady flow and hydrostatic 
pressure 100 mmHg for 6, 12 and 24 hours. Cells appear to elongate and 
align more in flow direction at time 12 hours and 24 hours in the inlet and 
outlet regions. Cells within the ridges regions however are less aligned to 
flow direction. Cells are also observed on top of ridges at 12 and 24 hours. 
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7.3.3     MORPHOLOGICAL QUANTIFICATION      
 
Quantifying the morphology of cells after been exposed to the desired 
mechanical stimuli included cell orientation distribution, aspect ratio, average 
nuclei and cell size, local cell density and nucleus localisation. Statistical 
analyses of results were expressed as the mean ± SEM (standard error 
mean). Statistical significance was assessed by analysis of a 2 tailed, 
unpaired, Student’s T test with critical values of 𝑃 < 0.05 considered 
significant. The number of repeat for each specific test is denoted by the 
letter ‘n’. 
 
7.4      RESULT ANALYSIS II 
 
In this section, the change in morphology of sub-confluent and confluent 
cultured HUVECs when exposed to only sustained hydrostatic pressures are 
analysed. 
 
7.4.1    SUB-CONFLUENT CULTURED CELLS EXPOSED TO ONLY 
HYDROSTATIC PRESSURE    
 
The data presented here are of the experiments conducted with cell density 
of 10,114 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 and cells exposed to hydrostatic pressure of 
100 𝑚𝑚𝐻𝑔.  
 
 
 
 189 
 
CHAPTER 7 CELL-STRUCTURE INTERACTION EXPERIMENT 
 
 
Figure 7.7a Histogram graph showing orientation of sub-confluent cultured 
cells exposed to hydrostatic pressure of 100 mmHg for 0, 6, 12 and 24hrs. n 
= 1. Error bars show SEM of 6 images. From this graph, it can be reported 
that HUVECs randomly orientate when subjected only to hydrostatic 
pressure. 
 
Figure 7.7b  Line graph showing average aspect ratio of cells exposed to 
hydrostatic pressure of 100 mmHg for 0hrs, 6hrs, 12hrs and 24hrs. n = 1. 
Error bars show SEM of 6 images. 
Analysing the graph of figure 7.7b it could be deduced that HUVECs 
subjected to only hydrostatic pressure elongate. This deduction is made 
based on the decrease of cell aspect ratio with time under the stipulated 
condition.  
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Figure 7.7c  Line graph showing average number of cells within a local area 
of 0.18m2 after exposure to hydrostatic pressure of 100 mmHg for 0hrs, 6hrs, 
12hrs and 24hrs. n = 1. Error bars show SEM of 6 images. 
From figure 7.7c, it is realised that HUVECs only under hydrostatic pressure, 
first increase in density (0 to 6 hours) and then later decrease (6 to12 hours). 
There is however a surge in cell density again (12 to 24 hours).  
 
 
Figure 7.7d  Line graph showing average cell size in microns of cells 
exposed to hydrostatic pressure of 100 mmHg for 0hrs, 6hrs, 12hrs and 
24hrs. n = 1. Error bars show SEM of 6 images.  
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From the graph shown in figure 7.7d, it is seen that cells initially decrease in 
size and thereafter increase in size with respect to time when subjected to 
only hydrostatic pressure.  
 
Figure 7.7e  Line graph showing average nuclei size in microns of cells 
exposed to hydrostatic pressure of 100 mmHg for 0hrs, 6hrs, 12hrs and 
24hrs. n = 1. Error bars show SEM of 6 images. 
From figure 7.7e, it is observed that there is a relative change in nuclei size 
when subjected only to hydrostatic pressure for different timescales. 
 
Figure 7.7f Line graph showing average distance between centroid of 
nucleus and cell centroid after cells exposed to hydrostatic pressure of100 
mmHg for 0hrs, 6hrs, 12hrs and 24hrs. n = 1. Error bars show SEM of 6 
images. 
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From the graphs shown in figure 7.7f, it is observed that there is an increase 
in the average distance between the nucleus centroid and cell centroid of cell 
between 0 – 12 hours. This then tend to decrease at time 12 hours to 24 
hours.  
 
7.4.2    CONFLUENT CELLS EXPOSED TO ONLY HYDROSTATIC        
PRESSURE    
 
The data below are of the experiments conducted with cell density of 
26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 and cells exposed to hydrostatic pressure of 100 𝑚𝑚𝐻𝑔. 
 
    
 
 
* 
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Figure 7.8a  Histogram showing orientation of cells exposed to hydrostatic 
pressure of 100 mmHg for 6hrs, 12hrs and 24hrs. n = 3. Error bars show 
SEM of 3 images. * p < 0.05 vs. 6 hrs and ** p < 0.05 vs. 12 hrs. 
From the histogram graph presented in figure 7.8a, it is seen that confluent 
cultured cells tend to orientate randomly when subjected to only hydrostatic 
pressure for different timescales.   
 
 
 
** 
* * 
* 
* * 
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Figure 7.8b  Line graph showing average nuclei size in microns of cells 
exposed to hydrostatic pressure of 100 mmHg for 6hrs, 12hrs and 24hrs. n = 
3. Error bars show SEM of 3 images. * p < 0.05 vs. 6 hrs and ** p < 0.05 vs. 
12 hrs. 
It is observed from the above graph that the nuclei size of confluent cells 
generally tend to decrease when exposed to only hydrostatic pressure with 
increase timescales.   
 
Analysis of the density of the cells when HUVECs were exposed to 
hydrostatic pressure for 6 hours, 12 hours and 24 hours are presented 
below. 
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Figure 7.8c  Line graph showing average number of cells within a local area 
of 0.18mm2 after exposure to hydrostatic pressure of 100 mmHg for 6hrs, 
12hrs and 24hrs. n = 3. Error bars show SEM of 3 images. * p < 0.05 vs. 6 
hrs and ** p < 0.05 vs. 12 hrs. 
Analysis of the graphs in figure 7.8c show a general increase in cell density 
with increasing time periods when cells are subjected to hydrostatic 
pressure.  
 
7.5      DISCUSSION TO RESULT ANALYSIS II 
 
7.5.1     HUVECs EXPOSED TO SUSTAINED HYDROSTATIC PRESSURE   
 
Most studies investigating into the effects of hydrostatic pressure on ECs 
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morphology have reached similar conclusions that ECs elongate without 
prime cell orientation upon exposure to sustained hydrostatic pressure in a 
time dependent manner [313, 405]. Also, the actin cytoskeleton is reported to 
rearrange to form a multilayer structure. So it was as expected when results 
of HUVECs seeded under both sub-confluent (10,114 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2) and 
confluent (26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2) conditions and exposed to hydrostatic 
pressure of 100 𝑚𝑚𝐻𝑔 exhibited similar behaviour. The random 
orientations of cells when subjected to hydrostatic pressure are shown 
in figures 7.7a and 7.8a respectively. In figure 7.9, cell elongation is 
marked by decrease in aspect ratio. Below is a comparative quantitative 
analysis of HUVECs aspect ratio under sub-confluent and confluent 
conditions for 6, 12 and 24 hours. 
 
Figure 7.9  Line graph of average aspect ratio of HUVECs exposed to 
sustained hydrostatic pressure of 100 mmHg for 6, 12 and 24 hours. Cells 
under confluent condition before exposure to stimulus (dashed lines) and 
cells under sub-confluent conditions before exposure to stimulus (straight 
line). Error bars show SEM of 6 images. 
From figure 7.9 it is shown that there is a general decrease of cell aspect 
ratio with increase in time when subjected to hydrostatic pressure. This 
decrease in aspect ratio of cell can be related to as cell elongation. Thus  
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continuous exposure of cells to hydrostatic pressure may cause cells to 
elongate. It is important however to note that morphology and cell 
function of sub confluent ECs could differ to those of confluent 
conditions [406, 407]. Hence results of ECs under different confluency 
and exposed to hydrostatic pressure were careful analysed.  
Under sub-confluent conditions, HUVECs were inferred to elongate as the 
aspect ratio of the cells were quantified to decrease with time (average 
aspect ratio of ~ 0.65 at 0 hours to ~0.55 at 24 hours) as shown in figure 
7.7b. Also in figure 7.7c, local density of cells within a 0.18mm2 area is 
observed to increase with time with only a slight decrease in local density at 
12 hours. However results from the cells seeded under confluent conditions 
and exposed to same hydrostatic pressure level showed a general increase 
in local cell density from 6 hours to 24 hours. This data is presented in figure 
7.8c.  From these results, it is implied that hydrostatic pressure promotes 
ECs proliferation, a deduction which has been made in several similar 
investigations [313, 405, 408, 409]. The hypothesis that the confluency level 
of ECs could affect experimental findings was justified when HUVECs 
seeded at confluent conditions were qualitatively demonstrated to form 
multilayers as opposed to ECs under sub-confluent condition at 24 hours. 
Shown below are the figures of stained HUVECs exposed to hydrostatic 
pressure for 24 hours when seeded under two different confluent levels. 
Multilayering of HUVECs is suggested in the image ‘A’ of figure 7.10 as 
distinct features of the cells actin cytoskeletons reported to be only present in 
multi-layered  cell form were noticed.  
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                  A.             B.               
Figure 7.10  HUVECs exposed to sustained hydrostatic pressure of 100 
mmHg for 24 hours. Cells under confluent conditions (A) and cells under 
sub-confluent conditions (B) before exposure to stimulus. 
The multi-layered cells were observed to have more apparent thicker and 
central actin filaments (shown by the very bright green fluorescence around 
the cells) and formed a web-like structure. Additionally, cells further away 
from the substrate level are seen to exhibit cobblestone morphology 
characteristics. It is also realised that the dense peripheral band around the 
cells were lost and thus the shape of the cells were not evidently defined.  
These observations are analogous to that reported by Salwen et al. [410]. In 
contrast to these observations, the non-confluent cell result showed ECs 
which were more elongated, had parallel actin fibres and thin actin filaments. 
Salwen et al. [410] also reported similar ECs characteristics of non-confluent 
cells exposed to hydrostatic pressures of 1.5 𝑐𝑚𝐻2𝑂, 5 𝑐𝑚𝐻2𝑂, 10 𝑐𝑚𝐻2𝑂 
respectively for 7 days at substrate level. 
Furthermore, it is observed that the nuclei size of the confluent cells exposed 
to the sustained pressure tend to decrease (from ~ 23um to ~ 21um) whilst 
that of the non-confluent cell increased (~ 20.5um to ~ 22.5um) with time. 
This is evidently shown in figures 7.8b and 7.7e respectively. It would 
therefore be of great interest in future to investigate if these changes in the 
nuclear form would evoke different and/or similar gene activities of the cells. 
Thus this investigation might provide some insight into the influence of 
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pressure on endothelialisation after PCI. It is thought that as the nucleus is a 
mechanosensor, its nuclear form just like the cytoskeleton of the cell is 
induced by mechanical stimuli. Thus understanding the changes to the 
nucleus morphology as a result of stress could be indicative of the process 
by which cells respond to physical stimuli; for instance cell migration. In fact, 
the roles played by cytoskeleton and nucleus in ECs mechanotransduction 
are not mutually exclusive and may be interrelated through complex cellular 
pathways [411].  
To further quantify the nuclei response to mechanical stimuli and in this case 
sustained hydrostatic pressure, the average distance between the centroid of 
cell and its respective nucleus was determined. Figure 7.11 shows a 
schematic line graph representation of this measured average distance 
between the cell and nucleus at 6, 12 and 24 hours.  
 
Figure 7.11  Line graph showing average distance between the centroid of 
cells and nucleus for HUVECs under confluent condition (dashed lines) and 
HUVECs under sub-confluent conditions (straight line) exposed to 
hydrostatic pressure of 100 mmHg for 6, 12 and 24 hours. Error bars show 
SEM of 6 images. 
A negative distance is defined as the centroid of the nucleus displaced 
downstream to the centroid of the entire cell. From figure 7.11 it is thus  
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observed that nuclei centroid of HUVECs under confluent conditions tend to 
move from the downstream of the cell (~ -0.45um) at 6 hours to the upstream 
of the cell (~ 0.20um) at 24 hours. On the other hand, HUVECs under the 
non-confluent condition showed the centroid of the nuclei to initially move 
upstream (~ 0.3um at 6 hours to ~ 0.5um at 12 hours) before being located 
downstream of the cell (~ -0.35 um) at 24 hours.      
 
7.6      RESULT ANALYSIS III 
 
In this section, the change in cell morphology when exposed to a 
combination of fluid stress and hydrostatic pressure is analysed 
 
7.6.1   CELLS EXPOSED TO COMBINED LAD FLUID STRESS AND 
HYDROSTATIC PRESSURE    
 
The data below are of the experiments conducted with cell density of 
26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 and cells exposed to LAD pulsatile flow waveform with a 
mean shear stress of 2 𝑃𝑎 and hydrostatic pressure of 120/80 𝑚𝑚𝐻𝑔. 
The following set of data show the statistical analysis of cell orientation 
to flow direction within ± 10° and ± 20° respectively.  In addition to these 
data provided, analyses of the other morphological features of cells 
such as cell size and aspect ratio are also presented. 
 
 
 
 201 
 
CHAPTER 7 CELL-STRUCTURE INTERACTION EXPERIMENT 
 
 
 
 
Figure 7.12ai  Histogram showing orientation of cells exposed to LAD 
pulsatile flow and hydrostatic pressure of 120/80 mmHg for 6hrs, 12hrs and 
24hrs. n = 3. SEM of 3 images. Statistical significance of cells aligned in 
± 10° of flow direction; * p < 0.05 vs. 6 and ** p < 0.05: 24 hrs vs. 12 hrs. 
Analyses of the graphs in figure 7.12ai show that cells align more in the 
± 10° of flow direction with increase time period under LAD pulsatile flow 
simulation at the inlet and outlet regions. However, cell alignment to ± 10° 
* 
* 
* 
* 
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of flow direction within inter-ridges regions are not pronounced but generally 
are more randomly aligned. 
 
The analysis of cell alignment to ± 20° of flow direction under LAD pulsatile 
flow is presented below.   
 
 
 
 
 
 
 
 
* 
*  
Inlet Region 
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Figure 7.12aii  Histogram showing orientation of cells exposed to LAD 
pulsatile flow and hydrostatic pressure of 120/80 mmHg for 6hrs, 12hrs and 
24hrs. n = 3. SEM of 3 images. Statistical significance of cells aligned in 
± 20° of flow direction; * p < 0.05 vs. 6 hrs and ** p < 0.05: 24 hrs vs. 12 hrs.  
Analyses of the graphs in figure 7.12aii show that cells tend to align more in 
the ± 20° of flow direction with increase time period under LAD pulsatile flow 
simulation at the inlet and outlet regions. More so, this time dependent 
increase in the cell alignment to the ± 20° of flow direction is statistically 
significant. Conversely, although there may be a time dependent increase of 
cells aligned to ± 20° of flow direction within inter-ridges regions, these 
increments are not statistically significant. 
 
The next set of data show the aspect ratio of cells when subjected to a 
combination of LAD pulsatile fluid shear stress and hydrostatic pressure of 
120/80 𝑚𝑚𝐻𝑔.  
 
 
 
* 
** 
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Figure 7.12b  Line graph showing average aspect ratio of cells exposed to 
LAD pulsatile flow and hydrostatic pressure of 120/80 mmHg for 6hrs, 12hrs 
and 24hrs. n = 3. SEM of 3 images. * p < 0.05 vs. 6 hrs and ** p < 0.05: 24 
hrs vs. 12 hrs.  
It is observed from figure 7.12b, that there is a time dependent gentle 
decrease of aspect ratio of cells. However at the inlet and outlet regions, the 
decrease in aspect ratio of cell with respect to time is generally statistically 
significant. 
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Figure 7.12c  Line graph showing average cell size in microns of cells 
exposed to LAD pulsatile flow and hydrostatic pressure of 120/80 mmHg for 
6hrs, 12hrs and 24hrs. n = 3. Error bars show SEM of 3 images. * p < 0.05 
vs. 6 hrs and ** p < 0.05: 24 hrs vs. 12 hrs. 
It is noted from figure 7.12c that there is a general statistically significant time 
dependent increase of cell size across the experimental model when 
subjected to the stipulated fluid stress and hydrostatic pressure. 
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Figure 7.12d  Line graph showing average nuclei length size in microns of 
cells exposed to LAD pulsatile flow and hydrostatic pressure of 120/80 
mmHg for 6hrs, 12hrs and 24hrs. n = 3. Error bars show SEM of 3 images. * 
p < 0.05 vs. 6 hrs and ** p < 0.05: 24 hrs vs. 12 hrs. 
The graphs presented in figure 7.12d show an increase in nuclei size with 
increase in time period although generally not statistically significant when 
subjected to stipulated fluid stress and hydrostatic pressure.  
** 
* 
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Figure 7.12e  Line graph showing average number of cells within a local area 
of 0.18mm2 after exposure to LAD pulsatile flow and hydrostatic pressure of 
120/80 mmHg for 6hrs, 12hrs and 24hrs. n = 3. Error bars show SEM of 3 
images. * p < 0.05 vs. 6 hrs and ** p < 0.05: 24 hrs vs. 12 hrs. 
It is noticed from the graphs presented in figure 7.12e that local cell density 
tend to decrease at the inlet and outlet regions whilst there is a gentle 
increase in local cell density within the inter-ridges regions. 
* * 
* 
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7.6.2     CELLS EXPOSED TO COMBINED STEADY FLUID STRESS AND 
HYDROSTATIC PRESSURE    
 
The data below are of the experiments conducted with cell density of 
26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 and cells exposed to steady laminar flow of a shear stress 
of 2 𝑃𝑎 and hydrostatic pressure of 100 𝑚𝑚𝐻𝑔.  
The following set of data show the statistical analysis of cell orientation 
to flow direction within ± 10° and ± 20° respectively.  In addition to these 
data provided, analyses of the aspect ratio of cells and cell size are 
also presented. 
 
 
 
 
 
* 
* 
* 
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Figure 7.13ai  Histogram showing orientation of cells exposed to steady flow 
and hydrostatic pressure of 100 mmHg for 6hrs, 12hrs and 24hrs. n = 3. 
SEM of 3 images. Statistical significance of cells aligned in ± 10° of flow 
direction; * p < 0.05 vs. 6 hrs and ** p < 0.05: 24 hrs vs. 12 hrs. 
Analyses of the graphs in figure 7.13ai show that cells tend to align more in 
the ± 10° of flow direction in a time dependent manner at the inlet and outlet 
regions under steady flow simulation. However, cell within ridges regions are 
noticed to be generally randomly aligned. 
 
The analysis of cell alignment to ± 20° of flow direction under steady flow is 
presented below.   
 
 
Inlet Region 
* 
* 
* 
* 
 210 
 
CHAPTER 7 CELL-STRUCTURE INTERACTION EXPERIMENT 
 
 
 
 
Figure 7.13aii  Histogram showing orientation of cells exposed to steady flow 
and hydrostatic pressure of 100 mmHg for 6hrs, 12hrs and 24hrs. n = 3. 
SEM of 3 images. Statistical significance of cells aligned in ± 20° of flow 
direction; * p < 0.05 vs. 6 hrs and ** p < 0.05: 24 hrs vs. 12 hrs. 
Analyses of the graphs in figure 7.13aii show that cells tend to align more in 
the ± 20° of flow direction with increasing timescale under steady flow 
simulation at the inlet and outlet regions. More so, this time dependent 
increase in the cell alignment to the ± 20° of flow direction is statistically 
significant. Conversely, although there may be a time dependent increase of 
cells aligned to ± 20° of flow direction within inter-ridges regions, this 
increment is not statistically significant. 
 
Outlet Region 
* 
* 
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The next set of data show the aspect ratio of cells when subjected to a 
combination of steady fluid stress and hydrostatic pressure of 120/
80 𝑚𝑚𝐻𝑔. 
 
 
 
Figure 7.13b  Line graph showing average aspect ratio of cells exposed to 
steady flow and hydrostatic pressure of 100 mmHg for 6hrs, 12hrs and 
24hrs. n = 3. SEM of 3 images. * p < 0.05 vs. 6 hrs and ** p < 0.05: 24 hrs 
vs. 12 hrs. From figure 7.13b it is noted that generally there is a time 
dependent decrease of cell aspect ratio. Nonetheless, this decrease in cell 
* * 
** 
** 
* 
** 
* 
* * 
** 
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aspect ratio is slightly more pronounced at inlet and outlet regions.  
 
 
 
 
Figure 7.13c  Line graph showing average cell size in microns of cells 
exposed to steady flow and hydrostatic pressure of 100 mmHg for 6hrs, 
12hrs and 24hrs. n = 3. Error bars show SEM of 3 images. * p < 0.05 vs. 6 
hrs and ** p < 0.05: 24 hrs vs. 12 hrs. 
* 
* 
** 
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From data produced in figure 7.13c, it is generally seen that average cell size 
tend to increase with increasing timescale under steady flow simulation. This 
cell size increment with time is statistically significant. 
 
 
 
 
Figure 7.13d  Line graph showing average nuclei length size in microns of 
cells exposed to steady flow and hydrostatic pressure of 100 mmHg for 6hrs, 
12hrs and 24hrs. n = 3. Error bar show SEM of 3 images. * p < 0.05 vs. 6 hrs 
* 
* 
* * 
* 
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and ** p < 0.05: 24 hrs vs. 12 hrs. 
From the graphs presented in figure 7.13d, increase in nuclei size is seen to 
be time dependent although this phenomenon is more pronounced at the 
inlet and outlet regions. 
 
 
 
 
Figure 7.13e  Line graph showing average number of cells within a local area 
** 
** 
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of 0.18mm2 after exposure to steady flow and hydrostatic pressure of 100 
mmHg for 6hrs, 12hrs and 24hrs. n = 3. Error bars show SEM of 3 images. * 
p < 0.05 vs. 6 hrs and ** p < 0.05: 24 hrs vs. 12 hrs. 
From the data presented in figure 7.13e, the local cell density is seen to 
somewhat decrease with increase in time. This decrement however is 
generally not statistically significant.  
 
7.6.3     RESULTS COMPARING STEADY FLOW VS. LAD PULSATILE 
FLOW VS. HYDROSTATIC PRESSURE CONDITIONS   
 
The data below are of the experiments conducted with cell density of 
26,700 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2 and cells exposed to different flow and pressure 
conditions as discussed in this section.  
Comparative statistical analysis of cell orientation to flow direction within 
± 10° with respect to the different flow conditions at various time points 
is demonstrated in addition to the analysis of the morphological features of 
cells. 
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Figure 7.14ai  Histogram showing orientation of cells exposed to steady, LAD 
pulsatile flows and sustained hydrostatic pressure for 6hrs. n = 3. SEM of 3 
images. Statistical significance of cells aligned in ± 10° of flow direction; # p 
< 0.05 vs. static and ## p < 0.05: steady vs. LAD. 
It is observed from figure 7.14ai that cells subjected to either LAD, steady or 
sustained hydrostatic pressure for 6 hours exhibit random orientation and do 
not predominantly align in the ± 10° of flow direction.  
 
 
 
 
# # 
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Figure 7.14aii  Histogram showing orientation of cells exposed to steady, 
LAD pulsatile flows and sustained hydrostatic pressure for 12hrs. n = 3. SEM 
of 3 images. Statistical significance of cells aligned in ± 10° of flow direction; 
# p < 0.05 vs. static and ## p < 0.05: steady vs. LAD. 
From the above data it is observed that cells at inlet and outlet regions 
subjected to steady flow of 12 hours show more pronounced alignment in 
± 10° of flow direction compared to that of LAD flow and hydrostatic  
# 
# 
## 
# 
# 
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pressure for the same time duration. On the other hand, cells within the 
ridges regions do not show any strong alignment to flow ± 10° direction 
regardless of the type of flow or pressure subjected to them.  
  
 
 
 
Figure 7.14aiii  Histogram showing orientation of cells exposed to steady, 
LAD pulsatile flows and sustained hydrostatic pressure for 24hrs. n = 3. SEM 
of 3 images. Statistical significance of cells aligned in ± 10° of flow direction; 
# 
# 
## 
# 
# 
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# p < 0.05 vs. static and ## p < 0.05: steady vs. LAD. 
Figure 7.14aiii shows that there is statistically significant difference between 
the number of cells aligning within ± 10° flow direction at inlet and outlet 
regions when comparing steady flow, LAD pulsatile flow and hydrostatic 
pressure after 24 hours. However, although there are evidently slight 
differences in the cell proportion aligned within ± 10° flow direction when 
comparing steady flow with LAD flow at the inlet and outlet regions, these 
differences are not statistically significant. On the other hand, cells within the 
inter-ridges regions generally do not show strong alignment within ± 10° of 
flow direction regardless of the type of stimulus subjected to cells. Also, there 
are generally no statistically significant difference between the cells aligned 
within the 10 degrees at the inter-ridges region with the exception of steady 
flow stimulated cells within ridges 3 and 4 which are statistically significant 
when compared to that of the LAD flow stimulated cells. 
 
The next data presented shows comparative analysis of aspect ratio of cells 
when subjected to steady and LAD flow waveform 
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Figure 7.14b  Line graph showing average aspect ratio of cells exposed to 
steady and LAD pulsatile flows for 6hrs, 12hrs and 24hrs. n = 3. SEM of 3 
images. ## p < 0.05 vs. LAD flow.  
It is observed from figure 7.14b that cells to either steady flow or LAD 
pulsatile flow exhibit a time dependent decrease of cell aspect ratio. These 
decrease in cell aspect ratio are however very minimal and there is no 
statistical significance of cell aspect ratio with respect to the type of flow 
stimulus the cells were subjected to.  
 
Comparative analysis of the average cell sizes when HUVECs were 
subjected to either steady or LAD pulsatile flow is presented below. 
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Figure 7.14c  Line graph showing average cell size of cells exposed to 
steady and LAD pulsatile flows for 6hrs, 12hrs and 24hrs. n = 3. SEM of 3 
images. ## p < 0.05 vs. LAD flow.  
From figure 7.14c, a general trend of increase in cell size with respect to time 
when cells are subjected to either steady or LAD flow is observed. It is 
however noted that cells within the inter-ridges region and subjected to 
steady flow show greater increase in cell size than when subjected to LAD 
pulsatile flow. 
## 
## 
 ## ## 
## 
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Figure 7.14d  Line graph showing average number of cells within a local area 
of 0.18mm2 after exposure to steady, LAD pulsatile flows and sustained 
hydrostatic pressure for 6hrs, 12hrs and 24hrs. n = 3. SEM of 3 images. # p < 
0.05 vs. static and ## p < 0.05: steady vs. LAD. 
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As shown in figure 7.14d, HUVECs were subjected to either steady, LAD 
pulsatile flow or sustained hydrostatic pressure. From the graphs presented 
in this figure, it is clearly seen that cells subjected to sustained hydrostatic 
pressure show greater increase in cell density with respect to time. Cells 
subjected to steady flow show a relatively slow increase in cell density within 
the inter-ridges regions and decrease in cell density at the inlet and outlet 
regions. On the other hand, cell subjected to LAD pulsatile flow tend to 
decrease in cell density at the inter-ridges regions and also inlet and outlet 
regions.  More so, comparative analysis of the effect of sustained hydrostatic 
pressure, steady flow and LAD pulsatile flow on the local density of cell was 
showed to be statistically significant.  
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Figure 7.14e  Line graph showing average nuclei length size after exposure 
to steady, LAD pulsatile flows and sustained hydrostatic pressure for 6hrs, 
12hrs and 24hrs. n = 3. # p < 0.05 vs. static and ## p < 0.05: steady vs. LAD.  
The average nuclei size of cells subjected to sustained hydrostatic pressure 
tend to decrease with time whilst that of cells subjected to either LAD 
pulsatile flow or steady flow increase with time as shown in figure 7.14e. It 
however suggested that steady flow does have stronger effect on the nuclei 
size of cells compared to LAD pulsatile flow. This suggestion is made based 
on the results presented in figure 7.14e which showed greater increase in 
nuclei size of cells subjected to steady flow to cells subjected to LAD 
pulsatile flow. 
The average distances between nucleus centroid and cell centroid when 
cells are subjected to either steady or LAD pulsatile flow is analysed and 
results presented below. This analysis was grouped under cells that were 
subjected to steady uniform shear stress, steady non-uniform shear stress, 
LAD shear stress and LAD non-uniform shear stress.  
Classification of non-uniform shear stress was based on the shear stress 
dynamics within ridge regions. As reported in chapter 6, WSS dynamics at 
ridge regions are marked by WSS spikes on ridges and WSS valleys 
between the ridges and thus WSS at ridges region is non-uniform. Hence 
steady shear stress and LAD pulsatile shear stress at these regions are 
# 
# 
## 
# 
# 
# 
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categorised as steady non-uniform shear stress and LAD non-uniform shear 
stress respectively. Also, it is reported in chapter 6, that WSS at inlet and 
outlet regions of the experimental designed model were relatively uniform. 
So, steady stress and LAD stress at these regions are also categorised as 
steady uniform shear stress and LAD uniform shear stress respectively.  
 
 
Figure 7.14f  Line graph showing average distance between centroid of 
nucleus and cell centroid after cells exposed to steady and LAD pulsatile 
flows for 6hrs, 12hrs and 24hrs. n = 3. Error bars show SEM of 6 images. # p 
< 0.05: steady uniform stress vs. steady non-uniform stress and ## p < 0.05: 
LAD uniform stress vs. LAD non-uniform stress. 
A negative distance is defined as the centroid of the nucleus displaced 
downstream to the centroid of the entire cell. As shown in figure 7.14f, it is 
observed that steady uniform stress and LAD pulsatile uniform stress both 
have greater effect on nuclei centroid downstream displacement over 
increased timescale compared to steady and LAD pulsatile non-uniform 
shear stresses. Comparatively, steady uniform stress showed stronger effect 
on the nuclei centroid downstream displacement when compared to that of 
LAD uniform stress although not statistically significant.  
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7.7      DISCUSSION TO RESULT ANALYSIS III 
 
Biomechanical cues arising in the cellular milieu have generally been 
hypothesised to play major role in regulating EC function. Thus physical 
forces induced on ECs could lead to change in cell morphology and 
phenotype [61, 89, 289, 412-415]. It has been postulated that changes in cell 
shape does influence gene expression and cell cycle progression, albeit the 
precise mechanism and/or mechanisms which brings about this 
phenomenon remains unclear. It is however assumed that these cellular 
effects due to mechanical forces are mediated at least partly by changes in 
the actin cytoskeleton and nuclear structure of the cell [411, 412, 416]. 
Hence, it is imperative to understand how mechanical stimuli could bring 
about alterations in the cytoskeleton, nucleus and the cell in general. 
Understanding of how mechanical stimuli influence cell behaviour could be 
indicative to having better insight into the predictors of some arterial diseases 
such as restenosis.  It is well documented from in vitro and in vivo 
experiments that ECs elongate together with rearrangement of the 
cytoskeleton with increasing shear stress and align parallel to the dominant 
flow direction [180].  ECs are therefore considered as high resolution 
localised flow sensors and their morphology used to classically describe the 
shear stress patterns that may be present. Indeed whilst it is appreciated the 
knowledge gained in correlating shear stress to cell morphology and thus 
helped predict arterial disease prone sites, it is important that the nuclear 
form is not overlooked. This is because it has been realised that the nucleus 
of the cell plays an important role in the regulation of protein-gene 
expression and transcriptional activity [417]. In fact the nucleus itself has 
been suggested to be a mechanosensor as it elongates and aligns in the 
direction of imposed flow [418]. More so, some studies have proposed the 
nuclei to modulate cellular phenotype and have a stronger correlation to 
diseased states [419, 420]. For example, a study into the nuclear  
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organisation of breast cancer cells after being exposed to a level of shear 
stress found a striking correlation between cancer cells phenotype and 
nucleus morphology compared to that of cellular morphology and the 
cancerous cells [419].  It is therefore suggested that greater strides could be 
made in the quest of establishing mechanisms involved in the onset and/or 
progression of restenosis and subsequently better ISR treatment strategies if 
the role of the nucleus in the cell function is thoroughly examined. 
ECs in arteries are known not to be only exposed to shear stress due to 
blood flow dynamics but also hydrostatic pressure as a result of blood 
pressure. These stresses could therefore have independent or contributory 
effect on cells response. As shown in the results section of this chapter, ECs 
exposed only to hydrostatic pressure and combined stresses thus fluid stress 
and hydrostatic pressure resulted in marked cellular morphological 
differences. It is these differences and the effects of the physical stimuli on 
the cell state which would be elaborated in this chapter.  
 
7.7.1     HUVECs EXPOSED TO COMBINED PRESSURE AND SHEAR 
STRESS 
 
HUVECs exposed to combined stresses; thus steady WSSs and hydrostatic 
pressure of 100 𝑚𝑚𝐻𝑔  and also LAD pulsatile shear stress and hydrostatic 
pressure of 120/80 𝑚𝑚𝐻𝑔, in the cell-structure interaction experimental 
model showed ECs distinctive response to different type of stresses. 
HUVECs were observed to elongate and align predominately in the flow 
direction at the inlet and outlet regions of the model in a time dependent 
manner as shown in figures 7.12ai, 7.12aii, 7.12b, 7.13ai, 7.13aii and 7.13b. 
WSSs at these regions were proposed to be relatively uniform with an 
average stress magnitude of 2 𝑃𝑎 as indicated by the CFD simulations in  
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chapter 6. These observations are analogous to the findings reported in 
several in vitro and in vivo studies that ECs subjected to unidirectional WSS 
elongate and align in the direction of the imposed flow [61, 180, 304, 395, 
421, 422]. Analysis of the number of ECs aligned within ± 10° and ± 20° to 
the impinged flow directions over increasing timescales at the inlet and outlet 
regions indicated statistical significant differences. This statistical significant 
difference of time-dependent ECs alignment to flow is shown in figure 7.12ai, 
7.12aii, 7.13ai and 7.13aii. Nonetheless, although there were increased 
number of ECs aligned within ± 10° and ± 20° of flow direction at 24 hours 
than at 12 hours under exact same flow conditions, this difference in number 
of ECs alignment between the two timescales was not statistically significant. 
In general steady flow was observed to induce more ECs to align within the 
± 10° of the flow directions when compared to that of LAD pulsatile flow 
conditions as shown in figures 7.14aii and 7.14aiii. However the difference in 
number of ECs aligned to flow direction between the two flow conditions was 
generally not statistically significant. It is noted nonetheless that ECs 
alignment to flow direction at the outlet region at 12 hours between the 
steady and LAD pulsatile flow conditions was statistically significant whereas 
the inlet region of the same experiment showed otherwise. Plausible 
explanation for this observation could be that local cell density at the 
selected outlet region might have been slightly different from that of the inlet 
region. Hence the type of fluid stress subjected to the cells could have a 
profound effect on the number of cells aligned to the imposed flow direction. 
This variation in local cell density may be as a result of normal experimental 
procedural inconsistencies. However studies have demonstrated that steady, 
non-reversing pulsatile and reversing pulsatile flow conditions all have 
different effects on ECs morphological response [318, 423]. Steady flow 
conditions have been reported to influence strongly cell morphological 
response whilst that of reverse pulsatile flow conditions triggered weaker 
morphological response [318]. So as the experimental LAD pulsatile flow  
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condition included a small reversing component, it is possible that the 
associated stresses due to the LAD flow type such as OSIs, and also slight 
increase of SWSSG at the outlet region as shown in chapter 6 could cause 
weaker alignment of cells to the flow direction and thus bring about the 
statistical difference recorded. Further examination into this occurrence is 
therefore needed to clarify clearly if the observed outcome was more as a 
result of experimental inconsistencies or mechanical stress related. As 
explained earlier, different type of fluid stress have different effects on cells 
morphological response and this statement is justified as steady flow is 
shown to induce greatly an increase in cell aspect ratio when compared to 
that of the LAD pulsatile flow at the inlet and outlet regions.  
Conversely in the regions where flow was “disturbed” thus regions marked 
with flow recirculation, flow separations and flow recovery, HUVECs were by 
qualitative inspection seen to be somewhat of a polygonal shaped as shown 
in figures 7.6a and 7.6b. This disturbed flow phenomenon occurred at the 
inter-ridges regions and from the CFD analysis discussed in chapter 6, these 
regions were characterised with SWSSG, OSIs and both low (~ -2.5 Pa) and 
high (~ 2.5 Pa) WSSs. This observation presents the evidence that the 
application of disturbed stresses to ECs in vitro have distinct influence on 
ECs shape compared to the effects of uniform stresses on ECs shape. This 
said evidence is supported by results from other similar investigations [319, 
424]. Comparative quantitative analysis on the effects of “disturbed steady 
shear stress” and “disturbed LAD pulsatile shear stress” on ECs average 
aspect ratio showed similar results as illustrated in figure 7.14b.  However, 
this quantitative data tends to obviate the proposed hypothesis that different 
types of fluid stress (i.e. steady and pulsatile) do have different effects on 
ECs. To ascertain if this observation holds true for other morphological 
parameters of the ECs under the two stipulated disturbed stresses, further 
quantitative examinations of cell morphology was performed. Investigation  
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into the effect of disturbed stresses on cell size length revealed that steady 
disturbed shear stress stimulated greater increase in cell size than that of 
disturbed LAD pulsatile stress as shown in figure 7.14c.  Furthermore, there 
were recorded statistical significant differences in the cell sizes between ECs 
exposed to the two disturbed stresses at timescales of 12 hours and 24 
hours. Qualitative evidence of difference in cell size is shown in figure 7.15. 
A.               B.  
Figure 7.15  HUVECs exposed to disturbed steady shear (A) and disturbed 
LAD pulsatile shear (B) for 12 hours. 
This additional data helps clarify the inference made about the similar 
morphological disposition (i.e. aspect ratio) of HUVECs exposed to both 
disturbed steady and LAD pulsatile stresses. It is therefore suggested that 
although ECs exposed to different disturbed stresses may have the same 
average aspect ratio, the size of the cells could differ greatly, hence the said 
hypothesis stills holds true.  
Additionally, cells exposed to disturbed flow regimens were noticed to be 
more randomly aligned to the ± 10°  flow directions irrespective to the stress 
exposure duration as shown in figures 7.12ai and 7.13ai. However there 
were observed slight major alignment of cells to the ± 20° flow directions 
although this observation was not consistent across all the disturbed flow 
locations as also shown in figures 7.12aii and 7.13aii. Estrada et al. [425] in 
a study investigating ECs morphological response to disturbed flow 
conditions also reported similar observations. Saksamoto et al. [185] also  
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reported a weaker alignment of ECs to imposed flow direction and attributed 
this occurrence to high SWSSG present. Thus from our CFD simulations 
which showed high SWSSGs at the disturbed flow regions, this conclusion 
reached by Saksamoto et al. [185] tends to support our experimental 
observation.  
Regardless of the type of combined fluid stress and pressure exposed to the 
cells, a general observation of the cells being able to maintain their 
monolayer integrity was made. Thus the effect of the hydrostatic pressure of 
cells to cause the cells to form multilayer structure is void. It is therefore 
suggested that in the presence of hydrostatic force and shear stress, shear 
stress becomes the overriding force that tends influence the morphology of 
the ECs.  
As previously discussed, hydrostatic pressure is reported to stimulate 
increase in ECs proliferation whereas studies have demonstrated uniform 
shear stress inhibits ECs proliferation [423, 426, 427]. On the contrary, 
disturbed shear stresses which may give rise to shear gradients, more 
specifically temporal shear gradient have been attributed to enhance ECs 
proliferation [24, 428]. White et al. [24] concluded from their investigations on 
the effect of temporal gradient in shear and spatial gradient in shear on EC 
proliferation that temporal shear gradient induced ECs proliferation. Spatial 
shear stress gradient on the other hand was suggested to affects ECs 
proliferation similarly to that of a uniform shear stress. If increase in local cell 
density is implied to as increase in ECs proliferation, then these hypotheses 
are suggested to be in accord with the results achieved from our 
experimental studies. This is because it has been demonstrated clearly that 
ECs subjected to predominant hydrostatic pressure of 100 𝑚𝑚𝐻𝑔 enhanced 
increase of local cell density per unit area. The local cell density of HUVECs 
exposed to steady flow where observed to decrease even at regions where 
flow was classified disturbed. Since steady flow has no transient  
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characteristics, the effect of TWSSG on HUVECs may be very minimal or 
non-existent. This hence explains why there was no increase in local cell 
density at the disturbed flow region under steady flow simulation. On the 
other hand, the local cell density of cells exposed to LAD pulsatile flow 
decreased at regions where shear stress was classified uniform (inlet and 
outlet regions) and increased at disturbed stress regions (inter-ridges 
regions). It is reasoned that due to the transient nature of the LAD flow 
waveform, disturbed LAD flow brings into effect strongly the influence of 
TWSSG on HUVECs present and thus elucidate the observation made.  
It is also important to take into account the effect of the different type of fluid 
stress on the nucleus morphology. The shape of EC nuclei is well defined as 
an ellipse and aligns in the direction of an imposed uniform flow as reported 
by Flaherty et al. [429] The nucleus is also reported to elongate upon 
exposure to shear stress. In the analysis of the nucleus morphology after 
HUVECs had been exposed to both LAD pulsatile and steady shear stress, it 
is observed that the latter had a dominant time dependent effect on the 
nuclei length size. Interestingly, this effect on nuclei size was generally not 
statistically significant when compared to that of the LAD pulsatile stress as 
shown in figure 7.14e. If the increased in nuclei length size is thus inferred to 
as elongation of the nuclei since the shape of nuclei is generally well defined, 
then it could be suggested that cells exposed to both flow conditions (i.e. 
steady and LAD pulsatile) caused elongation of the nucleus. This deduction 
of nuclei elongation thus tends to support Flaherty et al. [429] experimental 
findings on nuclei elongation due to shear stress. Bond et al. [318] in a study 
of endothelial nuclei elongation around mouse aortic branches reported that 
steady flow had more dominant effect on ECs nuclei elongation than the 
corresponding reverse pulsatile flow. This conclusion by Bond et al. [318] 
therefore supports our evidence of HUVECs nuclei elongation under the 
stipulated flow conditions. Conversely, HUVECs exposed to sustained  
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hydrostatic pressure showed a general time-dependent decrease of nucleus 
length size.  
In a study conducted by Tkachenko et al. [418] into the sensory role played 
by the nucleus of ECs, a hypothesis that ECs upon sensing the direction of 
shear stress through hydrodynamic drag induce the nucleus to polarise 
downstream of the cell was proposed. To confirm this hypothesis in our 
experiments, an investigation into the effect of steady and LAD pulsatile 
flows on the downstream displacement of the nuclei within HUVECs was 
conducted. In the study by Tkachenko et al. [418], cells were only subjected 
to uniform steady shear flow, thus results of nuclei displacement within cells 
was that of cells under steady flow conditions. In our experimental model 
however, cells were exposed to both physiological relevant shear (LAD 
pulsatile WSS) and steady WSS. Also, due to the design of the experimental 
model there were regions where ECs were exposed to uniform shear stress 
(inlet and outlet regions) and other regions where ECs were exposed to 
disturbed shear stress (ridge regions).  The localisation of the nuclei within 
HUVECs when exposed to uniform and disturbed LAD pulsatile WSS and 
also uniform and disturbed steady WSS are shown in figures 7.16 and 7.17 
respectively.  
 
Figure 7.16  Line graph showing average distance between nucleus and cell  
## 
# 
 234 
 
CHAPTER 7 CELL-STRUCTURE INTERACTION EXPERIMENT 
 
centroids after exposure to stimuli for 6hrs, 12hrs and 24hrs. n = 3. Error 
bars show SEM of 6 images. # p < 0.05 vs. 6 hrs and ## p < 0.05: 12 hrs vs. 
24 hrs. 
Cells localised at the inlet and outlet regions are predicted to experience 
constant uniform shear stress across these regions. It is thus suggested that 
LAD shear stress at these areas is uniform and this suggestion is supported 
by the evidences presented in chapter 6. On the other hand WSS at the 
ridges region are marked by WSS peaks and valleys and because of the 
irregularities of WSSs at this region, LAD shear stress at this region is 
classified as non-uniform shear stress. From figure 7.16, it is observed that 
from time duration of 6 hours to 12 hours, cells being subjected to either LAD 
uniform shear stress or LAD non-uniform shear stress both show a similarly 
gradual negative displacement of nuclei centroid. However after 12 hours, 
there is a sharp increase in the negative displacement of nuclei centroid with 
cells that were subjected to LAD uniform shear stress whilst cells subjected 
to LAD non-uniform shear stress maintained a gradual increase in negative 
displacement of the cell nuclei centroid.   
 
Figure 7.17  Line graph showing average distance between nucleus and cell 
centroids after cells exposed to stimuli for 6hrs, 12hrs and 24hrs. n = 3. SEM 
of 6 images. # p < 0.05 vs. 6 hrs and ## p < 0.05: 12 hrs vs. 24 hrs. 
## 
# 
## 
# 
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The nuclei centroid displacement of cells when subjected to steady uniform 
shear stress and steady non-uniform shear stress show similar behaviour to 
that observed for the LAD pulsatile shear stresses in figure 7.16. 
A negative distance is defined as the centroid of the nucleus displaced 
downstream to the centroid of the entire cell. As could be seen from figures 
7.16 and 7.17, both flow conditions induced a downstream displacement of 
the nucleus within HUVECs, thus our findings support the hypothesis 
proposed by Tkachenko et al. [418].  It is however noted that the uniform 
shear stress had greater effect of the nuclei displacement when compared to 
that of the disturbed shear stress. Also there were time dependent statistical 
significant differences of the nuclei displacement when subjected to uniform 
shear stresses. Of interest, whilst disturbed steady shear brought about a 
time dependant statistical significant differences in nucleus displacements, 
disturbed LAD pulsatile shear on the other hand showed no statistical 
significant difference. Additionally, comparative analysis of the nuclei 
localisation between HUVECs exposed to steady and LAD pulsatile flow 
conditions revealed steady flow conditions to induce more the downstream 
localisation of the nucleus. This steady flow effect on the nucleus 
displacement was however not statistically significant when compared to that 
under LAD pulsatile flow condition as shown in figure 7.14f. Nonetheless, 
these experimental evidences reiterate the earlier stated hypothesis that 
different fluid stresses have different effects on endothelial cellular response.  
Another important observation made about the response of HUVECs 
exposed to the stated combined mechanical stresses within the experimental 
model was the presence of HUVECs on the fabricated micro-structure ridges 
at 12 hours and 24 hours. During the experimental seeding procedure, the 
ridges were covered with a sheath to prevent HUVECs from being seeded 
onto the ridges before being subjected to fluid stresses and pressure. Upon 
exposure of the stresses on the cells for a duration of 6 hours there were no  
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observed cells on the ridges, however at time points 12 hours and 24 hours, 
there were cell present on the ridges as shown in figures 7.6a and 7.6b. 
Several possible explanations to this phenomenon could include that some 
cells might have been seeded on the ridges during the seeding process due 
to experimental procedure negligence. This explanation although reasonable 
is considered not probable as the ridge sheath covered fully the ridges and 
was taken off until the cells had fully bedded down. Additionally this 
explanation does not tend to justify the non-existence of HUVECs on the 
ridges after exposure to the stated stimuli for 6 hours.  So, another plausible 
explanation to this phenomenon could be that the mechanical stresses 
subjected to HUVECs induced cells to “migrate” and hence led to the cells 
covering the ridges. This latter explanation is deemed more appropriate for 
the observed occurrence. In a study by Ostrowski et al. [430] on ECs 
migration, it was reported that gradient in shear due to fluid flow stimulated 
ECs to migrate against the impinged flow direction and concentrate in region 
of high WSS. As shown in our CFD simulation in chapter 6, high WSSs (> 10 
Pa) were recorded on top of the ridges and also high SWSSGs were 
recorded at the inter-ridges region. So in relating to Ostrowski et al. [430] 
explanation on ECs migration, it is proposed that HUVECs within the inter- 
ridges region upon sensing gradient in shear stress migrated towards the 
region of increased WSSs (i.e. the top of the ridge). 
 An in vivo study by Sprague et al. [431] into the impact of parallel micro-
engineered stent grooves on ECs migration and function produced results 
that further supported our experimental observations. Sprague et al. [431], 
reported that parallel microgrooves stent within coronary artery of a swine 
induced cell migration and positive cell function which consequently inhibited 
the NI formation.   
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7.8      SUMMARY 
 
From the discussions presented in this chapter, it can be concluded that the 
type of fluid stimuli or hydrostatic pressure subjected to cells show marked 
difference in the morphological response of cell. Cells subjected to either 
LAD pulsatile flow or steady flow tend to align more to the direction of flow 
with increase time periods whilst cells subjected to only hydrostatic 
pressures show random orientation. However, cells subjected to unstable 
flow regimes which are characterised by WSS peaks and valleys tend to 
show random alignment to flow direction. Additionally whilst exposure of cells 
to only hydrostatic pressure caused strong increase in local cell density, the 
effect of steady and LAD pulsatile flow on cell density was opposite. Thus, 
cell density decreased when cells were exposed to steady flow. Cells 
exposed LAD pulsatile flow however showed a gentle increase in cell density 
within the ridge regions whilst at the inlet and outlet regions cell density 
decreased. It is also noticed that cells within the inter-ridges region and 
exposed to steady flow showed increased average cell size when compared 
to that of cells exposed to LAD pulsatile flow.   
 
7.4.3     LIMITATIONS 
 
It is notable from the results produced of HUVECs exposed to independent 
and combined stresses that the designed flow bioreactor system is capable 
of supporting healthy cultured ECs for experimental investigations for at least 
24 hours. Qualitative and quantitative analyses of the HUVECs response 
when subjected to defined mechanical environment are in parallel agreement 
to similar studies reported by other researchers. Thus these scientific studies 
have been the benchmark for which our experimental results have been  
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compared and validated. Additionally, results observed in the designed cell-
structure interaction experimental model demonstrates the feasibility of 
studying HUVECs response to mechanical stimuli that may be present within 
stented arteries.  
Despite experimental results of cells response to a given stimuli which has 
been shown to be analogous to that observed in vivo, one should 
nonetheless be very careful when interpreting the results achieved for clinical 
relevance. This is because the timescales for which the cells experiments 
were conducted, although sufficiently long to induce significant cell 
morphological response, was relatively short compared to the timescales for 
which cells may be experiencing same stimuli in vivo. It is known that ECs in 
stented arteries characteristically experience mechanical stimuli relevant to 
restenosis and/or ISR for timescales of many months or even years [432, 
433]; a system which cannot practically be repeated in vitro. Thus practical 
experimental considerations dictate the duration of in vitro experiments 
performed and that certain cellular responses occurring at later stages might 
have been overlooked. 
The common use of HUVECs in the investigation of cells response to 
mechanical stresses have been well documented and with results suggested 
to represent in vivo arterial occurrences [424, 434-436]. However, it must be 
made clear that HUVECs are not arterial cell type and thus the phenotype of 
cell could influence differently the cells response to stimuli. It should 
therefore be considered that results achieved from the experiments may not 
be an entirely accurate indicator of arterial cells response to mechanical 
stimuli. Albuquerque et al. [437] reported a weak correlation between 
HUVECs response to steady laminar shear and human coronary arterial 
endothelial cells response to the same shear. It is therefore of importance 
that future work would involve the use of arterial ECs to compare and 
validate results documented.       
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CHAPTER  8 
 
EXPERIMENTAL ANALYSIS OF ECs MOLECULAR 
RESPONSE TO PHYSIOLOGICAL RELEVANT FLUID 
DYNAMICS IN STENTED MODEL 
 
8.1        INTRODUCTION 
 
As previously discussed in chapter 7, the choice of stress applied to cells 
could influence significantly the cells morphology. Moreover, the ability of 
cells to discriminate between flow types is dependent on the shear-induced 
molecular mechanochemical signal transduction [415]. The complex interplay 
and processes involved in the shear induced signalling molecules tend to 
alter transcription factors which modulate endothelial gene expression and 
thus results in differential cell function [438]. Amongst the transcriptional 
factors being altered is the nuclear factor kappa B (NF-𝑘B). NF-𝑘B is thought 
to play a very important role in controlling inflammation, cell adhesion 
molecules and proliferation and if activated becomes the bane of the arterial 
system [439]. A mechanobiological modelling of restenosis in stented artery 
by Boyle et al. [389] suggested that inflammation accounted for restenosis in 
stented artery. Studies have demonstrated that 𝑝50/𝑝65 NF-𝑘B heterodimer 
lies dormant in the cell cytoplasm complexed to 𝐼𝑘B, its inhibitory element 
[440]. Upon stimulation of the cells by cytokines or low/disturbed shear 
stress, NF-𝑘B tend to dissociates from 𝐼𝑘B and translocates into the nucleus, 
thus becomes active [100, 440, 441]. The activation of NF-𝑘B therefore 
promotes inflammation and other adverse gene transcription which 
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subsequently evokes arterial disease. It should however be noted that not all 
genes modulated by NF-𝑘B is deleterious to the arterial system [442]. One of 
the many cytokines regulated by NF-𝑘B is the tumour necrosis factor-alpha 
(tnf-𝛼). Tnf- 𝛼 is considered a critical mediator of inflammatory process that 
occurs during atherosclerosis and known to promote the expression of 
adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion molecule-1 (VCAM-1) and endothelial selectin (E-
selectin) [443].  Although studies have reported inflammation to play critical 
roles in atherosclerosis and restenosis development, it is still necessary to 
clarify that inflammatory pathway leading to each stated disease could be 
different. Hence investigations into restenosis based on atherosclerosis and 
the role played by inflammation in the development of atherosclerosis could 
be entirely flawed.  It is therefore suggested that the role of inflammation in 
restenosis should be explicitly investigated. In addition to cytokines inducing 
inflammatory genes and expression of adhesion molecules, fluid shear stress 
has also been reported to modulate ECs adhesion molecules [444]. 
Nonetheless, as it is suspected that inflammation may play a pivotal role in 
linking arterial injury to the eventual consequence of restenosis, it is 
proposed that key inflammatory molecules be investigated. The main 
objective of this chapter is therefore to gain better understanding of how 
combined stresses thus fluid stress and hydrostatic pressure affect the 
expression of ICAM-1 and NF-𝑘B.    
 
8.2        METHOD 
 
Pre cell culture preparation and cell seeding process for this experiment was 
similar to that discussed in sections 7.2.2 and 7.2.3 respectively but with the 
difference that cells were seeded under low density (≈ 13,000 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2) 
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so as to attain confluency within 4 days. Cells were seeded under low 
confluence so as to allow cells enough time to regenerate new membrane 
proteins which may have been damaged when cells were initially trypsinized. 
Initial experiment performed with the now confluent cells involved stimulating 
the cells with the cell growth media containing human recombinant tumour 
necrosis factor alpha; tnf-𝛼 (Life Technologies, UK) of different 
concentrations; thus 100 𝑢𝑛𝑖𝑡𝑠/𝑚𝑙, 200 𝑢𝑛𝑖𝑡𝑠/𝑚𝑙 and 300 𝑢𝑛𝑖𝑡𝑠/𝑚𝑙 for 1 
hour and kept under static flow conditions in the incubator. This experiment 
was to determine the most appropriate tnf-𝛼 dose level to cause 
translocation of 𝑝65 subunit of NF-𝑘B from the cytoplasm of HUVECs to the 
nucleus. A positive control did not involve any stimulation of the cells; 
however the cells were kept under static flow conditions in the incubator for 
equal duration. After the cells had been stimulated with tnf-𝛼 for an hour, the 
cells were then washed once in 20 𝑚𝑙 of HBSS and then twice with PBS 
before fixing them in 20 𝑚𝑙 of 3.7% formaldehyde for 20 minutes. The 
unstimulated cells were also fixed in the exact manner as the stimulated 
cells. Both stimulated and unstimulated cells were then stained for the 
location of NF-𝑘B. 
Subsequent experiments involved the investigation of the effect of the 
stipulated combined stresses on NF-𝑘B and ICAM-1 expressions. In the 
experiment to investigate NF-𝑘B expression due to stress conditions, this 
experiment involved similar flow setup as discussed in section 7.2.4 but this 
time the confluent cells were exposed to combined flow and pressure 
conditions for 1 hour. Investigation of ICAM-1 expression also involved same 
experimental flow setup as illustrated in 7.2.4 at different timescales of 6 
hours, 12 hours and 24 hours. Negative controls of the ICAM-1 investigation 
involved stimulating confluent HUVECs for 6 hours, 12 hours and 24 hours 
respectively with cell growth media containing tnf-𝛼 at a concentration of   
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200 𝑢𝑛𝑖𝑡𝑠/𝑚𝑙 under static culture. On the contrary, positive controls of this 
investigation involved HUVECs not being stimulated under static culture for 
also 6 hours, 12 hours and 24 hours. 
 
8.2.1     CELLS STAINING  
 
8.2.1.1  STAINING FOR NF-kB  
 
After the cells had been fixed, they were washed three times with PBS for 5 
minutes each. After the third wash, the PBS was aspirated and then the cells 
permeabilised by adding 1% Triton X-100 for 3 minutes. The cells were 
washed again three times with PBS for 5 minutes each after being 
permeabilised. After this step, 1% bovine serum albumin (BSA) in PBS 
solution was added to the cells for 1 hour to block nonspecific binding. A 
primary antibody solution containing 40𝑢𝑙 of a 200𝑢𝑔/𝑚𝑙 concentration anti-
NF-𝑘B/𝑝65 goat polyclonal IgG (Santa Cruz Biotechnology, Santa Cruz) in 
4 𝑚𝑙 of 1% BSA-PBS was pipetted onto the cells and left for 1 hour at room 
temperature. After an hour, the primary antibody solution was aspirated from 
the cells and the cells washed three times in PBS with each wash lasting for 
5 minutes. The cells were then incubated with a secondary antibody solution 
made of 10𝑢𝑙 of a 1.5𝑚𝑔/𝑚𝑙 concentration biotinylated anti-goat IgG 
(Vector Laboratories, UK) in 10 𝑚𝑙 of 1% BSA-PBS for 1 hour at room 
temperature. The cells were then washed three times with PBS again after 
the 1 hour had elapsed and then stained with a fluorophore solution 
containing 40𝑢𝑙 of a 1𝑚𝑔/𝑚𝑙 concentration fluorescein streptavidin (Vector 
Laboratories, UK) in 4 𝑚𝑙 of 1% BSA-PBS for 30 minutes at room 
temperature. Then after, the cells were washed twice with PBS before being  
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stained with the DAPI solution for 10 minutes. The cells were for the final 
time washed with PBS after being stained with DAPI and visualised using 
confocal microscopy. The fluorophore stain for the NF-𝑘B was able to be 
seen using the same confocal settings used with the FITC conjugated 
Phalloidin.  
 
8.2.1.2  STAINING FOR ICAM-1  
   
HUVECs were stained for ICAM-1 expression after stimulations with the 
stipulated combined stresses and also tnf-𝛼. After having initially fixed the 
stimulated cells, the cells were then washed three times with PBS and each 
wash lasted for 5 minutes. After the third wash, the PBS was aspirated and 
the cells then permeabilised by adding 1% Triton X-100 for 3 minutes. After 
the 3 minutes had elapsed, the cells were washed again three times with 
PBS. After the third wash, 1% bovine serum albumin (BSA) in PBS solution 
was added to the cells for 1 hour to block nonspecific binding. A primary 
antibody solution containing 20𝑢𝑙 of a 0.5𝑚𝑔/𝑚𝑙 concentration purified anti-
human CD54 ICAM-1 (Affymetrix eBioscience, UK) in 10 𝑚𝑙 of 1% BSA-
PBS was pipetted onto the cells and left overnight in a 4℃ fridge. After the 
cells have been left in the fridge overnight, the primary antibody solution was 
then aspirated from the cells. The cells were again washed three times with 
PBS and each wash lasted for 5 minutes. The cells were later incubated with 
a secondary antibody solution made of 20𝑢𝑙 of goat anti-mouse IgG, Alexa 
fluor 633 (Life Technologies, UK) in 20 𝑚𝑙 of 1% BSA-PBS for 1 hour at 
room temperature. The cells were then washed three times and the 
cytoskeleton and nuclei stained with FITC conjugated Phalloidin (Sigma-
Aldrich, UK) and DAPI solution respectively. The cells were then washed for 
the final time with PBS and after visualised using confocal microscopy. The  
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fluorophore stain for ICAM-1 was able to be seen using 632𝑛𝑚 excitation 
laser with an emission filter of 647𝑛𝑚 setting on the confocal microscopy. 
8.3        RESULTS 
 
Images of all stained cells taken were at the centre plane of the stamped 
glass slides. Additionally all images were taken with a x10 objective lens of 
the confocal microscopy and a standard scale bar of 200 𝑢𝑚 was set on the 
images. 
 
8.3.1     CELLS STAINED FOR NF-kB    
 
Figure 8.1  Image showing localisation of NF-kB after static culture 
simulation of human recombinant Tnf-𝛼 at different concentrations for 1 hour. 
Scale bar (0 – 6) shows activation level of NF-kB in nuclei. n = 1. 
N
U
C
L
E
I 
N
F
-k
B
 
M
E
R
G
E
D
 
 245 
 
CHAPTER 8 CELL-STRUCTURE INTERACTION EXPERIMENT (II) 
 
As seen in figure 8.1, when NF-kB is inactive, the nucleus form within the cell 
and the cytoplasm is clearly identified and defined. However when NF-kB is 
active; the structure of the cytoplasm becomes less defined. 
 
 
 
Figure 8.2  Image showing localisation of NF-kB in HUVECs after stimulation 
for 1 hour. Static culture stimulation; positive Control (Top row), stimulation 
with human recombinant Tnf-𝛼 at concentration of 200 units/ml under static 
control (2nd row), combination of steady flow and hydrostatic pressure of 
100mmHg (3rd row), combination of LAD pulsatile flow and hydrostatic 
pressure of 120/80mmHg (4th row). Scale bar (0 – 6) shows activation level 
of NF-kB in nuclei. n = 1. As illustrated in figure 8.2, cells subjected to LAD 
and steady flow showed no activation of NF-kB. However, NF-kB was 
activated when cells were stimulated with Tnf-𝛼.  
Inlet Inter R1 
and R2 
Inter R2 
and R3 
Inter R3 
and R4 
Inter R4 
and R5        
Outlet       
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8.3.2     CELLS STAINED FOR ICAM-1  
                  
Figure 8.3  Images showing expression of ICAM-1 (Red stain) and stained 
nucleus (Blue) in HUVECs after stimulation for 6 hours. Static culture  
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stimulation; positive control (Top row), stimulation with human recombinant 
Tnf-𝛼 at concentration of 200 units/ml under static control (2nd Row), 
combination of steady flow and hydrostatic pressure of 100mmHg (3rd Row), 
combination of LAD pulsatile flow and hydrostatic pressure of 120/80mmHg 
(4th Row). Scale bar (0 – 6) shows expression level of ICAM-1 with 0 being 
least or no expression of ICAM-1 and 6 being fully expressed ICAM-1. n = 1. 
Stimulation of HUVECs with human recombinant Tnf-𝛼 for 6 hours caused 
an increased level of ICAM-1 expression as shown in figure 8.3. However 
it is noticed that HUVECs exposed to both steady and LAD pulsatile flow 
exhibited selective expression of ICAM-1 in HUVECs for same time duration.  
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Figure 8.4  Images showing expression of ICAM-1 (Red stain) and stained 
nucleus (Blue) in HUVECs after stimulation for 12 hours. Static culture 
stimulation; positive control (Top row), stimulation with human recombinant 
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Tnf-𝛼 at concentration of 200 units/ml under static control (2nd row), 
combination of steady flow and hydrostatic pressure of 100mmHg (3rd row), 
combination of LAD pulsatile flow and hydrostatic pressure of 120/80mmHg 
(4th row). Scale bar (0 – 6) shows expression level of ICAM-1 with 0 being 
the least or no expression of ICAM-1 and 6 being fully expressed ICAM-1. n 
= 1. 
Stimulation of HUVECs with human recombinant Tnf-𝛼 for 12 hours caused 
an increased level of ICAM-1 expression in HUVECs as shown in figure 
8.4. However it is noticed that HUVECs exposed to both steady and LAD 
pulsatile flow exhibited selective expression of ICAM-1 in HUVECs for same 
time duration.  
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Figure 8.5  Images showing expression of ICAM-1 (Red stain) and stained 
nucleus (Blue) in HUVECs after stimulation for 24 hours. Static culture  
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stimulation; positive control (Top row), stimulation with human recombinant 
Tnf-𝛼 at concentration of 200 units/ml under static control (2nd row), 
combination of steady flow and hydrostatic pressure of 100mmHg (3rd row), 
combination of LAD pulsatile flow and hydrostatic pressure of 120/80mmHg 
(4th row). Scale bar (0 – 6) shows expression level of ICAM-1 with 0 being 
the least or no expression of ICAM-1 and 6 being fully expressed ICAM-1. n 
= 1. 
Stimulation of HUVECs with human recombinant Tnf-𝛼 for 24 hours 
showed increased levels of ICAM-1 expression in HUVECs as 
illustrated in figure 8.5. However it is noticed that HUVECs exposed to both 
steady and LAD pulsatile flow exhibited selective expression of ICAM-1 in 
HUVECs for same time duration.  
 
8.4        DISCUSSION  
 
ECs in the arterial vasculature are constantly being subjected to different 
combined stresses such as shear stress, cyclic strain and hydrostatic 
pressure. The effect of combined shear stress and hydrostatic pressure at 
physiological levels on HUVECs has been discussed to elicit marked 
changes of cell morphology; thus change in nuclear and actin cytoskeleton 
forms. Several studies have proposed that ECs predisposed to disturbed or 
low shear were more prone to atherogenesis [90, 413]. In most cases of 
arterial disease development, inflammation has been suggested to play a 
notable mediating role of disease [389, 445]. Many studies have reported low 
and disturbed shear induced NF-𝑘B to cause adhesion molecules and 
inflammatory cytokines to be upregulated [441, 446-448]. However, there are 
few studies which have considered the role of combined hydrostatic pressure 
and shear stress on the regulation of NF-𝑘B and subsequently on the 
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expression of NF-𝑘B dependent adhesion molecules.  
In vitro experiment presented in this chapter shows the activation of NF-𝑘B 
and expression of ICAM-1 in HUVECs exposed to combined stresses (i.e. 
steady shear stress and hydrostatic pressure of 100 mmHg; and LAD 
pulsatile shear stress and hydrostatic pressure of 120/80 mmHg). Due to the 
design of the experimental model, fluid stresses were characterised by 
unidirectional mean shear stress of 2 𝑃𝑎 and disturbed shear stress of 
approximately −2 𝑃𝑎 to 2.5 𝑃𝑎. Activation of NF-𝑘B as previously discussed 
is marked by the translocation of the 𝑝65 subunit NF-𝑘B from the cytoplasm 
into the nucleus. The reason why HUVECs were stimulated for 1 hour in the 
investigation of NF-𝑘B activation and no longer was that studies have 
reported ECs subjected to high shear stress to exhibit a biphasic response of 
NF-𝑘B [449, 450]. Thus, stimulation of ECs to high shear stress causes an 
initial increase of NF-𝑘B expression level followed by a steady decrease to a 
level at which NF-𝑘B cannot be detected. Lan et al. [450] reported maximum 
activation of 𝑝65 subunit NF-𝑘B  at 1 hour of BAECs being subjected to only 
shear stress of 1.2 𝑃𝑎  and then a decrease in activation thereafter. Based 
on the conclusion reached by Lan et al. [450], it was considered appropriate 
that the investigation of NF-𝑘B activation in HUVECs when subjected to the 
stipulated stresses be for a duration of 1 hour. Qualitative analysis of 
HUVECs exposed to these combined stresses for 1 hour showed no 
activation of NF-𝑘B as the nuclei of HUVECs appeared “black”. However, 
HUVECs stimulated with tnf-𝛼 for the same duration showed full activation of 
NF-𝑘B as the nuclei this time appeared “green” as shown in figure 8.2. This 
observation made however conflicts with that reported by Lan et al. [450] and 
more so with Nagel et al. [446] report which suggested disturbed shear to 
promote NF-𝑘B activation.  Reason to these differences in results could be 
due to the added stress; thus the hydrostatic pressure in our experiment. 
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We can draw some parallels of results on the effect of combined stresses on 
HUVECs in the activation of NF-𝑘B presented here to that of Nakadate et al. 
[316] studies on the effect of combined hydrostatic pressure and shear stress 
on ECs expression of adhesion molecules. In the study by Nakadate et al. 
[316], it was reported that cells subjected to combined stresses induced 
different gene expression compared to the genes expressed by the cells 
subjected to only individual stress. The report further concluded that not only 
does the type of stress and/or combined stresses applied to the cells have 
an effect on the type of gene expressed but also the magnitude of these 
stresses also account for the difference in the gene expressed. It should be 
noted however that results presented are of a singular experiment and thus 
should only be considered as an indication of the possible response of cells 
exposed to a combination of shear stress and hydrostatic pressure on NF-𝑘B 
activation. Further experiments are therefore needed to validate results. 
HUVECs exposed to the stipulated combined stress conditions for ICAM-1 
expression showed sporadic expression ICAM-1 at 6 hour, 12 hours and 24 
hours whilst HUVECs stimulated with tnf- 𝛼 showed maximum ICAM-1 
expressions at the same timescales as shown figures 8.3 – 8.5. Due to the 
experimental model design, there were regions where HUVECs were 
exposed to uniform shear and other regions they were exposed to ‘disturbed’ 
shear. Quantification of the levels of ICAM-1 expression of HUVECs exposed 
to uniform steady shear and uniform LAD pulsatile shear are shown in figure 
8.6. Also the level of ICAM-1 expression of HUVECs exposed to disturbed 
steady shear and disturbed LAD pulsatile shear are shown in figure 8.7.  
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Figure 8.6 Line graph showing ICAM-1 expression level of HUVECs 
stimulated under stipulated combined stresses and Tnf-alpha. SEM = 3 
images. n = 1.  
As shown in figure 8.6, HUVECs stimulated with tnf-alpha show high 
expression levels of ICAM-1 when compared to HUVECs stimulated under 
LAD pulsatile and steady flow. However, the level of ICAM-1 expressed by 
cells stimulated with tnf-alpha is seen to decrease with time. On the other 
hand, there is a gentle increase in the expression levels of ICAM-1 when 
cells were exposed to either steady or LAD pulsatile uniform stress from time 
6 hours to 12 hours and then decreased from 12 hours to 24 hours. 
 
Figure 8.7 Line graph showing ICAM-1 expression level of HUVECs 
stimulated under stipulated combined stresses and Tnf-alpha. SEM = 3 
images. n = 1. 
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As shown in figure 8.7, HUVECs exposed to disturbed steady and LAD 
pulsatile shear stress exhibit a time dependent ICAM-1 expression. 
Therefore, there is an increase in ICAM-1 expression of cells subjected to 
disturbed steady and LAD pulsatile shear stress from 6 to 12 hours and then 
a decrease in the level of ICAM-1 expression from 12 to 24 hours. On the 
other hand, HUVECs stimulated by tnf-alpha do exhibit generally a time 
dependent decrease of ICAM-1 expression levels. 
 
Quantitative analysis of ICAM-1 expression levels of HUVECs exposed to 
combined stress (i.e. steady shear stress and hydrostatic pressure of 100 
mmHg; and LAD pulsatile shear stress and hydrostatic pressure of 120/80 
mmHg) was performed by using the image toolbox in ImageJ to identify and 
count cells with ICAM-1 molecules stained as red. Whilst it is assumed that 
identification and count of ICAM-1 cells with ImageJ were accurate, it should 
be noted that form of analysis is operator dependent and therefore it is to be 
expected that results may be variable between operators. However, the 
human brain is very capable of recognising and interpreting images and thus 
it should be expected that analysis performed is sufficiently accurate. 
From the quantitative data shown in figures 8.6 and 8.7, the local ICAM-1 
expression levels are seen to increase up to 12 hours and then decrease 
until 24 hours when HUVECs are subjected to combined stress. This result is 
comparable to the results presented by Nakadate et al. [316] after exposing 
human aortic endothelial cells to combined stress of steady shear stress of 
1.5 𝑃𝑎 and hydrostatic pressure of 100 𝑚𝑚𝐻𝑔 and also pulsatile flow with a 
shear stress of 1.2/1.8 𝑃𝑎 and hydrostatic pressure of 120/80 𝑚𝑚𝐻𝑔. It is 
however suggested that to validate results further experimental analysis is 
needed. 
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8.5        CONCLUSION     
 
HUVECs were subjected to either a combination of shear stress and 
hydrostatic pressure conditions or stimulated with human recombinant Tnf-𝛼 
to investigate the effects of these stimuli on ICAM-1 and NF-𝑘B activation of 
the cells. It is observed that NF-𝑘B and ICAM-1 are fully activated when 
HUVECS is stimulated with Tnf-𝛼 as shown in figures 8.2 to 8.7. Taking into 
consideration the design and CFD analysis of our cell-structure 
interaction model, cells were predicted to experience either a uniform 
or ‘disturbed’ shear stress depending on the localisation of the cells 
within the model. It was therefore interesting to observe that regardless 
of the localisation of the cells within the model, cells subjected to combined 
shear and hydrostatic pressure (i.e. LAD pulsatile shear and 120/80 mmHg 
or steady shear and 100 mmHg) for a given duration showed no activation of 
NF-𝑘B. There was however a decreased level time-dependent selective 
expression of ICAM-1 when HUVECs were subjected to afore mentioned 
combined shear stress and hydrostatic pressure as shown in figures 8.6 and 
8.7. These data suggest that combination of shear stress and hydrostatic 
pressure may play significant role in genes that could be expressed in ECs.  
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CHAPTER  9 
 
CONCLUSIONS AND FUTURE WORK 
 
9.1        CONCLUSIONS        
 
This thesis sought to provide insights into the interrelation between physical 
forces arising in a stented arterial model and ECs response to elucidate the 
occurrence of restenosis within stented coronary artery. To achieve this 
purpose, the objectives as discussed in Chapter 1 were needed to be 
executed. Summarised below were the work done to achieve the following 
objectives of this thesis. 
1. Establishing appropriate rheological blood model to be used in CFD 
analysis of fluid dynamics within straight stented artery: To achieve 
this objective the three most commonly used rheological blood models 
were investigated (i.e. Newtonian model, Non-Newtonian Power Law 
model and Carreau model) as discussed in Chapter 3. Based on the 
specific geometrical dimensions of the stented model simulated, fluid 
dynamics analysis based on Newtonian model were seen to be >80% 
comparable to non-Newtonian blood dynamics based on Carreau 
model. It was thus suggested that analysing blood dynamics within a 
stented model using Newtonian fluid model in this case was 
acceptable. 
 
2. Establishing a computational model of a 2D cell-stent interaction 
design: This objective was to mimic an in vivo 2D stented artery and  
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consequently investigate the mechanical forces created within the 
local stented artery. The classic hemodynamic factors such as WSSs, 
OSIs, SWSSGs and TWSSGs proposed in many experimental (in vivo 
and in vitro) and computational studies to play critical roles in the 
development and progression of CADs were also considered in the 
investigation. As demonstrated in Chapter 6, the proximal and distal 
regions of the stented region were characterised with uniform shear 
and no shear gradients. However, within the stented regions were 
marked high shear gradients, disturbed WSSs and high OSIs. 
 
3. Develop a flow bioreactor system capable of applying physiologically 
relevant parameters and producing appropriate mechanical milieu 
within stented artery model: This objective was achieved as the flow 
system developed was able to produce physiologically realistic LAD 
pulsatile flow waveforms and also physiological hydrostatic pressure 
of 120/80 𝑚𝑚𝐻𝑔. As further elaborated in Chapter 4, data produced 
from the flow bioreactor system was comparable with that of analytical 
data. The design of the test section; thus the cell-interaction structure 
model, of the flow bioreactor system as discussed in depth in Chapter 
5, helped elicit the characteristic fluid flow dynamics experienced 
within a stented artery. Indeed, the application of the flow bioreactor 
system and the designed test section produced the WSSs, SWSSGs 
and OSIs illustrated in Chapter 6 at approximately physiological 
levels. Thus the CFD analysis performed in Chapter 6 was used to 
quantify the mechanical environment applied to the cells in the test 
section of the flow bioreactor system. More importantly, this flow 
bioreactor system was capable of maintain cells under sterile 
conditions. 
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4. Quantitatively analyse ECs morphological response to either 
combined or individual stress: As demonstrated in Chapter 7, ECs 
subjected to a specific type of stress resulted in a marked change in 
the morphology of cultured cells. HUVECs subjected to uniform shear 
stress elongated and aligned to flow direction whilst HUVECs 
subjected to varied shear stresses exhibited random orientation to 
flow direction. These morphological changes were then quantified 
using commercial image programming software called CellProfiler. 
Results of morphological cells response reported in this thesis were 
similar to that reported by other researchers undertaking similar 
experimental investigations.  
 
5. Investigate into shear-induced molecules expressed by the ECs: As 
discussed in Chapter 8, HUVECs exposed to shear stresses and 
hydrostatic pressures created within the cell-structure interaction 
model did not activate the inflammatory molecule NF-kB. However, 
ICAM-1 was selectively expressed in respect to stimulation duration. 
To the author’s knowledge there has been no investigation into the 
effects of cells exposed to a combination of shear stress and 
hydrostatic pressure on NF-kB activation.  
 
Based up on the above observations, the following conclusions were 
reached: 
1. The mechanical milieu within a stented artery is marked by varied 
WSSs, high SWSSGs and High OSIs due to flow disturbances at local 
site. WSS spikes are observed on top of stent struts whilst WSSs at 
the immediate regions of stent struts are very low.  
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2. There is a relationship between WSS, SWSSG and OSI present within 
stent struts regions. It was elucidated in chapter 6 that regions within 
stent struts which were predicted to experience flow separations were 
not only marked by high OSIs but both negative and positive WSSs 
and also high SWSSGs.  
 
3. HUVECs subjected to steady and LAD pulsatile shear stress although 
may show qualitatively very similar response to shear stress may be 
quantitatively different. As discussed in chapter 7, HUVECs subjected 
to increase LAD SWSSGs showed slight increase in cell density whilst 
those subjected to increase steady SWSSG exhibited a decrease in 
cell density for the same time duration. Plausible reasoning to this 
observation is that TWSSGs may induce cell proliferation. Thus as 
steady flow has no transient characteristics, the effect of TWSSG on 
cells may be minimal or non-existent. Also as discussed in chapter 7, 
HUVECs subjected to steady and LAD pulsatile flow all show cell 
elongation and alignment to flow direction. More so there were no 
statistical differences in the number of cells that aligned to flow 
direction depending on the type of shear stress the cells were 
subjected. However, as evidently shown in figures 7.14aii and 7.14aiii, 
steady flow induced more cells to align to the flow direction compared 
to LAD pulsatile flow. Hence the type of stress subjected to cells may 
have a more distinctive effect compared to the other.   
 
4. Most studies have focused on the individual stress effects of on ECs 
response albeit the effects of combined stress on ECs response more 
specifically on the type of genes being expressed could be different. It 
is thus proposed that investigations based on individual stress may 
not yield sufficient data to clarify clinical incidence of restenosis. 
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5.  The modular design of the flow bioreactor system allows for easy 
addition and/or alteration of components such as the test sections and 
pulsatile cams. Thus permits a wide range of investigations into 
different types of combined stresses that may be applied to cells.   
 
   
9.2        FUTURE WORK 
 
Results presented in this thesis has provided some insights into how semi-
circular struts dictate the fluid flow dynamics experienced on cells and how 
this stimuli influence cells response. It is however suggested that different 
strut designs may cause different fluid flow dynamics. Hence it is proposed 
that for future works, cells are subjected to different fluid flow dynamics 
dictated by the different stent strut designs and the cells response under 
each flow dynamics investigated to determine which strut design provides 
fluid dynamics more favourable to cells physiological behaviour.   
It was also realised that combined stress and individual stress may influence 
differently the type of genes that are expressed. Hence future work may 
involve the investigation of various genes and signalling molecules that may 
be induced by different types of stress. 
As previously stated the modular design of the flow bioreactor system allows 
for addition of other enabling technologies. It is therefore envisaged that a 
video camera could be incorporated to the bioreactor system so as to 
capture in real-time how cells respond to specific mechanical stimuli.      
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APPENDIX A      
 
This appendix contains stimulated HUVECs stained for ICAM-1 expressions 
and also showing the stained cytoskeleton of the cell. 
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Figure 1  Images showing expression of ICAM-1 (Red stain), stained nucleus 
(Blue) and stained cytoskeleton (Green) in HUVECs after stimulation for 6 
hours. Static culture stimulation; positive control (Top row), stimulation with 
human recombinant Tnf-𝛼 at concentration of 200 units/ml under static 
control (2nd row), combination of steady flow and hydrostatic pressure of 
100mmHg (3rd row), combination of LAD pulsatile flow and hydrostatic 
pressure of 120/80mmHg (4th Row).  
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Figure 2  Images showing expression of ICAM-1 (Red stain), stained nucleus 
(Blue) and stained cytoskeleton (Green) in HUVECs after stimulation for 12 
hours. Static culture stimulation; positive control (Top row), stimulation with 
human recombinant Tnf-𝛼 at concentration of 200 units/ml under static 
control (2nd row), steady flow and pressure of 100mmHg (3rd row), LAD flow 
and pressure of 120/80mmHg (4th row). 
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Figure 3  Images showing expression of ICAM-1 (Red stain), stained nucleus 
(Blue) and stained cytoskeleton (Green) in HUVECs after stimulation for 24 
hours. Static culture stimulation; positive control (Top row), stimulation with 
human recombinant Tnf-𝛼 at concentration of 200 units/ml under static 
control (2nd row), steady flow and pressure of 100mmHg (3rd row), LAD flow 
and pressure of 120/80mmHg (4th Row). 
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